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1 INTRODUCTION 
Nowadays, we witness of impressive development of medical sciences that allow 
saving patients from life threatening diseases. However, at the same time the number of 
immunocompromised patients is growing. Patients of this group very often become infected 
with invasive or opportunistic fungi. Unfortunately, physicians have at their disposal only few 
antifungal drugs, which are at the same time harmful to the patients’ health. Moreover, some 
fungal isolatesfrom the very specific environment of the hospital ward acquire resistance to 
the drugs used there. Therefore, an urgent demand exists for the discovery of novel antifungal 
drugs. For these reasons, many scientific teams are working hard studying fungal biology with 
the aim of revealing mechanisms which could be targeted by new antifungal drugs or which 
could explain the resistance to those already in use. 
The majority of the presently available antifungal drugs (azoles, thiocarbamates and 
morpholines) target ergosterol biosynthesis, a branch of the isoprenoid pathway. Ergosterol in 
yeast is the equivalent of cholesterol synthesized in human, a critical health risk factor. Thus, 
the signal transduction involved in the regulation of both molecules, in yeast as well as in 
mammals, is of considerable interest. A second group of antifungal drugs target the fungal 
cell wall and are represented by echinochandins and papulacandins. For pathogenic fungi, the 
cell wall is the first point of interaction with the host. More importantly, it is essential for the 
fungus survival and morphogenesis while human cells do not possess this structure. For this 
reason, the fungal cell wall has been recognized as an attractive and safe target for antifungal 
drug development.  
In this work, we affected, either pharmacologically or genetically, the cell wall 
integrity and the isoprenoid pathways, in an attempt to elucidate the mechanisms involved in 
the cell’s response to stress conditions. For the experiments we chose the yeast 
Saccharomyces cerevisiae that is considered a good model to study fungal cell wall as well as 
the isoprenoid pathway. Most of the proteins and regulation features known so far are 
conserved between S. cerevisiae and pathogenic yeast, especially Candida albicans, one of 
the wide spread cause of fungal infections. Importantly, also yeast and mammalian cells are 
very similar in the arrangement and the regulation of the isoprenoid pathway. 
   2
 Aim of the work 
In this work, we focused our interest on the two pathways that are important for the 
survival of fungi treated with antifungal drugs, i.e. the cell wall assembly and isoprenoid 
biosynthesis. We examined the basic processes that are initiated while the cell struggles 
survival. Thus, the results obtained in this work may become useful in the future, in the 
attempts to design novel antifungal drugs.  
In order to investigate the cellular response of yeast to an impairment of the cell wall, 
we disturbed the cell wall assembly using drugs that have distinct modes of action. Firstly, we 
treated cells with Papulacandin B, an inhibitor of the enzyme that synthesizes glucan which is 
one of the main components of the cell wall. Secondly, we treated cells with Congo red and 
Calcofluor white, compounds that do not inhibit enzymatic activities but bind directly to the 
fibrillar components of the cell wall, which causes weakening of the whole structure. Thirdly, 
we investigated caffeine, a supposed cell wall drug of unknown molecular function. 
Regarding the isoprenoid pathway, our goal was to investigate the response of the cells to 
chemical compounds that similarly to antifungal drugs inhibit this pathway. 
 
The specific aims of the work were: 
o Characterization of the yeast transcriptome response to the cell wall damage 
o Investigation of the changes in the cell wall structure induced by the cell wall 
impairment and identification of the transcription factors involved 
o Verification of caffeine action against the cell wall and identification of its cellular 
targets 
o Characterization of the yeast transcriptome response to the isoprenoid pathway 
inhibitors that have opposing effects on the cellular availability of farnesyl diphosphate, a 
crucial molecule of this pathway 
o Identification of genes that could potentially be regulated by changing the availability 
of farnesyl diphosphate 
o Further investigation of the function of a representative gene belonging to the group of 
those potentially regulated by farnesyl diphosphate or its derivatives 
 
   3
Yeast cell wall 
 
1.1 YEAST CELL WALL 
 
1.1.1 Characteristics of the fungal cell wall 
The cell wall, despite its rigid appearance, is a highly dynamic structure adapting to 
changing environmental conditions. The yeast cell during its life increases in size and buds, 
thus changing its shape constantly. Moreover, during growth, the cell wall can adapt to a 
limited space, which was elegantly shown by obtaining cubic yeast cells (Suzuki et al., 2004a) 
(Figure 1). Modification of the cell wall shape can also occur more rapidly due to changes in 
the osmotic pressure of the environment. The yeast cell can shrink by up to 50% of its volume 
and this change of the shape is reversible, which illustrates the great elasticity of the cell wall. 
This elasticity could also explain why the cell wall of live cells is permeable for molecules 
larger than 760 Da, the mass that was established during studies on the isolated cell wall 
(Scherrer et al., 1974). Remarkably, it has been shown that the yeast cell wall exhibits local 
periodic nanomechanical motion depending on the temperature and ATP production (Pelling 
et al., 2004). However, the reason for the occurrence of these motions remains completely 
unexplained. Importantly, the cell wall not only changes its shape but also its composition and 
the present work is focused on these changes that occur in response to cell wall damaging 
drugs. 
Figure 1: The shape of the cell wall is 
constantly changing during growth.  
G1 S G2 M
A. B.
A. Main stages of the yeast cell cycle 
illustrating changes of the cell shape. 
B. Upper panel shows a yeast cell with 
altered shape, which was placed in a 
cubic hole and grown for 4 h. The 
lower panel shows an elliptical cell 
grown on the surface of a silicon wafer 
for 4 h (Suzuki et al., 2004a). 
 
Electron microscopy shows that the cell wall is a layered structure. As indicated in 
Figure 2, this structure consists of an electron-transparent inner layer mainly built of β-1,3-
glucan, β-1,6-glucan and chitin, and an electron-dense outer layer built of heavily 
glycosylated mannoproteins. While the inner layer gives the wall mechanical strength, the 
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outer layer is involved in cell-cell recognition and limits the permeability; together, the two 
layers provide physical protection and osmotic support to the cell (Smith et al., 2000). 
 
plasma membrane
chitin
β1,3-glucan
β1,6-glucan
cell wall proteins
cytoplasm
A. B.
Figure 2: Outline of the yeast cell wall structure. 
A. Budding cell of S. cerevisiae. Electron-transparent inner layer and electron-dense outer layer are visible (from 
(De Groot et al., 2005)). B. Model of the cell wall structure (adapted from (Smits et al., 1999)). The outer layer 
of proteins and the inner layer containing a network of carbohydrate polymers: β1,6-glucan, β1,3-glucan and 
chitin are indicated. 
 
Characteristics of the cell wall constituents are summarized in Table 1 below. The 
mechanical strength of the cell wall and the above mentioned elasticity are mainly due to β-
1,3-glucan consisting of approximately 1500 glucose monomers and representing 
approximately 50-55% of the dry weight of the cell wall. β-1,3-glucan chain forms a helix 
which can exist in different states of extension, explaining the elasticity of the structure 
formed. β-1,3-glucan is synthesized as a linear chain but the mature form contains 3-4% of β-
1,6-linked glucose residues. This fact suggests the existence of additional processing enzymes 
rearranging the newly synthesized chains and integrating them into the existing wall. Proteins 
like Gas1p, Bgl2p and Crh1p are likely involved in these processes but their function in vivo 
is not well understood. Fraction of β-1,3-glucan is partially crystalline but the moderate 
branching of the mature chain prevents extensive crystallization.  
Approximately 5 to 10% of the cell wall consists of a highly branched water-soluble 
polymer, β-1,6-glucan, built of about 130 glucose monomers. Although several genes have 
been identified to be involved in the biosynthesis of β-1,6-glucan (for a review see (Shahinian 
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and Bussey, 2000)), the mechanism of its synthesis remains largely unknown. The main 
function of this polymer in vivo is to enable connection of GPI- dependent cell wall proteins 
to the β-1,3-glucan network but it may also serve as an acceptor site for chitin. 
Another constituent of the cell wall accounting only for 1-2% of the wall dry mass is 
chitin concentrated mainly in achitin ring and in the bud scars. In some exceptional situations, 
when the cell wall is weakened, synthesis of chitin is activated and then it can reach even 20% 
of the wall dry mass (Molano et al., 1980). This linear polymer is built of about 190 N-
acetylglucosamine monomers and in S. cerevisiae it is synthesized by three tightly regulated 
chitin synthases (Cabib et al., 2001).  
 
Table 1: Cell wall composition in the yeast Saccharomyces cerevisiae (from (Klis et al., 2002)) 
Macromolecule Wall dry weight (%) Site of synthesis Branching  
Mannoproteins 35-40 Secretory pathway Highly branched 
β-1,6-glucan 5-10 (Plasma membrane) Highly branched 
β-1,3-glucan 50-55 Plasma membrane Moderately branched 
Chitin 1-2 Plasma membrane Linear 
 
The outer protein layer accounts for about 40% of the wall dry mass. Proteins are 
covalently linked directly to the β-1,3-glucan-chitin network or indirectly through the β-1,6-
glucan moieties. Cell wall proteins (CWPs) are so heavily glycosylated that their 
carbohydrate fraction can amount to over 90% of their mass. Usually, highly branched 
carbohydrate side chains are linked to asparagine residues, whereas short oligomannosyl 
chains are linked to the residues of serine and threonine. While the general function of the 
CWPs is limiting the cell wall permeability, the functions of particular proteins are often 
unknown. In general, CWPs are involved in processes such as mating, flocculation, biofilm 
formation, invasive growth, sporulation and the stationary phase of growth, response to low 
temperature and anaerobic growth (for a review see (Klis et al., 2002)).  
Depending on the attachment to the cell wall constituents, CWPs can be divided into 
two groups, i.e. GPI-CWPs and Pir-CWPs. The first group of proteins are modified in the 
endoplasmic reticulum (ER) by addition of a glycosylphosphatidylinositol (GPI) anchor. This 
modification is required for trafficking of the protein to the plasma membrane. Then, 
depending on the sequence of the protein it will remain in the plasma membrane or will be 
liberated and linked to β-1,6-glucan through a remnant of the GPI anchor. In yeast, the 
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existence of approximately 60 GPI-CWPs has been predicted (Caro et al., 1997). The second 
group contains Pir proteins (Pir-CWPs) that are probably directly linked to β-1,3-glucan 
through an alkali-sensitive linkage. In S. cerevisiae four such proteins have been found, Pir1p, 
Pir2p/Hsp150p, Pir3p and Pir4p/Cis3p being involved in wall strengthening (Toh-e A et al., 
1993). Additionally, some cell wall proteins like sexual agglutinin Aga2p or protease Bar1p 
might retain their cell wall localization through disulfide bonds with other proteins.  
 
 
1.1.2 Cell wall biosynthesis and organization 
 
1.1.2.1 Basic regulation of cell-wall polymer biosynthesis 
In general, expression of CWP-encoding genes increases during bud formation, 
separation of the daughter cell and while mating projections are being formed, i.e. when the 
cell wall has to change its shape or structure (for a review see (Smits et al., 1999)). 
Consequently, expression of the cell wall genes is regulated by the cell cycle, nutrient 
availability and environmental conditions. Transcript levels of some genes encoding CWPs 
change upon respiratory growth or in the stationary phase. Some genes like DAN1, TIP1 and 
TIR1 are specifically induced under hypoxic conditions. Some others like FLO11 and PIR2 
increase transcription during pseudohyphal growth.  
From studies of genetic cell wall defects, it was concluded that lowered level of β-1,3-
glucan caused an increase of chitin content in lateral walls and increased the amount of GPI-
CWPs bound through β-1,6-glucan to chitin (Dallies et al., 1998; Garcia-Rodriguez et al., 
2000b; Ram et al., 1998). Reduced level of β-1,6-glucan resulted in an increased amount of 
Pir-CWPs, β-1,3-glucan and chitin in the cell wall but also in the release of the GPI-CWPs 
into the medium (Kapteyn et al., 1999; Lu et al., 1995). Furthermore, defects in glycosylation 
caused an increase in chitin level (Kapteyn et al., 1999). 
As we mentioned before, the major filamentous component of the cell wall, 
responsible for its rigidity, is β-1,3-glucan synthesized by β-1,3-glucan synthase. This 
enzyme is localized to the plasma membrane together with cortical actin patches allowing its 
translocation directly to the sites of the cell wall remodeling (Utsugi et al., 2002). There are 
two alternative catalytic subunits of glucan synthase, which are encoded by the FKS1 and 
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FKS2/GSC2 genes and one regulatory subunit, Rho1p. The small GTPase Rho1p plays an 
essential role in the control of the cell wall synthesis, as in its active GTP-bound form it binds 
and activates Fks1p (Drgonova et al., 1996).  
The expression of FKS1 predominates in the optimal growth conditions and is cell-
cycle regulated (Mazur et al., 1995; Ram et al., 1995) while FKS2 is induced by mating 
pheromone, high extracellular Ca2+ concentration, in the fks1∆ mutant or in the stationary 
phase of growth.  
Regarding β-1,6-glucan, which is the crucial component of the cell wall 
interconnecting all other components (Kollar et al., 1997), a gene coding for a putative β-1,6-
glucan synthase has not been found. However, several genes were identified to be involved 
in the biosynthesis of this component, since their deletion caused a decrease in β-1,6-glucan 
and subsequent resistance to K1 killer toxin (for a review see (Bussey et al., 1990)). These 
genes were named KRE for killer toxin resistant (for a review see (Shahinian and Bussey, 
2000)).  
In S. cerevisiae, three chitin synthases are known Chs1p, Chs2p and Chs3p. They 
have the same polymerizing activity but deposit chitin at different times during the cell cycle 
and at different locations. Chs1p acts at the end of the cytokinesis to deposit chitin to the birth 
scar on the daughter cell. Chs2p synthesizes chitin in the primary septum. The majority of 
chitin is synthesized by Chs3p, which is localized to the ring at the base of the emerging bud 
and also to a lesser extent in the lateral walls (for a review see (Henar et al., 1999)). 
Expression of CHS3 is not regulated by the cell cycle (Choi et al., 1994). In the steady state, 
Chs3p is localized to the internal stores called chitosomes, but under stress conditions, it is 
shifted to the plasma membrane where the biosynthesis occurs (Valdivia and Schekman, 
2003). This redistribution is very rapid and requires the G protein Rho1p and protein kinase 
Pkc1p. The enzymatic activity and trafficking through the ER to the plasma membrane is 
regulated by several proteins – Chs4p/Skt5p, Chs5p, Chs6p and Chs7p. Chs4p is crucial for 
Chs3p binding to the septin ring in the bud-neck region. Chs5p and Chs6p are involved in the 
transport of chitosomes to the plasma membrane (Santos et al., 1997; Ziman et al., 1998). 
Chs7p plays a role in the exit of Chs3p from the ER (Trilla et al., 1999). 
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1.1.2.2 Guardians of the cell wall integrity 
 
1.1.2.2.1 Cell wall integrity (CWI) pathway 
In this chapter we describe the defensive mechanisms of the yeast cell allowing 
reinforcement of the cell wall. Indisputably, the cell wall integrity pathway (CWI) is so far the 
best characterized pathway permitting changes of the cell wall structure in response to a vast 
spectrum of events that a cell might encounter during its life. These events include high 
temperature (Kamada et al., 1995), hypotonic shock (Davenport et al., 1995), impairment of 
the cell wall synthesis (Ketela et al., 1999; Lagorce et al., 2003), exposure to cell wall binding 
agents such as Calcofluor white and Congo red (Garcia et al., 2004; Martin et al., 2000) as 
well as a response to rapamycin, an antibiotic that inhibits the TOR pathway (Torres et al., 
2002). Depending on the source and the type of the stimulus, the CWI pathway can be 
activated at the ‘top’, through cell surface sensors, or laterally by activating one of the kinases 
eventually activating a mitogen activated protein (MAP) kinase, Mpk1p (Harrison et al., 
2004).  
As shown in Figure 3 below, the main activators of this pathway (Wsc1p, Wsc2p, 
Wsc3p and Mid2p) are integral plasma membrane proteins with heavily O-mannosylated 
extracellular domains (Ketela et al., 1999; Lodder et al., 1999). These proteins, upon stress of 
the cell wall, are able to activate a MAP kinase cascade (Pkc1p-Mpk1p) through Rom2p 
(Philip and Levin, 2001) and Rho1p, a small G-protein. Rho1p is active in its GTP-bound 
form and inactive in the GDP-bound form. Thus, both GTPase activating proteins (GAPs) and 
guanosine nucleotide exchange factors (GEFs) can regulate its action. Nevertheless, the main 
regulator of Rho1p, regarding response to the cell wall stress, is the Rom2 GEF (Ozaki et al., 
1996). Rom2p can bind phosphatydylinositol-4,5-bisphosphate which allows its proper 
localization to the plasma membrane, where it can interact with the Wsc1 and Mid2 proteins 
can the bind inactive form of Rho1p in order to activate it. Four known GAPs, Bem2p, Sac7p, 
Bag7p and Lrg1p, seem to inactivate Rho1p in a target-specific manner. Thus, Lrg1p is 
involved in controlling Rho1p function concerning glucan synthase activity, Bem2p and 
Sac7p affect the MAP kinase cascade, while Bag7p is rather devoted to the control of the 
actin cytoskeleton.  
When active, Rho1p activates in turn a linear MAP kinase cascade comprised of 
Pkc1p, Bck1p, two redundant Mkk1p and Mkk2p, and Mpk1/Slt2p. Loss of function of any of 
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the kinases below Pkc1p causes cell lysis at an elevated growth temperature. This effect can 
be prevented by osmotic protection, e.g. supplementation with 1 M sorbitol. Loss of the 
Pkc1p function causes lysis at any temperature and this effect is also osmoremedial. A few 
other phenotypes like sensitivity to Congo red, Calcofluor white or caffeine are typically 
associated with the MAP kinase cascade mutants (for an extensive review on CWI see (Levin, 
2005)).  
 
Figure 3: CWI in Saccharomyces cerevisiae. 
The sensors of the cell wall damage located in the plasma 
membrane (Wsc1-3p, Mid2p) pass the signal through the 
Rom1/2 proteins to Rho1p, which in turn activates the Pkc1p-
dependent cascade of MAP kinases (Bck1p, Mkk1/2p). The 
Mpk1 kinase activates its main targets, the Swi4p and Rlm1p 
transcription factors that activate expression of the cell wall 
genes. Arrows indicate activation of signaling, and bars 
indicate repression (adapted from (Levin, 2005)). 
 
The main known output of the MAP kinase 
cascade is the activation of the SBF (Swi4/Swi6p) 
and Rlm1p transcription factors, which control, 
respectively, the expression of cell-cycle regulated 
genes at the G1/S transition (Madden et al., 1997) 
and the cell wall-related genes (Jung and Levin, 
1999). However, SBF has also been reported to 
control expression of several cell wall genes. This 
transcription factor is comprised of two proteins, 
Swi6p and Swi4p, of which the latter is activated by 
Mpk1 kinase in order to induce expression of the 
cell wall genes (Andrews and Herskowitz, 1989; 
Madden et al., 1997). These genes are involved in 
different aspects of the cell wall biosynthesis that is coordinated with the cell cycle (β-1,3-
glucan: FKS1, GAS1; β-1,6-glucan: KRE6; mannoproteins: MNN1, VAN2; and chitin: CHS3) 
(Igual et al., 1996). In addition, Swi4p was proposed to activate the GSC2 gene during a cell 
wall stress (Levin, 2005). Consistently, it was reported that cells deleted for SWI4 were 
hypersensitive to Calcofluor white and sodium dodecyl sulfate, which suggests weakened cell 
wall.  
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1.1.2.2.2 An involvement of the TOR pathway in the cell wall organization 
The TOR pathway is the major controller of growth and proliferation in eukaryotic 
cells. TOR kinases were discovered in yeast in a search of molecular targets of the 
immunosuppressive and anticancer drug rapamycin (TOR- target of rapamycin) (Heitman et 
al., 1991). This drug forms a complex with a conserved immunophilin, FKBP12 (FPR1-
encoded in S. cerevisiae), which binds and inhibits Tor kinase. Yeast, having two homologous 
genes, TOR1 and TOR2, are an exception among eukaryotes which have only one TOR gene. 
However, all eukaryotic organisms have two protein complexes TORC1 and TORC2 which 
are composed of distinct protein partners, and this organization is conserved also in yeast 
(TORC1: Tor1p or Tor2p, Lst8p, Kog1p and Tco89p; TORC2: Tor2p, Lst8p, Avo1/3p and 
Bit61p (Reinke et al., 2004)). As shown in Figure 4, the two yeast TOR proteins have a 
redundant function in the ‘temporal’ control of cell growth by regulating translation, 
transcription, ribosome biogenesis, nutrient transport and autophagy in response to nutrient 
availability (for a review see (Martin and Hall, 2005)). In addition, TOR2 uniquely has a 
rapamycin-insensitive function in the ‘spatial’ control of cell growth by regulating the cell-
cycle-dependent polarization of the actin cytoskeleton. This ‘spatial’ control of the cell 
growth by TORC2 is mediated by Rho1 GTPase and Pkc1 kinase (Helliwell et al., 1998b). 
Thus, Tor2p is able to perform all essential functions of Tor1p but Tor1p cannot perform all 
essential functions of Tor2p. This is reflected also in the fact that only deletion of TOR2 is 
lethal. 
Although TOR kinases are members of the protein family containing 
phosphatidylinositol 3-kinase (PI3K) related kinases (other yeast members: Tel1p, Mec1p and 
Rad53p), their lipid kinase activity has never been shown. On the other hand, both 
mammalian and yeast TOR kinases posses a Ser/Thr protein kinase activity. The role of the 
yeast TOR kinases has been extensively studied (for a review see (Crespo and Hall, 2002)) 
and it was reported to control the cell growth in response to nutrient signals. Under favorable 
nutrient conditions, TOR maintains some starvation-specific transcription factors (Gat1p, 
Gln3p, Msn2/4p, Rtg1/3p) in the cytoplasm where they are inactive. Upon starvation TOR is 
inactivated and the transcription factors can enter the nucleus where they induce transcription 
of specific genes. For instance, when TOR is inhibited by rapamycin or by nitrogen 
starvation, a heterodimeric transcription factor composed of Rtg1p and Rtg3p is immediately 
accumulated in the nucleus and activates transcription of TCA cycle and glyoxylate cycle 
genes (Komeili et al., 2000). Further, the expression of nitrogen responsive genes is regulated 
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by two GATA transcription factors, Gat1p and Gln3p. When TOR is active, Gln3p is in 
phosphorylated form and is retained in the cytosol by Ure2p. Probably, Ure2p also regulates 
Gat1p but a direct interaction has not been shown (Beck and Hall, 1999). The other proteins 
regulated by TOR are two redundant Zn2+ finger transcription factors, Msn2p and Msn4p. 
Active TOR promotes formation of the complex of Msn2p and Msn4p with cytoplasmic 14-3-
3 proteins Bmh1p and Bmh2p preventing their entrance into the nucleus (Beck and Hall, 
1999; Bertram et al., 1998). The stress response controlled by TOR includes also regulation of 
tRNA, rRNA and r-protein genes (Zaragoza et al., 1998). Moreover, it has been shown that 
repression of polymerase III transcription upon depletion of TOR kinases occurs via Maf1p 
(Pluta et al., 2001; Upadhya et al., 2002).  
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Figure 4: The TOR pathway in Saccharomyces cerevisiae. 
In the presence of nutrients, the TORC1 and TORC2 complexes promote cell growth and proliferation. In the 
figure, functions shared by two complexes are shown and TORC2-specific functions such as G1 phase 
progression and cytoskeleton organization. The functions of TORC1 as well as TORC2 are inhibited by 
rapamycin except for cytoskeleton organization. Protein components of TORC1 or TORC2 are listed. 
 
Recently, the TOR pathway has been implicated also in the regulation of the cell wall 
integrity, in particular the Pkc1p-Mpk1p signaling cascade. Torres and co-workers showed 
that Mpk1p was rapidly activated when TOR was inactivated by rapamycin or when cells 
entered stationary phase (Torres et al., 2002). Those authors proposed that TOR function 
could maintain the signal(s) that prevent the cell integrity pathway from being activated when 
cells grow under favorable nutrient conditions. Interestingly, another study showed that 
rapamycin-induced depletion of TOR caused remodeling of the cell wall that was dependent 
on Pkc1p but independent of Mpk1p (Krause and Gray, 2002). Further, some groups reported 
cell wall defects associated with particular TOR complexes. Regarding TORC2, it has been 
shown that a temperature-sensitive ts of AVO3 exhibited cell wall defects and caffeine 
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sensitivity (Ho et al., 2005). In another report, a connection between Tor2p and Rom2p has 
been established. However, this link concerned only regulation of the actin cytoskeleton 
through the components of the CWI pathway, Rom2p and Rho1p, while effects on the cell 
wall integrity were not tested in that case. Recently, Powers and co-workers described cell 
wall-related phenotypes of the tor1∆ and tco89∆ mutants (Reinke et al., 2004). Additionally, 
they identified an SSD1-mediated cell integrity pathway as partially alleviating these 
phenotypes. Importantly, the observed cell integrity phenotypes were not rescued by 
additional copies of PKC1 or MPK1. Overall, depletion of TOR causes remodeling of the cell 
wall but the exact way of signaling from TOR to the cell wall remains largely 
uncharacterized.  
 
 
1.1.2.2.3 An involvement of the cAMP signaling cascade in cell wall organization 
The Ras/cAMP pathway, similarly to the TOR pathway, is responsible for the control 
of growth in response to nutrients and mediates global stress response. As shown in Figure 5, 
an increased level of cAMP in the cell activates protein kinase A (PKA), which regulates 
transcription of numerous genes. PKA holoenzyme is a heterotetramer composed of two 
regulatory and two catalytic subunits (Toda et al., 1987a; Toda et al., 1987b). Binding of 
cAMP to the regulatory subunits of PKA results in the releasing of the catalytic subunits and 
in their activation. cAMP is biosynthesized by CYR1-encoded adenylate cyclase. There are 
two major ways to activate this enzyme (for a review see (Thevelein and de Winde, 1999)). 
The first is mediated through Ras2 GTPase. To make this activation possible, Ras2p has to be 
modified and translocated to the plasma membrane with the help of Erf2p. The second way to 
activate adenylate cyclase goes via Gpr1p receptor and Gpa2 G-protein that activates 
adenylate cyclase in response to high glucose or low nitrogen. Another protein, Plc1p, enables 
a physical interaction between these two proteins (Ansari et al., 1999). Recently, it has been 
proposed that the Ras/cAMP pathway is also under control of TOR kinases. The subcellular 
localization of PKA catalytic subunit, Tpk1p, depends on TOR kinases (Schmelzle et al., 
2004). When TOR and/or PKA are inactivated, cells exhibit similar effects like the G1 cell 
cycle arrest, accumulation of storage carbohydrates (trehalose, glycogen) and enter the 
stationary phase of growth, which is accompanied by reinforcement of the cell wall structure. 
The entrance into the stationary phase of growth requires Rim15p. In the presence of 
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nutrients, Rim15p is inhibited by PKA-mediated phosphorylation and, additionally, TOR 
prevents its nuclear localization (Pedruzzi et al., 2003). However, Rim15p is not the only 
protein known to be regulated by both Ras/cAMP and TOR pathways, since it is also the case 
of the Msn2/4p transcription factor (Beck and Hall, 1999; Boy-Marcotte et al., 1998; Gorner 
et al., 1998). The exact mechanism of Msn2/4p repression by PKA is not known, although 
these proteins link functionally the Ras/cAMP signaling to the cell wall integrity. Lagorce and 
co-workers have shown that Msn2/4p contributes to the response of yeast cells to the cell wall 
impairment (Lagorce et al., 2003). In that study, a cluster comprising 79 genes that were 
induced in the cell wall mutants was identified. Fifty-seven percent of those genes contained 
in their promoter regions the STRE element that is a binding site for Msn2p and Msn4p 
transcription factors. 
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Figure 5: Activation of the cAMP signaling cascade. 
The common action of Gpr1p receptor, Plc1p and Gpa2 G protein activates adenylate cyclase (Cyr1p). Gpa2p 
can be inactivated by GAP Rgs2p. Another way to induce cAMP biosynthesis goes through the Ras signaling. 
Ras2p is anchored to the plasma membrane via palmitoyl moiety (red triangle). GEF Cdc25p promotes an active 
state of Ras2p while GAPs, Ira1p and Ira2p, inactivate this protein. The intracellular concentration of cAMP can 
be reduced by the action of the Pde1 and Pde2 cAMP phosphodiesterases. A complex of protein kinase A (PKA) 
comprises two regulatory subunits (Bcy1p) and two catalytic subunits (Tpk1p, Tpk2p or Tpk3p). cAMP binds 
PKA regulatory subunits which leads to dissociation of the complex and activation of the catalytic subunits. 
 
Another link between the Ras/cAMP pathway and the cell wall integrity is the fact that 
PKA is a negative regulator of Crz1p transcription factor (Kafadar and Cyert, 2004). Crz1p is 
required for the induction of the GSC2/FKS2-encoded glucan synthase’s expression but only 
in some particular conditions like response to mating pheromone, high concentration of CaCl2 
or loss of FKS1 function (Zhao et al., 1998). While PKA phosphorylates Crz1p and 
negatively regulates its import to the nucleus, calcineurin, a protein phosphatases, promotes 
nuclear localization of Crz1p where it is active. Calcineurin is activated by an increased level 
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of Ca2+ in the cell. Probably, when the cell wall structure is weakened, an increased plasma 
membrane tension activates mechanosensitive channels and intracellular concentration of 
Ca2+ is elevated.  
To summarize, the cell wall integrity can be affected also by Msn2/4p and Crz1p 
transcription factors, which are both regulated by the Ras/cAMP pathway.  
 
 
1.1.3 Cell wall drugs - Papulacandin B, Congo red, Calcofluor white and Caffeine 
In order to study cell wall defects, two approaches -‘genetic’ and ‘chemical’- are often 
in use. The genetic approach is based on studies of cell wall defects in mutants impaired in the 
cell wall functions. This method is limited in the sense that weakening of the cell wall caused 
by deletion of a given gene results in various reinforcing reactions which at the same time 
depend on the particular defect. In other words, for instance, many mutations can cause a 
decrease in β-1,3-glucan level but the response of the cell will depend not only on the fact that 
the level of β-1,3-glucan is decreased but also on the particular mutation which permits or not 
a proper cellular response. The chemical approach uses various chemicals to disturb the cell 
wall structure. An obvious limitation of this method is the fact that usually the exact 
mechanism of action of a given agent is not known and we cannot exclude activation of some 
additional cellular processes that are not implicated in cell wall biosynthesis. In this work, we 
investigated the action of four drugs affecting the cell wall, however, in some cases, we 
observed transcriptional effects which could not be simply explained by impairement of the 
cell wall structure. 
 
 
1.1.3.1 Papulacandin B 
In this study, we focused our interest on Papulacandin B, a lipophilic antifungal 
antibiotic synthesized in nature by the fungus Papularia spaerosperma. Structurally, 
Papulacandin B is a glycolipid, which consists of a modified disaccharide linked to two fatty-
acyl chains (see structure in Figure A 1, pg 157) (Traxler et al., 1977). This compound is 
known mainly for its inhibitory effect on β-1,3-glucan synthase (Baguley et al., 1979; 
Kopecka, 1984b) but it was shown to inhibit also other plasma membrane enzymes like ATP 
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synthase, adenylate cyclase and 3’,5’-cyclic phosphodiesterase (Surarit and Shepherd, 1987). 
Papulacandin B in yeast causes a transition of the polar growth into spherical one and the cell 
walls become apparently fragile and amorphous. Dividing cells fail to separate properly and at 
a higher concentration of the antibiotic (8-32 µg/ml) perforations in the cell wall occur, 
leading to cell lysis. These perforations are the most frequent at the basis of the bud or at its 
apex and eventually the cell proliferation is stopped (Komiyama et al., 2002; Kopecka, 
1984a). Mutations in 22 genes caused hypersensitivity to Papulacandin B but, surprisingly, no 
correlation was found with changed levels of glucose, mannose or glucosamine (Lussier et al., 
1997; Ram et al., 1994) leading to the conclusion that Papulacandin B- hypersensitivity was 
not specific to the cell wall mutants. In order to learn the molecular mechanisms which drive 
the cellular effects mentioned above we decided to analyze the transcriptional response of 
yeast cells to Papulacandin B. 
 
 
1.1.3.2 Congo red and Calcofluor white 
Here, we describe two compounds, Congo red and Calcofluor white, which exert their 
effects through a similar mechanism leading to the loss of the cell wall integrity. Both 
compounds induce phosphorylation of Mpk1p, an effect that is mediated by the Mid2p sensor, 
and can be diminished by 1 M sorbitol. Remodeling of the cell wall in response to these 
agents is dependent on Mpk1 kinase (de Nobel et al., 2000). 
Congo red (CR) is a dye known to interfere with the glucan network, which results in 
the loss of the cell wall rigidity (see structure in Figure A 1, pg 157) (Kopecka and Gabriel, 
1992). Nevertheless, it was also suggested that it could bind chitin (Raclavsky et al., 1999). A 
model was proposed in which CR binds the helical chains of β-1,3-glucan leading to the loss 
of interaction between the helices. A second model, which is not exclusive with the first one, 
proposes that CR could interfere with the action of enzymes responsible for the assembly of 
the cell wall components (for a review see (Klis et al., 2006)). Whatever the reason, 
protoplasts regenerating the cell wall in the presence of CR cannot form thick fibrils of glucan 
assembled into broad ribbons, which are present in the walls of cells growing without the 
presence of the dye (Kopecka and Gabriel, 1992). In addition, cells treated with CR were 
shown to deposit more chitin in the lateral walls and septa (Vannini et al., 1987) and they 
formed chains of cells, as they were unable to disconnect (Kopecka and Gabriel, 1992). 
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Calcofluor white (CFW) is an antifungal drug that interacts specifically with chitin in 
yeast (Roncero et al., 1988a; Roncero and Duran, 1985) and with cellulose in other organisms 
(see structure in Figure A 1, pg 157). Yeast cells in the presence of this drug in the medium 
increase the biosynthesis of chitin, but the biosynthesized polymer has an abnormal structure 
and does not provide an appropriate support for the cell. Several mutants have been isolated in 
which resistance to CFW was accompanied by a decreased chitin content (Roncero et al., 
1988b; Trilla et al., 1999). Although all these data suggested that chitin was a primary target 
of CFW, later other mutants were discovered which had apparently functional chitin 
biosynthesis (Lussier et al., 1997). Additionally, it has been shown that the sensitivity to CFW 
is also dependent on the high-osmolarity glycerol response (HOG) pathway. This pathway is 
normally required in yeast for growth in a high-osmolarity environment, like medium 
supplemented with 0.9 M NaCl or 1.5 M sorbitol. However, an involvement of this pathway 
in the CFW sensitivity is not clear. While deletion of genes coding for particular components 
of the HOG pathway increased resistance to CFW, activation of Hog1p was not detected in 
wild-type cells grown in the presence of CFW. Nevertheless, the intracellular level of glycerol 
was increased upon CFW treatment (Garcia-Rodriguez et al., 2000a).  
 
 
1.1.3.3 Caffeine 
Caffeine (1,3,7-trimethylxanthine) is an analogue of purine bases that has been 
implicated to affect a variety of functions in different organisms including antagonistic effects 
on adenosine receptors or stimulation of muscle contraction (see structure of caffeine in 
Figure A 1, pg 157). There is also increasing evidence that caffeine inhibits formation of some 
tumors and induces apoptosis in already existing tumors (Hashimoto et al., 2004). However, 
effects of caffeine at the cellular level are not clear (exemplary effects are reported in Table 
2). Original studies on the caffeine action have shown that it could affect the level of 
intracellular cAMP, hence modifying the cAMP-dependent protein kinase (PKA) pathway 
(description of the PKA pathway is given in chapter 1.1.2.2.3, pg 13). However, the effects of 
caffeine on cAMP level and PKA pathway are very controversial. Some authors reported an 
increase of cAMP due to the inhibition of the enzyme cyclic 3’,5’ nucleotide 
phosphodiesterase (Butcher and Potter, 1972; Liao and Thorner, 1981; Tsuzuki and 
Newburgh, 1975), others observed a blockage of a glucose-induced cAMP increase in the 
  INTRODUCTION 17
Yeast cell wall 
presence of caffeine (Tortora et al., 1982); {J. François, unpublished data} or an absence of 
any effects of this drug on cAMP (Tsuboi and Yanagishima, 1973). 
Another reported effect of caffeine was an exacerbation of chromosomal breakages 
induced by UV irradiation, alkylating agents or maleic hydrazide in plants and animals 
(Kihlman et al., 1973; Lehmann and Kirk-Bell, 1974). The recent finding that caffeine can 
inhibit in vitro phosphoinositide 3-kinase (PI3K)- related protein kinases ATM and ATR 
(Blasina et al., 1999; Hall-Jackson et al., 1999), whose major role is to control DNA damage 
checkpoints during the cell cycle (Kuruvilla and Schreiber, 1999), may give some clues 
regarding the mechanism by which caffeine elicits the hypersensitivity to the DNA-damaging 
agents. Yeast homologues of those proteins, Tel1p and Mec1/Rad3p, are regulators of 
telomere length, and their inhibition causes reduction of telomere length, which could account 
for the lethal actions of caffeine in yeast (Saiardi et al., 2005). 
In fungi, caffeine is currently used as a phenotypic criterion to evaluate the 
performance of the cell wall integrity (CWI) pathway, since mutants defective in the 
components of this pathway are usually caffeine-sensitive (Costigan et al., 1992; Jacoby et 
al., 1998; Martin et al., 2000; Martinez-Pastor et al., 1996; Park et al., 2005; Watanabe et al., 
1997). The sensitivity to caffeine was also correlated with the cell wall related mutants 
(Lussier et al., 1997). So far, the best-studied effect of caffeine is an increase in the cellular 
amount of phosphorylated Mpk1 kinase, which is diminished by addition of sorbitol (Martin 
et al., 2000).  
It was thought that the cell wall integrity pathway mutants were hypersensitive to 
caffeine due to their weakened cell wall. However, for several reasons it is unlikely that 
caffeine acts on the cell wall directly; rather, it exerts its effect only after entering the cell. 
First, caffeine was suggested to be actively imported into the yeast cells by an unknown 
adenine permease (Bard et al., 1980) and addition of adenine to the yeast culture alleviated 
caffeine effects. Another reason is the fact that overexpression of SNQ2, a gene coding for a 
plasma membrane transporter involved in multidrug resistance, was able to suppress the 
caffeine sensitivity of the mpk1∆ mutant (Martin et al., 2000). This result suggested that 
SNQ2 could be involved in pumping caffeine out of the cells. Altogether, these reports imply 
that by blocking the entrance into the cell or by expulsing caffeine out of the cell, we can 
eliminate its detrimental effects.  
 
  INTRODUCTION 18
Yeast cell wall 
Table 2 : Exemplary cellular effects of caffeine observed in various organisms 
Caffeine effect: Organism/Cells Reference 
- Day 7 and day 15 guinea pig endometrium 
cells in culture 
(Naderali and Poyser, 
1997) 
- Alveolar macrophages from rat lung (Jafari and Rabbani, 
2000) 
- ADPKD (Autosomal dominant polycystic 
kidney disease) cells 
(Belibi et al., 2002) 
- Porcine oocyte (Kren et al., 2004) 
- Trichoderma harzianum (Silva et al., 2004) 
Increase of cAMP 
- Schizophyllum commune (Kinoshita et al., 2002) 
Decrease of cAMP - HKC (Human Kidney Cortex) cells (Belibi et al., 2002) 
 - Saccharomyces cerevisiae (Tortora et al., 1982) 
Induction of apoptosis - Human neuroblastoma cells (Jang et al., 2002) 
 - Human pancreatic adenocarcinoma cells (Gururajanna et al., 1999) 
 - Human A549 lung carcinoma cells (Qi et al., 2002) 
 - Mouse epidermal JB6 Cl 41 (He et al., 2003) 
Repression of cell proliferation - Human lung adenocarcinoma (Qi et al., 2002) 
- Human fibroblast (Taylor et al., 1993) 
- Murine T-lymphoma cells (Palayoor et al., 1995) 
Induction of cell prolirefation 
- Chinese hamster V 79 cells (Labanowska et al., 
1988) 
- plant and animal cells (Kihlman et al., 1973) Exacerbation of chromosomal 
breakage - mammalian cells (Lehmann and Kirk-Bell, 
1974) 
Inhibition of PI3K-related 
kinases 
- breast cancer cells 
- HeLa cells 
- HEK293 cells 
(McMahon et al., 2005) 
(Blasina et al., 1999) 
(Hall-Jackson et al., 
1999) 
Induction of Mpk1 kinase 
phosphorylation 
Saccharomyces cerevisiae (Rajavel et al., 1999) 
(Martin et al., 2000) 
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1.2 ISOPRENOIDS in yeast 
1.2.1 Isoprenoid biosynthetic pathway 
In nature, the biosynthesis of isoprenoids occurs through two distinct pathways, using 
two distinct precursors, i.e. deoxyxylulose 5-phosphate in eubacteria and higher plants (Lange 
and Croteau, 1999), or mevalonate characteristic for archebacteria and eukaryotes. In 
eukaryotic cells, production of isoprenoids starts with the biosynthesis of acetoacetyl 
coenzyme A catalyzed by ERG10-encoded thiolase (Figure 6). This and subsequent reactions 
lead to the biosynthesis of mevalonate which in the following steps is transformed into 
farnesyldiphosphate (FPP), a compound serving in the cell as a precursor of numerous 
essential metabolites like sterols, dolichols, ubiquinons and as a substrate for protein 
prenylation. In human, this pathway produces also such critical end products like steroid 
hormones, cholesterol and bile acids and for this reason it has been extensively studied in 
mammals, while its equivalent in yeast gained considerably less interest. In yeast, the two last 
reactions leading to the synthesis of FPP are catalyzed by FPP synthase (FPPS) encoded by 
the ERG20 gene. In the first step of this reaction, FPPS condenses isopentenyl diphosphate 
(IPP) and dimethylalyl diphosphate (DMAPP) to form geranyl diphosphate (GPP), in order to 
add another molecule of IPP in the second step (Anderson et al., 1989b). Prior to the synthesis 
of FPP, a molecule of DMAPP is created by IDI1-encoded IPP isomerase (Anderson et al., 
1989a). Interestingly, FPPS competes for the limited pool of DMAPP with Mod5p 
responsible for the synthesis of isopentenylated (i6A) tRNA, thus disrupting the balance 
between both enzymes is going to affect not only FPP synthesis but also translation (Benko et 
al., 2000). 
Once FPP is synthesized, various enzymes consume it. However, the cell requirement 
for sterols is greater than for the non-sterol products of the IP pathway. The first enzyme 
consuming FPP and committed to the branch of sterol biosynthesis is squalene synthase 
(SQS). In yeast, SQS is known to be regulated at the transcriptional level by heme-activating 
protein transcription factors, namely Hap1/2/3/4p, yeast activator protein transcription factor 
yAP-1 and the phospholipids transcription factor complex Ino2/4p (Kennedy et al., 1999). 
Further, in a sequence of 15 enzymatic reactions, squalene is converted to the final sterol 
product, ergosterol that is accumulated in yeast. This final product is integrated into 
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membranes and secretory vesicles (Bagnat et al., 2000) and it plays a role in endocytosis 
(Heese-Peck et al., 2002) and oxygen sensing (Hughes et al., 2005). 
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Geranyl diphosphate [GPP]
Dimethylallyl diphosphate [DMAPP]
Farnesyl diphosphate [FPP]
Thiolase (ERG10)
HMG-CoA synthase (ERG13)
HMG-CoA reductase (HMG1,HMG2)
Mevalonate kinase (ERG12)
Phosphomevalonate kinase (ERG8)
Mevalonate pyrophosphate decarboxylase (ERG19)
FPP synthase (ERG20)
Ubiquinone Q6
Heme A
Squalene Ergosterol
Dehydrodolichyl-PP Dolichol
Prenylated proteins
Cis-prenyltransferase (RER2)
Squalene synthase (ERG9)
Farnesyltransferase (COX10)
Hexaprenyl diphosphate synthetase (COQ1)
Farnesyltransferase (RAM1/RAM2)
Isopenthenyl pyrophosphate isomerase (IDI1)
FPP synthase (ERG20)
Lovastatin
Zaragozic acid
i6A tRNA
tRNA isopentenyltransferase
(MOD5)
Figure 6: Isoprenoid (IP) pathway in the yeast Saccharomyces cerevisiae. 
The sequence of reactions is shown with the enzymes catalyzing them. Names of the genes coding for the 
enzymes are given in parentheses. Enzymes affected by lovastatin and zaragozic acid, inhibitors of the IP 
pathway, are indicated. For some compounds abbreviations of the names, which are used later in the text, are 
given in the brackets. The dashed lines indicate the multi-component pathways (adapted from (Grabinska and 
Palamarczyk, 2002)). 
 
The next branch of the IP pathway depending on FPP is the biosynthesis of dolichol. 
The first enzyme, exclusively dedicated to this task, is cis-prenyltransferase encoded by the 
RER2 gene. Rer2p is a peripheral ER protein and as revealed by immunofluorescence 
microscopy, it is present in the form of dots in the ER membrane (Sato et al., 2001). Cis-
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prenyltansferase uses FPP as a starter and catalyzes subsequent additions of IPP molecules to 
form a long-chain (12-24 isoprene units) polyprenyl diphosphate (Adair, Jr. and Cafmeyer, 
1987). Polyprenyl diphosphate is immediately dephosphorylated by isoprenoid phosphatases 
and by the action of unknown α–saturase dolichol is formed (for a review see (Grabinska and 
Palamarczyk, 2002)). In addition, the SRT1 gene has been found to encode a protein with 
enzymatic activity of cis-prenyltransferase, however, SRT1 is expressed only under particular 
conditions of growth and synthesizes longer polyprenols then does the main cis-
prenyltransferase ((Sato et al., 2001; Szkopinska et al., 1997). The number of isoprene 
residues in the dolichol molecule is specific for each species and varies from 14 to 17 for 
Saccharomyces cerevisiae (Quellhorst, Jr. et al., 1998) to 19 to 22 in mammals (Rip et al., 
1985). The function of dolichol is generally associated with the biosynthesis of glycoproteins, 
but in fact, it is dolichol phosphate, localized mainly to the ER membranes, that is involved in 
this process. Free dolichol in the cells is present mainly in the lysosomes and peroxisomes and 
has been shown to reside in the center of the membrane bilayer, parallel to its plane. Up to 
date the precise function of free dolichol remains unclear. Based on membrane studies, it has 
been proposed that dolichol can inhibit the leak of protons (H+, Na+ and K+) through 
biological membranes (for a review see (Haines, 2001)) which could at least partially explain 
its high amount in the membrane of organelles with extreme pH, like lysosomes or 
peroxisomes. Interestingly, dolichol accounts for 14% of the mass of neuromelanin pigment 
in dopaminergic neurons of the human substantia nigra and it was proposed to play there an 
antioxidant role (Bergamini et al., 2004).  
FPP or GPP can be also used for protein prenylation, a post-translational 
modification of proteins that are usually implicated in signal transduction pathways. 
Generally, this modification is regarded to be important in the attachment of proteins to the 
cellular membranes but also in protein-protein interactions including those that facilitate 
protein trafficking and subcellular localization. In yeast, four proteins are involved in this kind 
of protein modification, i.e. type II (RAB-protein) geranylgeranyltransferases Bet2p and 
Bet4p, and both farnesyltransferases and geranylgeranyltransferases Ram2p and Ram1p. 
Ram1p and Ram2p are both required for membrane localization of Ras proteins and α-factor 
but only Ram2p is an essential protein (He et al., 1991). 
Ubiquinone Q is another product of the isoprenoid pathway requiring FPP for its 
biosynthesis. This lipid, a soluble antioxidant, participates as an electron carrier in the 
mitochondrial respiratory chain, oxidation of sulfide and also regulates the physicochemical 
properties of membranes. All the genes identified in yeast (COQ1-8) that are involved in the 
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biosynthesis of ubiquinone Q have a mitochondrial targeting signal, nevertheless, ubiquinone 
Q is probably actively transported as it is found in all the cellular compartments (for a review 
see (Turunen et al., 2004)). 
FPP is also used in the biosynthesis of heme A, a prosthetic group of cytochrome c 
oxidase. This process begins with farnesylation of heme B (protoheme) by COX10-encoded 
farnesyltransferase (Tzagoloff et al., 1993). In human, a COX10 ortholog is associated with 
mitochondrial disorders. 
Altogether, products of the IP pathway take part in various cellular processes, 
therefore it is important to precisely regulate the flux of intermediates through the pathway to 
satisfy the needs of the cell. Briefly, we can say that transcription of the genes encoding 
enzymes of the IP pathway is regulated by the levels of the cellular sterols as well as the non-
sterol derivatives of FPP, and by FPP itself. Aspects of this regulation are discussed in the 
next chapter. 
 
 
1.2.1.1 Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. 
So far, the best-studied enzyme of the early steps of this pathway is 3-hydroxy-3-
methylglutaryl coenzyme A reductase (HMGR). This enzyme is responsible for the overall 
control of the synthesis of the non-sterol and sterol products, which is of particular importance 
in human, where HMGR controls the biosynthesis of cholesterol. Currently, statins, a class of 
HMGR inhibitors are used to treat hypercholesterolemia (described in the next chapter 1.2.2). 
There is a high degree of similarity between mammalian and yeast HMGR. Unlike the 
prokaryotic enzyme, the eukaryotic one is not freely dispersed in the cytoplasm but instead is 
tethered to the ER membrane through an additional domain (Hampton et al., 1996). Yeast 
have two HMGR isozymes encoded, respectively, by the HMG1 gene that provides 83% of 
the total cellular activity and the HMG2 gene (Basson et al., 1986). These two isozymes are 
differently regulated, which is probably a consequence of different destination of their 
products. The HMG1-encoded HMGR is the dominant enzyme in the logarithmic phase of 
growth in aerobic conditions while the HMG2-encoded enzyme becomes more important in 
anaerobiosis or in the stationary phase of growth. Therefore, it was proposed that Hmg1p 
would rather supply isoprenoids for processes requiring oxygen, such as heme biosynthesis, 
cyclization of squalene and demethylation of lanosterol while the need for Hmg2p activation 
would occur due to the accumulation of isoprenoids during anaerobiosis (Casey et al., 1992; 
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Thorsness et al., 1989). Interestingly, a very recent study which investigated sterol-regulated 
gene expression in Schizosaccharomyces pombe (fission yeast) discovered that regulation of 
gene expression by sterol responsive element was a part of the oxygen-sensing mechanism 
(Hughes et al., 2005). It is likely that this pathway is used for the same purpose in other yeast 
species, especially that sterol synthesis requires oxygen.  
In addition, overexpression of the HMG1 and HMG2 genes brings divergent results for 
the cell morphology. Both genes when overexpressed cause proliferation of smooth ER 
membranes that nevertheless have different protein composition and different cellular 
localization. The Hmg1p-induced membranes (karmellae) are tightly associated with the 
nucleus while the Hmg2p-induced ones can be located in the cytoplasm or associated with the 
nucleus or plasma membrane (Hampton et al., 1996).  
The regulation of HMGR occurs at multiple levels including transcription, translation, 
and protein stability controlled by the IP pathway products (for a review see (Panda and Devi, 
2004)). While Hmg1p seems to be very stable, with a half-life in excess of 8 h, Hmg2p half-
life is regulated by rapid degradation depending on signals derived from mevalonate. The 
physiological role of this degradation is not clear, since it is Hmg1p that serves as the main 
source of the HMGR activity and not Hmg2p. However, since Hmg2p has been a model 
protein for studies of protein degradation we have now a clear picture of the feedback 
regulation of the mevalonate pathway acting via Hmg2 p but we lack the information about 
Hmg1p regulation. Hmg2p in response to signals derived from mevalonate is ubiquitinated 
and targeted to proteasome 26 S for its degradation. The signals for degradation can originate 
from the different steps of the mevalonate pathway: 
i) Inhibition of HMGR with lovastatin leads to a decrease of Hmg2p ubiquitination 
and degradation. Conversely, inhibition of squalene synthase with zaragozic acid leads to a 
rapid degradation of Hmg2p. This was consistent with the regulation through FPP level and it 
was further confirmed by genetic experiments showing that overexpression of a gene 
encoding squalene synthase had a stabilizing effect on Hmg2p while downregulation of this 
gene facilitated protein degradation (Gardner and Hampton, 1999; Hampton and Bhakta, 
1997). Thanks to a recent work led by Hampton (Shearer and Hampton, 2005) it became clear 
that it was not FPP itself but the FPP-derived farnesol that was responsible by changing the 
Hmg2p structure into a less folded state more sensitive for degradation. 
ii) Degradation of Hmg2p is enhanced upon oxysterol accumulation in the cells. 
Oxysterol can be created via cyclization of 2,(3S),(22S),23-dioxidosqualene. However, unlike 
  INTRODUCTION 24
Isoprenoids in yeast 
in mammalian cells oxysterols alone are not a sufficient signal to cause the Hmg2p 
degradation in yeast (Gardner et al., 2001).  
Information concerning Hmg1p regulation is more restricted. It was shown that 
Hmg1p was not ubiquitinated but high level of ergosterol strongly inhibited HMG1-dependent 
squalene synthesis when this process was barely affected in a strain expressing only HMG2. 
In mammals, regulation of gene expression by sterols is possible due to the presence of sterol 
regulatory element (SRE-3) in their promoter sequence which is recognized and positively 
regulated by SRE-3-binding protein 1 (SREBP1) (Spear et al., 1994). Whether this kind of 
regulation exists in yeast remains an open question. 
 
 
1.2.2 Isoprenoid pathway inhibitors. 
In this work, we investigated the effects of two inhibitors of the IP pathway, lovastatin 
and zaragozic acid (see structures in Figure A 1, pg 157). The exact sites of their action are 
presented in Figure 6 (pg. 21).  
Lovastatin (Lo) belongs to a larger group of statins which are known to inhibit the 
activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) (Alberts et al., 1980) 
In human, HMGR catalyzes the rate-limiting step in cholesterol biosynthesis and due to this 
fact statins are extensively used in medical practice. They bind HMGR at nanomolar 
concentrations leading to competitive displacement of the natural substrate, HMG-CoA, 
which binds at micromolar concentrations (Istvan and Deisenhofer, 2001). However, the 
medical use of statins suffers major setbacks, as their effects in the cell are broader than those 
that could be explained just by inhibition of HMGR. For example, lovastatin has been shown 
to cause cytoskeletal actin fragmentation in cardiomyocytes (Kong and Rabkin, 2004) and to 
affect immune response in the mouse (Sun and Fernandes, 2003). Lovastatin-induced 
apoptosis was proposed to be a mechanism of its suppressing effects on tumor genesis and 
metastasis described in various rodent models (Otsuki, 2004). In yeast, lovastatin (40-50 
µg/ml) has been shown to inhibit the biosynthesis of squalene, oxysterol and ergosterol and to 
increase the cellular amount of Hmg1p (Dimster-Denk et al., 1994; Gardner et al., 2001). 
Moreover, the inhibition of Hmg2p ubiquitination was observed upon lovastatin treatment (25 
µg/ml, 30 min incubation) (Gardner and Hampton, 1999). 
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Zaragozic acid (ZA) was discovered in a fungal culture isolated from a water sample. 
The name of this compound comes from the place of the origin of this sample, the city of 
Zaragoza in Spain. The established function of this naturally derived compound is inhibition 
of squalene synthase (SQS). The general structure of zaragozic acid is analogous to that of 
presqualene diphosphate, an intermediate in squalene synthesis, thus it was proposed to mimic 
its binding to the enzyme (Bergstrom et al., 1993). Inhibition of SQS causes an increase of 
FPP utilization in other branching pathways of isoprenoid metabolism. In mammalian cells, 
inhibition of squalene synthase by zaragozic acid was accompanied by a decrease of 
cholesterol levels and an increase in IPP (5-fold), FPP (20-fold), farnesol and organic acids 
levels. Additionally, the levels of dolichol and dolichyl phosphate increased (3-fold) as well 
as the amount of ubiquinone (90%) (Bergstrom et al., 1993; Keller, 1996). Most likely the 
observed increase in the amount of organic acids is caused by conversion of farnesol into 
farnesoic acid and consequently in a dicarboxylic acid (Vaidya et al., 1998). Farnesol is 
produced from FPP by farnesyl pyrophosphatase (Bansal and Vaidya, 1994) and it exhibits 
various biological effects like cell growth inhibition or induction of HMG-CoA reductase 
degradation (Bradfute and Simoni, 1994; Meigs et al., 1996). In yeast, zaragozic acid (10 
µg/ml) has been shown to inhibit the biosynthesis of squalene, oxysterol and ergosterol 
without affecting other modes of acetate metabolism, like fatty acids biosynthesis (Dimster-
Denk et al., 1994; Gardner et al., 2001). Effects of zaragozic acid have been shown on the 
both Hmg1 and Hmg2 proteins. Treatment of yeast cells with this inhibitor caused a decrease 
of HMG1-lacZ activity and induced Hmg2p ubiquitination (Dimster-Denk et al., 1994; 
Gardner and Hampton, 1999). It has also been shown that zaragozic acid caused an increase in 
expression of ERG9, a gene coding for SQS (Kennedy et al., 1999). 
To summarize, both inhibitors have a repressing effect on the sterol branch of the IP 
pathway. However, their major action differs in the effects on the part of the pathway at the 
level of FPP biosynthesis. While lovastatin would decrease the flux of the substrates also 
through this section, zaragozic acid, by inhibiting the main FPP-consuming enzyme, would 
increase FPP availability in the cell. Since FPP and FPP-derived farnesol are positive signal 
for the Hmg2p ubiquitination (Gardner and Hampton, 1999; Hampton and Bhakta, 1997) in 
many studies lovastatin and zaragozic acid were used to alter inversely the availability of 
these compounds in the cell and to examine details of Hmg2p degradation (e.g. (Cronin et al., 
2000; Gardner et al., 2001; Shearer and Hampton, 2005)). In the present work, we used this 
model to study response of yeast cells to the impairment of the isoprenoid pathway.  
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1.2.3 General description of Yta7 protein. 
Here, we present a characteristic of Yta7p based on the work of other groups and our 
previous unpublished results that are not included in the present study.  
YTA7 is not an essential gene and its deletion does not cause any severe phenotype 
except the slight sensitivity to 6% ethanol (Agostoni Carbone et al., 1998) and the decreased 
sensitivity to killer toxin 1 (K1) (Page et al., 2003) that binds the cell wall β-glucan receptor 
subsequently forming lethal pores in the plasma membrane. It was also proposed that Yta7p 
could be one of the targets for Cdk1/Cdc28 kinase (Ubersax et al., 2003), suggesting that its 
activity could be dependent on the progression of the cell cycle. Our group found Yta7p to 
interact in a two-hybrid screen with Erg20p (FPP synthase). Moreover, it was shown, using 
gas liquid chromatography, that the amount of squalene increased 2-fold in the yta7∆ mutant 
{Grabińska, unpublished}. 
The YTA7 gene has been sequenced and the resulting protein is attributed to the family 
of ATP-ases Associated with diverse cellular Activities (AAA) as it contains two ATP-
binding sites (Figure 7) (Agostoni Carbone et al., 1998). However, with increasing knowledge 
about this family it becomes clear that the ‘diverse cellular activities’ are in fact mediated by 
structural remodeling, i.e. unfolding and disassembly of proteins and protein complexes (for a 
review see (Lupas and Martin, 2002)). The AAA domain is wide-spread in nature and 
represented in all kingdoms. In S. cerevisiae alone 22 proteins of the “triple-A” family have 
been found. Yta7p contains also a degenerated bromodomain. Bromodomains have been 
shown to be acetyllysine-binding modules (Hudson et al., 2000) and have been suggested to 
bind acetylated histones and other chromatin-associated proteins. However, Yta7p lacks the 
critical conserved tyrosine residue required for acetyllysine recognition by proteins involved 
in restriction of silencing (Dhalluin et al., 1999) and this position is taken by serine and 
threonine. Yta7p orthologues, in the related species of S. paradoxus, S. mikatae, S. bayanus 
and the less related Debaromyces hansenii, contain the same serine-threonine substitution in 
their bromodomains. Similar substitution exists in mouse and human Tif1 b (Jambunathan et 
al., 2005). 
Then, a more precise database search allowed the identification of three additional 
domains in Yta7p sequence (Figure 7) {M. Grynberg, unpublished data}. The N-terminal part 
(8-312aa) of Yta7p shows high similarity to an internal repeat fragment of the rat 
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microtubule-associated protein MAP1A (1336-1630), a structural protein involved in the 
filamentous cross-bridging between microtubules and other skeletal elements (Langkopf et 
al., 1992). The C-terminal part of Yta7p (1114-1329) was homologous to the N-terminal 
domain of syntaxin 1A, a protein required for membrane fusion (Bennett et al., 1993). At both 
the N- and C-termini of Yta7p, ER membrane retention signals were discovered (Teasdale 
and Jackson, 1996).  
IKFLSMARNL
MAP1A- Habc-AAA AAA Brom
Microtubule binding-like domain
N-terminus syntaxin-like domain
Degenerated bromodomain
AAA domain
8 - 312 449 - 639 772 - 925 1004-1090 1114 – 1329aa
Figure 7: Model of domain structure of Yta7p. 
The numbers below the structure depict the boundaries of each domain. The names of domains are given above. 
The Bromodomain name was shortened for space purposes to Brom. The bolded amino acid sequences shown at 
the termini are the putative ER membrane retention signals {M. Grynberg, unpublished data}. 
 
While this work was in progress Tackett and coworkers (Tackett et al., 2005) 
proposed that Yta7p was a component of a chromatin-associated complex of proteins that 
helps to define and preserve boundaries separating silent and active chromatin. In yeast, the 
majority of chromatin remains active and the remaining ~10% is concentrated mainly near the 
telomere at the rRNA-encoding locus. The best-studied example of this epigenetic regulation 
are the silent mating type loci, HML and HMR. In this work, Yta7p was copurified with 
Top2, Rpb2, Spt16, Sas3, Ylr455 and histones H3, H2B, H2A, Htz1 and H4. Moreover, 
deletion of the YTA7 gene caused an increased silencing of the URA3 reporter gene placed 
near a boundary region which suggested an involvement of Yta7p in maintaining active 
transcription near the silent regions of chromatin. A function of Yta7p in this process was 
further supported by another work of Jambunathan and coworkers (Jambunathan et al., 2005). 
In their study YTA7 was identified as a gene which, when mutated, allowed inappropriate 
spreading of silencing from HMR. Moreover, the degenerated bromodomain of Yta7p has 
been shown to be capable of binding histones in vitro.  
Altogether, these data supported mainly an involvement of Yta7p in silencing but 
other features of this protein suggested that it could be additionally involved in other cellular 
processes. 
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2 RESULTS and DISCUSSION 
2.1 YEAST RESPONSE TO CELL WALL DAMAGE 
2.1.1 Response to an inhibitor of β-1,3-glucan synthase, Papulacandin B 
In order to examine the response of yeast cells to the inhibition of glucan synthesis, we 
performed genome-wide expression analysis in wild-type cells treated with various 
concentrations of Papulacandin B. After heaving determined the minimal inhibitory 
concentration (MIC) as 2.5 µg/ml {A. Lagorce, unpublished data}, we decided to treat cells 
with 0.1, 1 and 10×MIC value for 1h. MIC was the smallest concentration of the drug that 
caused total inhibition of the growth measured after 24 h of incubation with the drug. As a 
result, we obtained three transcription profiles where sub-inhibitory (0.1 MIC) and inhibitory 
(1 MIC) concentration of Papulacandin B affected similar number of genes (48 and 59, 
respectively), and the highest concentration used affected roughly 4 times as many genes 
(207) (Figure 8A). 
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Figure 8: Transcriptional response of yeast cells to Papulacandin B. 
A. Number of genes whose expression significantly changed due to 1h treatment with indicated concentrations 
of Papaulacandin B. Overexpressed genes are represented in red and underexpressed genes in green. B. 
Distribution of differentially expressed genes among functional categories according to Slim Mapper. 
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To have an overview of the general changes of gene expression in response to 
Papulacandin B we pooled the genes affected by all concentrations tested and distributed them 
among the functional categories according to Slim Mapper (Figure 8B, above) (method in 
chapter 3.1.4.3.2, pg 122). It could be seen that the majority of these genes fell into broad 
categories such as transport, organization of organelles and RNA metabolism. Interestingly, 
we observed a strong downregulation of genes involved in biogenesis of ribosomes and the 
biosynthesis of proteins, which was consistent with the observed inhibition of growth.  
Next, to assess the contribution of the expression of genes from specific gene classes 
to the total gene expression, we grouped the genes according to gene ontology nomenclature 
(1389 groups), using T-Profiler. This software uses an unpaired t test which gives a measure 
of significance to the difference between the mean of a specific class of genes and the mean of 
the remaining genes of the total gene expression profile (see method in chapter 3.1.4.3.2, pg 
122). As expected, Papulacandin B affected mainly genes encoding proteins localized to the 
cell wall and in particular some cell wall structural constituents, which was in agreement with 
its action against β-1,3-glucan synthase (Table 3, below). Moreover, we again detected 
downregulation of ribosome biogenesis and protein biosynthesis. However, since this effect 
was elicited only by the highest concentration of this drug, we can suppose that 
downregulation of these categories was probably not associated with the specific action of 
Papulacandin B but it was a result of strong growth inhibition. Analysis of the data sets with 
T-Profiler also allows the identification of regulatory motifs in the promoters of responsive 
genes. It is important to note that T-Profiler does not take into account how often a particular 
motif occurs in a promoter region. Using this tool, we detected significant (t value = 4.21) 
upregulation of genes containing in their promoters the Rlm1p-binding motif 
(TAWWWWTAGM). This result suggested that Papulacandin B induces changes in the cell 
wall structure through the Rlm1p transcription factor, the major target of the CWI pathway. 
 
Table 3: Functional categories affected by Papulacandin B treatment a
Functional category (no. of ORFs) t-value at MIC: 
 0.1 1 10 
Sructural constituent of the cell wall (9) 4.57 4.01 - 
Cell wall component (91) - 5.18 4.44 
Protein biosynthesis (440) - - -6.35 
Component of ribosome (248) - - -7.39 
a The number of ORFs in each category is shown in parentheses. The  
selected categories have a number of ORFs ≤ 500 and a t value ≥ 4. 
‘-‘ indicates that a given category was not significantly changed (P value < 0.05). 
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Further, we used the GeneSpring software that allows clustering of similarly expressed 
genes (see method in chapter 3.1.4.3, pg 120). Using this method, we clustered all the genes 
whose expression was significantly changed and obtained a sub-cluster comprising 29 genes 
that were overexpressed at all concentrations of Papulacandin B tested (Figure 9, below). 
Among these genes, we found MLP1, a gene coding for Mpk1-like protein kinase that has 
been proposed to activate the Rlm1p transcription factor independently of Mpk1p (Watanabe 
et al., 1997). This result implied that this kind of regulation might occur in response to 
Papulacandin B, which was further supported by the fact that upregulation of the MPK1 gene 
was not detected in any of the tested conditions. On the other hand, the expression of BCK1, 
encoding an upstream component of the Pkc1p-Mpk1p signaling cascade, was induced. A 
genetic interaction between MLP1 and BCK1 has already been reported: overexpression of 
MLP1 rescued a caffeine-sensitive phenotype of cells depleted in the BCK1 gene (Watanabe 
et al., 1997). Therefore, we can envisage that Papulacandin B, by impairing cell wall 
biosynthesis, activates the CWI pathway but the signal to the Rlm1p transcription factor is 
relayed by Mlp1p instead of the Mpk1 kinase. Verifying this hypothesis needs further 
investigation. 
Additionaly, in the cluster of upregulated genes, we found some typical cell wall genes 
like CWP1, PIR3, FIT3, FLO11/MUC1 and SED1. SED1 is a gene coding for the major 
structural constituent of the cell wall that is normally expressed during the stationary phase of 
growth (Shimoi et al., 1998). We also found a protein of unknown function, encoded by 
YDR134C, which was nevertheless localized to the cell wall. Another upregulated gene was 
PRM5 that is known to be regulated by the Rlm1p transcription factor (Jung and Levin, 1999). 
Interestingly, this cluster contained also RHK1/ALG3. Alg3p is an alpha 1,3-
mannosyltransferase that catalyzes the addition of the sixth mannose moiety to the lipid-
linked oligosaccharide required for N-glycosylation of proteins. This protein was shown 
previously to be involved in cell wall mannoprotein biosynthesis, thus its presence in this 
cluster is also justified (Kimura et al., 1997).  
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ORF Gene Description 
YKL161C MLP1 Mpk1-like protein kinase 
YKL096W CWP1 Cell wall mannoprotein 
YML100WA  Uncharacterized  
YKL147C  Uncharacterized 
YKL141W SDH3 Succinate dehydrogenase 
YOR383C FIT3 Cell wall protein involved in iron transport 
YPR044C  Uncharacterised 
YDR077W SED1 Cell surface glycoprotein  
YDL122W UBP1 Ubiquitin-specific protease 
YKL163W PIR3 Cell wall protein 
YDR134C  Protein localized to the cell wall 
YML083C  Uncharacterized 
YBR267W  Uncharacterized 
YBL082C RHK1 Dol-P-Man dependent α1,3-mannosyltransferase 
YDR543C  Uncharacterized 
YIL102C  Uncharacterized 
YDR197W CBS2 Cytochrome b translational activator 
YGL157W  Dihydrokaempferol 4-reductase 
YKR046C  Protein involved in aerobic respiration 
YDL197C ASF2 Anti-silencing protein 
YGL023C PIB2 Phosphatidylinositol 3-phosphate binding protein
YLR378C SEC61 ER protein of translocation apparatus 
YNL017C  Uncharacterized 
YKL214C YRA2 Yeast RNA Annealing protein 
YDR093W DNF2 Potential aminophospholipid translocase 
YNR071C  Uncharacterized 
YIR019C FLO11 Cell surface flocculin 
YIL117C PRM5 Pheromone-Regulated Membrane protein 
YNR077C  Uncharacterized 
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Figure 9: Hierarchical clustering of genes responding to Papulacandin B treatment.
Figure represents cluster of 287 genes that significantly changed expression in response to Papulacandin B. The 
list of genes represents a sub-cluster comprising 29 genes that were overexpressed at all concentrations of the 
drug (0.1, 1 and 10 MIC) tested. For clustering, standard correlation was used as a similarity measure.  
 
The next step of the analysis was to identify more specific and narrow categories of 
genes affected by Papulacandin B stress. To this end, we used Term Finder, a statistical tool 
provided at the SGD database, which estimates significance of an involvement of a particular 
biological process in the response elicited by the conditions tested. The number of genes 
representing a given process in the transcription profile was compared with the number of 
genes representing this process in the whole genome, without taking into account their ratio of 
expression (see method in chapter 3.1.4.3.2, pg 122).  
This analysis revealed upregulation of genes involved in the invasive growth and cell 
adhesion as the processes significantly affected by Papulacandin B (Table 4, below). 
Importantly, this group of genes comprised FLO11, a hallmark of the invasive growth. This 
result brings an important insight into the mechanism of defence of yeast against antifungal 
drug as it suggests that the presence of the drug could in fact stimulate biofilm formation. 
Biofilm is a tight structure of normal yeast cells mixed with elongated pseudohyphal forms, 
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which are attached to solid surfaces. Formations of this kind often colonize various medical 
devices and cause serious problems at intensive care units, since biofilm is much more 
resistant to antifungal drugs than cells growing separately. The ability of cells to grow 
invasively and to increase their adhesion is essential for biofilm formation. Thus, it would be 
interesting to verify whether treatment of yeast with a non-inhibitory concentration of 
Papulacandin B could result in a change of the yeast growth to pseudohyphal. 
In addition, it turned out that the tested drug elicited induction of genes involved in 
ATP biosynthesis, namely OLI1/ATP9, ATP8 and ATP6 encoding integral membrane proteins 
and components of the mitochondrial ATP synthase (for a review see (Devenish et al., 2000)). 
OLI1- and ATP6-encoded subunits are components of the proton channel, while ATP8-
encoded subunit remains unassigned to any particular function. Remarkably, OLI1 was the 
gene that reached the highest rate of induction in the whole dataset (10.6-fold induction). This 
result suggested that Papulacandin B could inhibit ATP biosynthesis. This explanation could 
be supported by one of the original reports showing that Papulacandin B inhibited ATP-ase, 
localized to the plasma membrane in the yeast Candida albicans (Surarit and Shepherd, 
1987). 
Moreover, Term Finder pointed out to the repression of polyamine biosynthesis as 
strongly associated with the Papulacandin B stress (Table 4, below). This most significantly 
changed category (P value 7.13-05) contained just three genes SPE1, SPE2 and SPE3, although 
the whole process involves only four genes. Spe1p, ornithine decarboxylase, catalyzes the 
first step in polyamine biosynthesis. Spe2p, S-adenosylmethionine decarboxylase, produces 
S-adenosylmethioninamine that serves in subsequent reaction, catalyzed by Spe3p, for the 
synthesis of spermidine. The explanation of this result is not easy, since the biological 
function of polyamines in yeast is not clear. For instance, it is known that spermidine is 
required for growth of wild-type cells. The probable function of polyamines is stabilization of 
DNA by association of their amino groups with the phosphate residues of DNA. They are 
especially abundant in quickly dividing cells (Tabor and Tabor, 1985).  
 
Table 4: Processes associated with Papulacandin stress according to Term Finder 
Process Probability Gene Ratio Description 
0.00070 RIM21 1.54 Protein that affects invasiveness of haploid strains 
 FLO11 1.66 GPI-anchored cell surface glycoprotein required for diploid 
pseudohyphal formation and haploid invasive growth 
Invasive growth 
(activated) 
 STE20 1.67 Signal transducing kinase of the PAK (p21-activated 
kinase) family, involved in pheromone response and 
pseudohyphal/invasive growth 
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 DIA1 1,57 Protein of unknown function, involved in invasive and 
pseudohyphal growth 
 
 STE5 1.57 Scaffold protein that, in response to pheromone, shuttles 
from the nucleus to the plasma membrane and assembles 
kinases Ste11p, Ste7p, and Fus3p into a specific signaling 
complex 
0.00610 MUC1 1.66 GPI-anchored cell surface glycoprotein required for diploid 
pseudohyphal formation and haploid invasive growth 
 HSP12 1.83 Plasma membrane localized protein that protects 
membranes from desiccation; induced by heat shock, 
oxidative stress, osmostress, stationary phase entry, glucose 
depletion, oleate and alcohol 
Cell adhesion 
(activated) 
 SAG1 2.13 Alpha-agglutinin of alpha-cells, binds to Aga1p during 
agglutination 
0.00812 OLI1 10.66 F0-ATP synthase subunit 9 (ATPase-associated 
proteolipid) 
 ATP6 5.0 Mitochondrially encoded subunit 6 of the F0 sector of 
mitochondrial F1F0 ATP synthase 
ATP synthesis 
coupled to proton 
transport 
(activated) 
 ATP8 2.37 Subunit 8 of the F0 sector of mitochondrial inner 
membrane F1-F0 ATP synthase 
7.13-05 SPE1 0.47 Ornithine decarboxylase 
 SPE2 0.58 S-adenosylmethionine decarboxylase 
Polyamine 
biosynthesis 
(repressed)  SPE3 0.66 Putrescine aminopropyltransferase 
 
 
2.1.1.1 Discussion 
Papulacandin B is an antifungal drug that exerts its main action by inhibiting β-1,3-
glucan synthase (Kopecka, 1984b). However, this enzyme is not the only cellular target of this 
antibiotic, since it has detrimental a effect also on protoplasts (cells of which the cell walls 
were removed by treatment with cell-wall lytic enzymes) (Komiyama et al., 2002). The 
genome-wide expression analysis of cells treated with various concentrations of Papulacandin 
B performed in this work has shown that an additional target of this drug could be the 
mitochondrial complex of ATP synthase. Since this antibiotic has a lipophilic character it 
could possibly interact with this transmembrane complex. This hypothesis is likely because 
Papulacandin B has already been shown to be capable of inhibiting plasma membrane proton 
pumping ATP-ase activity in a related fungus, Candida albicans. However, it was not the 
mitochondrial ATP synthase but a synthase localized to the plasma membrane. 
As we expected, genes coding for the cell surface proteins were the most affected. We 
observed a significant upregulation of the cell wall genes as well as a significant upregulation 
of genes containing an Rlm1p-binding motif in their promoter regions. This result implies that 
in the tested conditions transcription of the cell wall genes could be activated through the 
Rlm1p transcription factor, which is the case in other kinds of the cell wall stress (Garcia et 
al., 2004; Jung et al., 2002; Jung and Levin, 1999). Interestingly, one of the genes identified 
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by this study to be strongly associated with Papulacandin B was MLP1, a gene implicated in 
the regulation of the Rlm1 transcripton factor (Watanabe et al., 1997). One of the perspectives 
of this work could be investigation of the Mlp1p function using Papulacandin B as an inducer 
of its transcription.  
Another feature of Papulacandin B transcription profile was induction of genes 
involved in the invasive growth and cell adhesion. These genes are required for biofilm 
formation. Hence, it would be interesting to verify whether small amounts of Papulacandins 
or other antibiotics introduced in the environment of the fungus could stimulate formation of 
the biofilm and whether biofilm formation could be in fact a mechanism of defense against 
harmful conditions and not only starvation. 
Actually, since all suggestions mentioned above are based exclusively on the 
transcriptome data they should be treated cautiously until confirmed by biochemical 
experiments. 
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2.1.2 Response to drugs destabilizing the cell wall structure, Congo red and Calcofluor 
white  
 
2.1.2.1 Response of yeast cells to Congo red 
2.1.2.1.1 Response to Congo red as deduced from transcriptome profiling 
In order to study the early transcriptomic response of yeast cells to Congo red (CR), 
we analyzed changes in gene expression caused by 20 µg/ml and 100 µg/ml CR. These two 
concentrations exert an effect smaller than 10% of that caused the IC50 value and twice that of 
the IC50 value and were termed a ‘non-inhibitory’ concentration and an ‘inhibitory’ 
concentration, respectively (Kuranda et al., 2006). Interestingly, the ‘non-inhibitory’ and 
‘inhibitory’ concentrations caused similar numbers of genes to respond and this number was 
increasing when measured after 5, 15 and 90 minutes of growth (Figure 10A; method in 
chapter 3.1.4, pg 117). The induction of the observed transcriptional changes was relatively 
slow, which was in agreement with the known fact that Congo red does not enter the cell but 
acts directly on the cell wall. Therefore, the transcriptional changes occur only after the cell 
will have sensed a perturbation of its outer layer or the plasma membrane. 
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Figure 10: Transcriptomic response of yeast cells to Congo red. 
A. The number of genes whose expression changed due to CR treatment. Wild-type cells were treated with 
indicated concentrations of CR, and the number of differentially expressed genes was scored after 5, 15 and 90 
minutes of growth. B. The main functional categories of the genes affected by CR treatment according to Slim 
Mapper.  
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Genes whose expression changed in response to CR could be assigned mainly to two 
functional categories, i.e. cell wall organization and biogenesis (14.3% of genes) and 
carbohydrate metabolism (10.2% of genes) (Figure 10B, above). In the first category, we can 
find representatives of both cell wall protein families: CWP1, encoding 
glycosylphosphatidylinositol (GPI)-dependent cell wall protein, and genes encoding PIR 
proteins (PIR1, PIR3). Also KRE2, coding for α-1,2-mannosyltransferase, involved in 
mannosylation of the cell wall proteins was overexpressed. Additionally, we detected an 
overexpression of the CHS7 gene, involved in chitin biosynthesis by regulating chitin 
synthase III (Chs3p) export, and the SKT5 gene, which activates chitin synthase III during 
sporulation. The up-regulation of these genes is commonly regarded as a compensation for the 
cell wall damage in order to maintain the cell wall integrity. In general, the same cell wall 
genes were induced by the high and low concentrations of CR (see Table A 1, pg 155). 
The group of genes implicated in carbohydrate metabolism contained ENO1, coding 
for enolase catalyzing the first common step of glycolysis and gluconeogenesis; ZWF1, 
encoding glucose-6-phosphate dehydrogenase, and GAL1, involved in galactose catabolism.  
Overexpression of the GAL1 gene is quite interesting as some groups have speculated 
that the cell wall could contain minor amounts of galactose. It has been shown that β1,6-
glucan extracted from the cell walls by hot acetic acid contains traces of galactose (Manners 
et al., 1973), which in some genetic backgrounds could be a part of the GPI-anchor remnant 
of GPI-CWPs (Muller et al., 1992). The overexpression of genes involved in carbohydrate 
metabolism could be explained by possibly higher energy demands of the cell remodeling its 
cell wall. 
Forty four percent of the genes responding to CR treatment had unknown functions. 
However, among these genes we found interesting ones like YAL053W, YHR097C and 
YHR209W whose involvement in the cell wall organization is still not proved but is supported 
by our and other author’s findings (see Table A 1, pg 155). All of these genes were previously 
found to be overexpressed due to CR treatment in an independent study (Garcia et al., 2004). 
Moreover, YAL053W has been shown to have synthetic interactions with GAS1 and KRE1, 
both genes involved in the cell wall assembly. Additionally, both YAL053W and YHR097C 
were overexpressed in several strains bearing cell wall mutations (Lagorce et al., 2003).  
Comparing our data with those obtained by Garcia et al. (Garcia et al., 2004) who 
focused their analysis on later time-points (2, 4 and 6 h) of the culture with CR, we found 
similar changes in the expression of 9 genes: SRL3, CWP1, YPS3, PIR1, PIR3, PRM10, 
YHR097C, YHR209W and YAL053W. 
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To conclude, regarding the transcripomic response to Congo red treatment, activation 
of genes involved in the cell wall remodeling prevailed. Remarkably, at this early moment of 
the cell wall stress, we did not detect changes in the expression of genes encoding 
components of the Pkc1p-Mpk1p signaling cascade. 
 
 
2.1.2.1.2 Induction of Mpk1p phosphorylation in response to Congo red 
In order to understand better the transcriptomic response of yeast cells to CR, we 
studied the state of the CWI pathway by observing Mpk1 kinase phosphorylation (method in 
chapter 3.1.8.1, pg 128). To this end, we measured the level of Mpk1p phosphorylation in the 
same conditions and at the same time-points at which we analyzed changes of gene 
transcription. In addition, to examine whether the state of phosphorylation lasted longer, we 
also took samples after 20 h of CR stress. An increase of the Mpk1p phosphorylated form was 
observed after 1.5 h of growth in the presence of the ‘inhibitory’ (100 µg/ml) concentration of 
the drug (Figure 11, results after 0, 5 and 15 min are not shown). Thus, the increase of 
phosphorylated Mpk1p was simultaneous with the previously observed overexpression of the 
cell wall genes. This result suggested that consistently with our knowledge phosphorylated 
Mpk1p activated its main downstream target, the Rlm1p transcription factor, which in turn 
could activate expression of the cell wall genes. This relatively slow response (1.5 h) could be 
explained by the gradually increasing damage of the cell wall. CR does not destroy the 
already existing glucan network but interferes with polymerization of new chains. Therefore, 
as the cell wall is slowly but constantly renewed at the presence of CR, the cell wall will 
gradually loose its integrity finally reaching the threshold of the activation of the CWI 
pathway. As we did not detect Mpk1p phosphorylation after 20 h of incubation with CR, we 
could conclude that it was a transient event. 
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Figure 11: Induction of Mpk1p 
phosphorylation in response to CR. 
A. Early exponential cultures of BY4742 
strain were exposed to the ‘non-inhibitory’ 
and the ‘inhibitory’ concentrations of CR. 
Samples were taken, at the indicated times, 
and assayed for the phosphorylation levels of 
Mpk1p. Anti-phospho-Mpk1p antibodies and 
anti-Mpk1p antibodies were used to quantify 
phosphorylated Mpk1p (Mpk1p-P) and total 
amount of Mpk1p (Mpk1p). Data shown 
represent one typical experiment that was 
performed at least twice with consistent 
results.  
B. The ratio between phosphorylated Mpk1p 
and total Mpk1p was calculated for all 
Western blots, and this ratio was normalized 
to 1 at time 0 (not shown) for each of the 
tested conditions.  
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2.1.2.1.3 Effect of Congo red on the yeast cell wall composition 
In order to verify whether the CR-induced expression of the cell wall genes was 
followed by actual changes in the cell wall structure, we assayed cells preincubated with CR 
for sensitivity to Zymolyase, a cocktail of cell wall lytic enzymes. In general, an increased 
resistance of cells to the lysis caused by Zymolyase indicates strengthening of the cell wall 
structure (Boorsma et al., 2004). Yeast were cultivated for 90 minutes with the ‘inhibitory’ or 
‘non-inhibitory’ concentrations of CR or without any additions (control). Then, the cells were 
collected, treated with Zymolyase and cell lysis was followed as a decrease in OD600 (Figure 
12A; method in chapter 3.1.5.1, pg 123). During 90 min, the ‘non-inhibitory’ concentration of 
CR did not change the Zymolyase sensitivity, which was in agreement with the negligible 
activation of Mpk1 kinase in these conditions. Nevertheless, prolonged incubation (5 h) of the 
cells with the low CR concentration resulted in a decrease of their sensitivity to Zymolyase 
(result not shown). An ‘inhibitory’ dose of CR caused a decrease in the sensitivity to 
Zymolyase already after 90 minutes. This result supported our transcriptomic data by showing 
that activation of the cell wall genes resulted in apparent changes of the cell wall composition. 
Both effects were simultaneous with the activation of Mpk1p. 
Further, to examine the character of the changes in the cell wall structure caused by 
CR stress, we measured levels of three main carbohydrate components of the cell wall (Figure 
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12B/C). Wild-type cells were grown in the presence of the ‘inhibitory’ or ‘non-inhibitory’ 
concentrations of CR, or without any additions, then the cell wall fraction was isolated and 
assayed for its main components (method in chapter 3.1.5.2, pg 124). The most significant 
changes caused by CR concerned mannans and chitin content. Cell walls of yeast growing at 
the ‘inhibitory’ concentration of CR contained 54% more mannans and 77% more chitin 
compared to non-treated cells. The ‘non-inhibitory’ concentration of CR also caused an 
increase in the mannose (43%) and glucosamine (42%) content but these changes were less 
pronounced. 
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Figure 12: CR-induced cell wall remodeling  
A. Zymolyase sensitivity. Yeast cells (BY4742) were challenged for 90 minutes with CR prior to Zymolyase 
assay. The cell lysis is expressed as a decrease of OD at 600 nm (percentage of the initial value). B. Changes in 
the main cell wall components caused by CR. After 20 h of growth of the wild type strain BY4742 in the 
absence (C) or presence of Congo red (CR1 20 µg/ml; CR2 100 µg/ml), yeast cell wall was purified and glucan, 
mannan, and glucosamine were determined by HPAIE. Results are averages of two independent experiments. 
 
 
2.1.2.1.4 Involvement of particular transcription factors in the CR-induced cell wall 
remodeling 
The group led by J. Arroyo has shown that the transcriptional response to long-term 
(2-6 h) CR stress involves induction of genes potentially regulated by the Rlm1p, Crz1p, 
Swi4p or Msn2/4p transcription factors (Garcia et al., 2004). To investigate which of those 
transcription factors is necessary for the strengthening of the cell wall during short-term 
treatment with CR, the Zymolyase sensitivity assays were performed in the respective mutant 
strains (method in chapter 3.1.5.1, pg 123). The increase of the Zymolyase resistance in wild-
type cells grown in the presence of CR was taken as 100% of resistance and compared to the 
increase of resistance observed in the rlm1∆, crz1∆, swi4∆ or the msn2∆msn4∆ mutants. It 
turned out that Rlm1p played the major role in the remodeling of the cell wall caused by CR. 
However, when the RLM1 gene was deleted the strengthening of the cell wall still took place 
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(50% of the wt level) suggesting a contribution of another transcription factor(s), most likely 
Crz1p, as the loss of this protein function also caused a slight (to 75% of the wt level) 
decrease in the resistance to Zymolyase. In contrast to the proposition of Arroyo’s group, we 
did not observe dependence of CR-induced cell wall remodeling on Swi4p and Msn2/4p. This 
result can be explained by different duration of the CR stress.  
Figure 13: Involvement of chosen transcription factors in 
the CR-induced cell wall remodeling. 
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Cells were treated for 90min with 100 µg/ml CR, washed and 
treated with Zymolyase. Resistance was measured as the OD600 
of cells remaining after lysis provoked by digestion of the cell 
wall with Zymolyase during 90 minutes. The increase of 
resistance after treatment of yeast with CR in the wild type 
strain was taken as 100% and the resistance of the mutant 
strains was compared to this value. 
 
In Table 5, genes overexpressed due to CR 
treatment and containing in their promoters binding sites for the transcription factors tested 
are listed. In agreement with the previous result, the majority of those genes contained a 
binding site for the Rlm1p transcription factor in their promoter regions. 
 
Table 5: Genes containing in their promoter sequence binding sites for Rlm1p, Crz1p, Swi4p or Msn2/4p, 
whose expression increased due to Congo red treatment 
Regulated 
genes 
Regulatory protein Description 
 Rlm1 Crz1 Swi4 Msn2/4  
CWP1 *  * p Cell wall mannoprotein, involved in cell wall organization 
PIR1 *   p O-glycosylated protein required for cell wall stability 
PIR3 *   p O-glycosylated cell wall protein required for cell wall 
stability 
PRY2 *  *  Uncharacterized 
SEC59 *    Dolichol kinase required for protein N-glycosylation 
SRL3 * p  p Uncharacterized   
YAL053W * *  p Uncharacterized 
YHR209W *   p Uncharacterized 
YOL159C *    Uncharacterized 
YPS3 *  * p Aspartic protease, attached to the plasma membrane via a 
GPI anchor 
BAG7 p *  p Rho GTPase activating protein (RhoGAP) 
KHA1  *  * Putative K+/H+ antiporter 
YHR097C  * p p Uncharacterized 
GAL1    * Galactokinase 
* -documented binding site;     p -potential binding site 
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2.1.2.2 Response of yeast cells to Calcofluor white 
 
2.1.2.2.1 Response to Calcofluor white as deduced from transcriptome profiling 
Calcofluor white (CFW) is a fluorescent dye binding to chitin and disturbing the cell 
wall assembly (Elorza et al., 1983). To study short-term response of yeast cells to this 
compound, as for Congo red, we chose two concentrations; ‘non-inhibitory’ equal to 20 µg/ml 
and ‘inhibitory’ equal to 100 µg/ml CFW (Kuranda et al., 2006). Similarly to CR, CFW 
caused changes in gene transcription mainly after 90 minutes but these changes concerned 
about twice as many genes as in the case CR (Figure 14A; method in chapter 3.1.4, pg 117). 
There was no significant difference between the numbers of genes affected by the low and 
high doses of the drug, which was also similar to the effect of CR.  
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Figure 14: Transcriptomic response of yeast cells to CFW. 
 A. The number of genes whose expression changed due to CFW treatment. Wild-type cells were treated with 
indicated concentrations of CFW, and the number of differentially expressed genes was scored after 5, 15 and 90 
minutes of growth. B. The main functional categories of genes affected by CFW treatment according to Slim 
Mapper. 
 
Genes whose expression changed significantly in response to CFW were distributed 
among the functional categories according to Slim Mapper (Figure 14B). Genes of unknown 
function represented 46% of all affected genes, which makes interpretation of these data 
rather incomplete. However, two among these genes, TIR4 and YLR194C, have been localized 
to the cell wall implying a cell-wall related function. According to our data, CFW caused 
changes mainly in five functional categories: RNA metabolism, ribosome biogenesis and 
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protein biosynthesis (presented in Table 6), response to stress (PER1, MSB2, HSP12, HSP30, 
BNI1, PEP4, SIP5, LSP1) and organelle biogenesis (MSB2, LSB6, SFK1, PTC1, CTF19, 
BNI1, VIK1, MDM30, PAC11). The latter category contained mainly genes involved in 
cytoskeleton organization. Two of these genes were down-regulated, BNI1 encoding formin 
which nucleates the formation of linear actin filaments and LSB6 encoding a protein involved 
in actin patch assembly and actin polymerization. Other genes like CTF19 (required for 
attachment of spindle microtubules to the kinetochore), SFK1 (suppressor of STT4), VIK1 
(required for sister chromatid cohesion) and PAC11 (dynein intermediate chain) were 
overexpressed. Their presence in this analysis is justified since it is known that properly 
working cytoskeleton is vital for the cell wall assembly (Utsugi et al., 2002).  
 
Tabl ist of genes whose expression changed due to Calcofluor white treatment, involved in RNA e 6: L
metabolism, ribosome biogenesis and protein synthesis 
ORF Gene* Description 
   
RNA metabolism 
YPR182W SMX3 Sm or Sm-like snRN RNA splicing via spliceosome 
YGR006W PRP18 pre-mRNA splicing fact
 
d in rRNA processing 
 
h is required for pre-18S rRNA processing
P protein, nuclear m
or 
YDL006W PTC1 type 2C protein phosphatase (PP2C), involved in precursor RNA splicing
YHR085W IPI1 Protein that may be involve
YKL208W CBT1 Subunit of complex involved in processing of cytochrome b pre-mRNA 
YPL097W MSY1 Mitochondrial tyrosyl-tRNA synthetase  
YOR168W GLN4 Glutamine tRNA synthetase 
YHR148W IMP3 Component of the SSU processome, whic
YBR084W MIS1 Mitochondrial C1-tetrahydroflate synthase 
Protein involved in processing of 20 S pre-rRNA YOR004W  
Ribosome biogenesis and assembly 
YPR102C RPL11A Protein com ubunit 
 
ponent of the large (60S) ribosomal s
YKL021C 
YIL148W 
MAK11 
RPL40A 
Protein involved in ribosomal large subunit biogenesis 
Ribosomal protein L40A also encodes a ubiquitin protein
YNR053C NOG2 Part of a pre-60S complex 
YDR101C ARX1 Protein involved in ribosomal large subunit biogenesis 
Protein biosynthesis 
YDR515W SLF1 Protein that associa osomes 
10 nit 
tes with translating rib
YNL284C 
YHR038W 
MRPL
RRF1 
Mitochondrial ribosomal protein of the large subu
Mitochondrial ribosome recycling factor 
   
*Genes represented in bold were overexpressed, other genes were underexpressed. 
he CWP1, PIR1, PIR2, PIR3 and CSR2 genes represented the cell wall organization 
and bio
 
T
genesis category. All of them, except CSR2, which is a multicopy suppressor of the 
temperature-sensitive phenotype of the chs5∆spa2∆ double mutant (Santos and Snyder, 
2000), were overexpressed by the ‘inhibitory’ and ‘non-inhibitory’ concentrations of CFW. 
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However, contrary to our expectations, known cell-wall related genes amounted only to 5% of 
the total number of genes affected by CFW. This result suggests that CFW could interfere 
with other processes in the cell than the cell wall assembly, for instance with RNA 
metabolism. Genes representing this latter category constituted 9% of all responsive genes 
and they are listed in Table 6 (above).  
As it was previously suggested by Garcia-Rodriguez and co-workers (Garcia-
Rodriguez et al., 2000a), the HOG (High-Osmolarity Glycerol) pathway is involved in the 
cellular response to CFW in yeast. Consistently, we found an up-regulation of two genes 
implicated in this pathway: MSB2, encoding an osmosensor protein, which can activate 
Hog1p, and PTC1, coding for type 2C protein phosphatase (PP2C) which inactivates Hog1p. 
Finaly, we compared our data with those obtained by Boorsma et al. (Boorsma et al., 
2004), 
2.1.2.2.2 Induction of Mpk1p phosphorylation in response to Calcofluor white 
Since the previous analysis of the genome-wide expression did not detect genes known 
to be i
where 51 genes were shown to be overexpressed due to 10 µg/ml CFW after 2 hours of 
exposure. Twelve of those genes (CWP1, SRL3, PIR1, PIR2, PIR3, HSP12, DDR2, YAL053W, 
YLR194C, YBR071W, YMR315W and YLR414C) were also induced in our analysis (see Table 
A 1, pg 155), suggesting that they were a constant trait of transcriptomic response to CFW. 
 
 
nvolved in the CWI pathway, we sought to verify if this pathway was active in the 
tested conditions. To answer this question we measured the level of phosphorylated Mpk1p in 
cells treated with the ‘inhibitory’ and ‘non-inhibitory’ concentrations of CFW (Figure 15). 
This experiment showed that the ‘inhibitory’ concentration of CFW caused a significant 
induction of Mpk1p phosphorylation, which indicated the activation of the CWI pathway at 
the protein level. The ‘non-inhibitory’ concentration also caused an increase in the abundance 
of phosphorylated Mpk1p but the effect was less pronounced (method in chapter 3.1.8.1, pg 
128). Similarly to the effect of CR, the CFW-induced activation of the cell wall integrity 
pathway was transient, as we did not detect phosphorylated Mpk1p after 20 h of incubation 
with CFW. 
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Figure 15: Induction of Mpk1p 
phosphorylation in response to CFW. 
A. Early exponential cultures of BY4742 
strain were exposed to the ‘non-inhibitory’ 
and ‘inhibitory’ concentrations of CFW. 
Samples were taken, at the indicated times, 
and assayed for the phosphorylation level of 
Mpk1p. Anti-phospho- Mpk1p antibodies and 
anti-Mpk1p antibodies were used to quantify 
phosphorylated Mpk1p (Mpk1p-P) and total 
amount of Mpk1p (Mpk1p). Data shown 
represent one typical experiment that was 
performed at least twice with consistent 
results.  
B. The ratio between phosphorylated Mpk1p 
and total Mpk1p was calculated for all 
Western blots, and this ratio was normalized 
to 1 at time 0 (not shown) for each of the 
tested conditions.  
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2.1.2.2.3 Effects of Calcofluor white on the yeast cell wall composition 
The next step in the study of the yeast response to CFW was verifying whether this 
drug could actually elicit changes in the cell wall composition after a short exposure and 
whether these changes were tuned with the observed Mpk1p phosphorylation. To this end, we 
used the standard procedure testing the sensitivity of the cells to Zymolyase treatment 
(method in chapter 3.1.5.1, pg 123). It turned out that only the ‘inhibitory’ concentration was 
able to elicit changes in the cell wall structure and these changes were detectable after 90 min 
of treatment (Figure 16A; measurements after 30 and 60 min are not shown). This result was 
in agreement with the induction of the cell wall genes and the increase of the amount of 
phosphorylated Mpk1p that were observed at the same time.  
To determine the character of the changes in the cell wall composition we measured 
carbohydrate compounds in the cell walls isolated from yeast treated with Calcofluor white 
(method in chapter 3.1.5.2, pg 124). The ‘inhibitory’ concentration of CFW did not cause 
significant changes in glucan content but levels of mannans and chitin increased by 44% and 
61% comparing to the wild type level, respectively (Figure 16B,C). The ‘non-inhibitory’ 
concentration caused a significant change only in chitin level (by 53%) confirming the fact 
that cells treated with CFW deposit additional chitin in the cell wall.  
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Figure 16: CFW-induced cell wall remodeling. 
A.Yeast cells (BY4742) were challenged for 90 minutes with CFW prior to Zymolyase assay. The cell lysis is 
expressed as a decrease of OD at 600 nm (percentage of the initial value). B. Changes in the main cell wall 
components caused by CFW. After 20 h of growth of the wild type strain BY4742 in the absence (C) or presence 
of Calcofluor white (CFW1 20 µg/ml; CFW2 100 µg/ml), yeast cell wall was purified and glucan, mannan, and 
glucosamine were determined by HPAIE. Results are averages of two independent experiments. 
 
 
2.1.2.2.4 Involvement of particular transcription factors in the Calcofluor white-induced cell 
wall remodeling 
When we verified the occurrence of changes in the cell wall structure due to treatment 
with the ‘inhibitory’ concentration of Calcofluor white, after 90 min, we asked which 
transcription factor was necessary for these early changes. Previously, it has been proposed 
that the Rlm1p transcription factor is involved in response to CFW stress, nevertheless this 
proposition was based only on transcriptional data (Boorsma et al., 2004). To answer this 
question, we tested the Zymolyase sensitivity of mutant cells depleted in some transcription 
factors, which could be potentially involved in the cell wall remodeling (Figure 17) (Jung and 
Levin, 1999; Lagorce et al., 2003; Zhao et al., 1998). This experiment showed that the 
strengthening of the cell wall was exclusively dependent on the Rlm1p transcription factor, as 
the Zymolyase resistance in the rlm1∆ mutant was almost completely abolished. Changes in 
the resistance to Zymolyase in other mutants tested (crz1∆, swi4∆, msn2∆msn4∆) were not 
significant. This result suggests that during the response to CFW, other proteins that could 
activate expression of the cell wall genes cannot replace Rlm1p. 
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Figure 17: Involvement of chosen transcription factors in 
the CFW-induced cell wall remodeling.  
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Cells were treated for 90min with 100 µg/ml CFW, washed 
and treated with Zymolyase. Resistance was measured as the 
OD600 of cells remaining after lysis provoked by digestion of 
the cell wall with Zymolyase during 90 minutes. The 
increase of resistance after treatment of yeast with CFW in 
the wild type strain was taken as 100% and the resistance of 
the mutant strains was compared to this value. 
 
As shown in Table 7, an Rlm1p-binding 
site was common in the promoter regions of the genes upregulated due to CFW action. In this 
group of genes, we can find mainly genes coding for proteins with well-established functions 
in the cell wall assembly. This result supports the main role of Rlm1p in the cell wall 
remodeling in response to CFW. 
 
Table 7: Genes containing in their promoter sequence binding sites for Rlm1p, Crz1p, Swi4p or Msn2/4p, 
whose expression increased due to Calcofluor white treatment 
Regulated gene Regulatory protein Description 
 Rlm1 Crz1 Swi4 Msn2/4  
CWP1 *  * p Cell wall mannoprotein, involved in cell wall organization 
HSP12 *   * Protein that protects membranes from desiccation 
PIR1 *   p O-glycosylated protein required for cell wall stability 
PIR2 *   p O-mannosylated protein required for cell wall stability 
PIR3 *   p O-glycosylated protein required for cell wall stability 
SRL3 * p  p Uncharacterized 
YBR071W * * * p Uncharacterized 
YLR194C * * p  Protein localized to the cell wall 
YNL05Cc *    Uncharacterized 
YOL159C *    Uncharacterized 
KHA1  *  * Putative K+/H+ antiporter 
PEP4 p *  * Vacuolar aspartyl protease (proteinase A) 
YHR097C  * p p Uncharacterized 
YLR414C p *   Uncharacterized 
YPR197C  *   Uncharacterized 
MSB2   *  Osmosensor acting in parallel to the Sho1p pathway 
YKR011C   * p Uncharacterized  
DDR2    * Multistress response protein 
GLK1    * Glucokinase 
YKR005C    * Uncharacterized 
YMR315W p   * Uncharacterized 
YNL144C    * Uncharacterized 
* -documented binding site;     p -potential binding site 
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2.1.2.3 Discussion 
In this part of the work, we characterized the genome-wide transcriptomic response to 
Congo red and Calcofluor white at the early stages of the applied stress. Despite the 
apparently different cellular targets (glucan and chitin, respectively), both drugs elicited very 
similar responses. We showed that the yeast cells needed a relatively long time to elicit 
changes in the gene expression, since first changes were detected only after 90 min of growth 
in the presence of either drug. This is most likely due to the fact that either of the tested drugs 
has been shown to enter the yeast cells where it could cause immediate changes in gene 
transcription. Another but not conflicting explanation is that the weakening of the cell wall 
was taking place progressively, reaching in the end the threshold when changes in 
transcription are induced. This delayed response was confirmed by the biochemical data that 
showed the occurrence of cell wall remodeling at the same time as induction of the cell wall 
genes was observed.  
Irrespectively of their distinct cellular targets, CR and CFW induced almost identical 
sets of cell wall related genes (Table A 1, pg 155). Thus, it was not surprising that eventually 
they caused similar changes in the cell wall composition, i.e. an increase in mannans and 
chitin levels. This result points to these processes as the general rescue response to this kind 
of ‘mechanical’ impairment of the cell wall. Moreover, although we did not detect changes in 
the expression of genes coding for components of the CWI pathway, we showed that 
induction of the cell wall genes was accompanied by an increased level of phosphorylated 
Mpk1 kinase. This observation implied that the observed induction of gene expression was 
dependent on the CWI pathway. Indeed, the cell wall remodeling induced by both drugs was 
strongly dependent on the Rlm1p transcription factor that is activated by phosphorylated 
Mpk1 kinase.  
Intriguingly, although the ‘non-inhibitory’ concentration of the tested drugs induced 
expression of the cell wall related genes after 90 min of incubation, we did not detect cell wall 
reinforcement at this time-point. In addition, activation of Mpk1 kinase at these conditions 
was quite modest. On the other hand, while the ‘inhibitory’ concentration elicited an almost 
identical induction of the cell wall genes, it caused intensive remodeling of the cell wall and it 
was accompanied by a clearly increased amount of phosphorylated Mpk1p. Since the majority 
of the induced cell wall genes were potentially regulated by the Rlm1 transcription factor, we 
can assume that active Mpk1p caused this induction. This result implies that even a moderate 
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increase of the level of phosphorylated Mpk1p is sufficient for transcriptional induction of the 
cell wall genes. A corollary of this result is the fact that yeast should be equipped with some 
kind of posttranscriptional regulation to prevent cell wall biosynthesis, even when the 
transcription of the cell wall genes is elevated. Furthermore, it is noteworthy that we observed 
remodeling of the cell wall when the growth of the cells was inhibited. Thus, the putative 
posttranscriptional control of the cell wall-related genes could be linked to the growth 
inhibition. Recently, the ‘cell wall integrity checkpoint’ was discovered, which arrests the cell 
cycle in response to the damage of the cell wall (Suzuki et al., 2004b). It is possible that a so 
far unidentified ‘sensor’ of the cell wall damage which signals to this checkpoint has a 
threshold of sensitivity and is not activated by the low concentrations of CR or CFW. Thus, 
progression of the cell cycle would be stopped only when the cell encounters a severe 
aggression while ignoring minor ones.  
Despite the similarities in the effects of CR and CFW, we observed also some 
differences. First, while the cell wall remodeling in response to CFW was almost completely 
dependent on the Rlm1p transcription factor, the response to CR likely involved other 
transcription factors, like Crz1p. Secondly, CFW affected expression of roughly twice as 
many genes and only 5% of them were previously identified to be involved in the cell wall 
assembly. Unlike in the case of CR, the most abundant category of genes influenced by CFW 
were those of RNA metabolism. However, this result cannot be explained without further 
investigation, it suggests that CFW may have some additional targets in the cell. 
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2.1.3 Response of yeast cells to caffeine 
 
2.1.3.1 Caffeine induces remodeling of the cell wall 
2.1.3.1.1 Treatment of yeast with caffeine induces changes in the cell wall composition 
Caffeine is commonly believed to affect cell wall biosynthesis, since mutants impaired 
in the CWI pathway are hypersensitive to this compound (Costigan et al., 1992; Jacoby et al., 
1998; Martin et al., 2000; Martinez-Pastor et al., 1996; Watanabe et al., 1997). Consistently, 
caffeine has been shown to be an inducer of the CWI pathway as demonstrated by the 
increased amount of phosphorylated Mpk1 kinase in caffeine-treated cells (de Nobel et al., 
2000; Martin et al., 2000; Rajavel et al., 1999). Nevertheless, the actual effects of caffeine on 
the cell wall composition have not been investigated before. In order to see whether caffeine 
causes changes in the cell wall structure, we tested Zymolyase sensitivity of cells treated with 
the ‘inhibitory’ and ‘non-inhibitory’ concentrations of this drug (Figure 18A, below). These 
concentrations were previously determined as 2 mM and 20 mM, respectively, similarly as it 
was done for Congo red and Calcofluor white (Kuranda et al., 2006). Yeast cultures were 
challenged for 90 minutes with caffeine and then cells were resuspended in a solution 
containing Zymolyase. Cell lysis was followed as a decrease of OD600 (method in chapter 
3.1.5.1, pg 123). The ‘inhibitory’ concentration of caffeine elicited Zymolyase resistance, 
which indicated occurrence of changes in the cell wall structure. The ‘non-inhibitory’ 
concentration did not cause changes in the sensitivity to Zymolyase. Although this result was 
similar to the effects of the typical cell wall damaging agents Congo red and Calcofluor white, 
the increase of resistance elicited by the ‘inhibitory’ concentration of caffeine was much more 
pronounced. After prolonged (5 h) incubation with the ‘non-inhibitory’ concentration of 
caffeine, we observed only a moderate increase of cell resistance to Zymolyase (result not 
shown). 
To investigate the exact character of the caffeine-induced changes in the cell wall 
composition we measured the content of glucan, mannans and chitin in cells growing for 20 h 
in the presence of caffeine or without it (Figure 18B,C below). The ‘non-inhibitory’ 
concentration of caffeine did not cause significant changes in any of the measured compounds 
while the ‘inhibitory’ concentration caused a prominent alteration of the cell wall 
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composition. We confirmed that, as could be expected, the higher resistance of caffeine-
treated cells to Zymolyase reflected an increase in the content of glucan. Additionally, chitin 
level was increased about two-fold when compared to the control conditions. The lack of 
significant changes in the cell wall composition of the cells treated for 20 h with the ‘non-
inhibitory’ concentration of caffeine was consistent with our assumption that caffeine at this 
concentration is somehow neutralized by the cell.  
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Figure 18: Caffeine-induced cell wall remodeling.  
A. Yeast cells (BY4742) were challenged for 90 min with caffeine prior to Zymolyase assay. The cell lysis is 
expressed as a decrease of OD at 600 nm (percentage of the initial value). B,C. Caffeine induces changes of the 
cell wall composition. Wild-type cells (BY4742) were cultivated for 20 h in the absence (C) or presence of 
caffeine (CAF1 2 mM; CAF2 20 mM), the cell wall was purified and glucose, mannose and glucosamine were 
determined by HPAIE. Results represent an average of two independent experiments. 
 
 
2.1.3.1.2 Induction of Mpk1p phosphorylation in response to caffeine 
Several reports have shown that treatment of yeast cells with caffeine leads to the 
activation of the Pkc1p-dependent MAP kinase signaling cascade, as measured by dual 
phosphorylation of Mpk1 kinase (de Nobel et al., 2000; Martin et al., 2000; Rajavel et al., 
1999). We investigated this event further by evaluating the rate and the potency of this agent 
to elicit phosphorylation of Mpk1p, and attempted to correlate the phosphorylation level of 
this MAP kinase with changes in the cell wall structure. To this end, we tested the state of 
Mpk1p after 5, 15, 90 min, 20 h and before addition of caffeine to the yeast culture (method in 
chapter 3.1.8.1, pg 128). It turned out that phosphorylation of Mpk1p upon exposure to the 
‘non-inhibitory’ concentration was detectable only after 90 min of incubation (Figure 19, only 
1.5 and 20 h time-points are shown), similarly to the case of low concentrations of CR and 
CFW. In contrast, the ‘inhibitory’ concentration elicited an increase of phosphorylated Mpk1p 
already after 5 min of incubation (1.5-fold increase, result not shown). While phosphorylated 
Mpk1p was no longer detectable after 20 h of incubation with CR or CFW (compare Figure 
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11, pg 40; and Figure 15, pg 46), caffeine was still able to elicit a strong response (Figure 19). 
Moreover, after 1.5 and 20 h of incubation with 20 mM caffeine, two additional 
phosphorylated bands were detected. These bands most likely corresponded to two related 
MAP kinases, Fus3p and Kss1p, since these proteins, when phosphorylated, are recognized by 
the same anti-phospho-p44/42 MAPK antibody used to visualize phospho-Mpk1p (Bardwell 
et al., 1998; Sabbagh, Jr. et al., 2001). Altogether, treatment of yeast cells with caffeine led to 
a faster and more potent activation of the Pkc1p-Mpk1p cascade than treatment with CR or 
CFW. Thus, this higher and sustained activation of the Mpk1p-dependent signaling pathway 
was at a first glance consistent with the higher resistance of caffeine-treated cells to 
Zymolyase compared to those treated with the other drugs.  
Figure 19: Induction of Mpk1p 
phosphorylation in response to CAF. 
A. Early exponential cultures of wild-type cells 
(BY4742) were exposed to the ‘non-inhibitory’ 
and the ‘inhibitory’ concentrations of CAF. 
Samples were taken, at the indicated times, and 
were assayed for the phosphorylation level of 
Mpk1p. Anti-phospho-Mpk1p antibodies and 
the anti-Mpk1p antibodies were used to 
quantify the phosphorylated Mpk1p (Mpk1p-
P) and the total amount of Mpk1p (Mpk1p). 
Data shown represent one typical experiment 
that was performed at least twice with 
consistent results.  
B. The ratio between phosphorylated Mpk1p 
2.1.3.1.3 Transcription factors involved in the caffeine-induced cell wall remodeling 
In order to verify which transcription factor was responsible for the caffeine-induced 
cell wa
and total Mpk1p was calculated for all Western 
blots, and this ratio was normalized to 1 at time 
0 (not shown) for each of the tested conditions.  
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ll remodeling, we measured the resistance to Zymolyase in mutants impaired in the 
function of several transcription factors that were previously implicated in the induction of 
cell wall genes (Figure 20) (Jung and Levin, 1999; Lagorce et al., 2003; Zhao et al., 1998). 
We observed a significant involvement of the Crz1p transcription factor since the crz1∆ 
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mutant exhibited only 38% of the resistance of wild-type cells. The swi4∆ mutant exhibited 
46% of the wild type resistance indicating importance of the Swi4p transcription factor in the 
remodeling process as well. Interestingly, loss of Msn2/4p function also caused a significant 
decrease of the resistance. Although it is difficult to explain how the genes regulated by 
Msn2/4p could contribute to the cell wall reinforcement, as most of them do not encode cell-
wall related proteins, they have been associated with the transcriptional response to the cell 
wall damage (Lagorce et al., 2003). Importantly, a typical transcription factor associated with 
induction of the cell wall genes, Rlm1p, was not significantly involved in the strengthening of 
the cell wall in response to caffeine. Altogether, these results indicated that caffeine-induced 
cell wall modifications are largely independent of the main target of Mpk1 kinase, i.e. Rlm1p, 
but this process is partially mediated by at least three other transcription factors, like Crz1p, 
Swi4p and Msn2/4p.  
Figure 20: Involvement of chosen transcription factors in 
AF, washed and 
2.1.3.2 Response to caffeine as deduced from transcriptome profiling 
To study the response of yeast cells to caffeine we analyzed genome-wide 
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the CAF-induced cell wall remodeling.  
Cells were treated for 90min with 20 mM C
treated with Zymolyase. Resistance was measured as the 
OD600 of cells remaining after lysis provoked by digestion of 
the cell wall with Zymolyase during 90 minutes. The increase 
of resistance after treatment of yeast with CAF in the wild 
type strain was taken as 100% and the resistance of the 
mutant strains was compared to this value. 
 
 
 
iption levels after 5, 15 and 90 min of growth in the presence of the ‘inhibitory’ and 
‘non-inhibitory’ concentrations of the drug. According to this analysis, caffeine caused rapid 
changes in gene transcription which could be observed already after 5 minutes of treatment 
(Figure 21A). The number of genes responding to caffeine was strongly dependent on the 
concentration of the drug used. After 5 min, the ‘non-inhibitory’ concentration caused 
changes in the expression of approximately 50 genes, and this number decreased upon 
prolonged incubation, which most likely illustrated neutralization or expulsion of caffeine 
from cells. In contrast, the number of genes responding to the ‘inhibitory’ concentration 
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increased with the duration of treatment and reached 260 differentially expressed genes after 
90 minutes.  
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Figure 21: Transcriptomic response of yeast cells to CAF. 
A. The number of genes whose expression changed due to CAF treatment. Wild-type cells were treated with 
indicated concentrations of CAF, and the number of differentially expressed genes was scored after 5, 15 and 90 
minutes of growth. B. The main functional categories of genes that were affected by CAF treatment. Distribution 
of genes according to Slim Mapper, SGD. 
 
Genes whose expression changed significantly were distributed among functional 
categories. As shown in Figure 21B (above), the genes involved in transport were the most 
affected and represented 16% of all the genes responding to the caffeine treatment. Figure 22 
represents particular genes belonging to this category and it can be seen that caffeine probably 
altered transport of metabolites and ions (sugars, amino acids, protons, Cu2+, Fe2+), as well as 
the translocation of proteins between cellular compartments. The most affected subgroup of 
this category was the vesicle-mediated transport. This result was consistent with earlier large 
scale phenotypic data (~5000 viable deletion mutants tested) indicating that deletions of genes 
implicated in transport and especially in the vesicle-mediated transport render cells 
hypersensitive to caffeine (Parsons et al., 2004). Interestingly, caffeine activated expression of 
SNQ2, QDR3 and MDL2, genes encoding putative drug transporters. It is possible that these 
transporters participate in the expulsion of caffeine from the cell, in particular SNQ2 that has 
been reported as a multicopy suppressor of caffeine sensitivity of the mpk1∆ mutant (Martin 
et al., 2000).  
In addition, RNA metabolism, organelle organization and response to stress were the 
other functional categories affected by caffeine. The function of 28% of affected genes 
remains unknown.  
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Figure 22: Genes involved in cellular transport whose expression changed due to caffeine treatment. Genes 
represented in bold were overexpressed while the other genes were underexpressed.
 
Although caffeine strongly remodeled the composition of the cell wall, genes 
potentially involved in this process amounted only to 2% of all responding genes. Moreover, 
the expression of these genes was affected exclusively by the ‘inhibitory’ concentration of 
caffeine (Table A 1, pg 155).  
Table 8 presents all the genes that were overexpressed due to caffeine treatment whose 
promoter region contained a binding site for the transcription factors involved in the cell wall 
remodeling. The majority of those genes (15) could be regulated by Msn2/4p. Fourteen genes 
were regulated by Crz1p supporting a strong involvement of this transcription factor in the 
cell wall remodeling. Nearly the same number of genes could be regulated by both Swi4p and 
Rlm1p (9 and 8). However, the majority of genes potentially regulated by Rlm1p contained 
also a Crz1p- or Msn2/4p-binding consensus in their promoter region. Thus, we assume that 
these genes could be activated by these latter transcription factors and not by Rlm1p. 
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Table 8: Genes containing in their promoter sequence binding sites for Rlmp1, Crz1p, Swi4p or Msn2/4p, 
whose expression increased due to caffeine treatment 
Regulated gene Regulatory protein Description 
 Rlm1 Crz1 Swi4 Msn2/4  
AFR1 *   p Alpha-factor pheromone receptor regulator 
HSP12 *   * Protein that protects membranes from desiccation 
MCH5 *   p Protein with similarity to monocarboxylate permeases 
PST1 *    Cell wall protein that contains a putative GPI-attachment site 
RCK1 *    Protein kinase involved in the response to oxidative stress 
YAL053W * *  p Uncharacterized 
YGP1 * * p * Cell wall-related secretory glycoprotein 
YSR3 * *   Dihydrosphingosine 1-phosphate phosphatase 
CPS1  *   Vacuolar carboxypeptidase yscS 
FUS3  *  p Protein kinase involved in mating pheromone response 
GSC2  * p  Catalytic subunit of β-1,3-glucan synthase 
KRE6 p * * p Protein required for β-1,6-glucan biosynthesis 
PEP4 p *  * Vacuolar aspartyl protease (proteinase A) 
PMC1  * * * Vacuolar Ca2+ ATPase involved in activation of calcineurin  
SPI1  *  * GPI-anchored, serine/threonine rich cell wall protein  
YDR370C  *  p Uncharacterized 
YOR220W  *  p Uncharacterized 
YPR170C  *   Uncharacterized 
ZSP1  *   Mutation results in a zinc sensitive phenotype 
AGP1   * * Low-affinity/broad substrate range amino acid permease   
APT2   *  Apparent pseudogene 
HAP1   * p Transcription factor responding to heme and oxygen 
HXT11   * p Putative hexose transporter that is nearly identical to Hxt9p 
MON2   * p Protein with a role in endocytosis and vacuole integrity 
SLM4   *  Protein involved in the regulation of microautophagy 
YLR256W-A p  *  TyA Gag protein 
ACH1    * Acetyl-coA hydrolase, primarily localized to mitochondria 
ALD3    * Aldehyde dehydrogenase, involved in beta-alanine synthesis 
CPR6    * Peptidyl-prolyl cis-trans isomerase (cyclophilin) 
CYB2   p * Cytochrome b2 (L-lactate cytochrome-c oxidoreductase) 
DNL4  p p * DNA ligase involved in meiosis 
ESBP6    * Protein with similarity to monocarboxylate permeases 
GAC1 p   * Regulatory subunit for Glc7p type-1 protein phosphatase 
GPH1    * Non-essential glycogen phosphorylase  
GPT2    * Glycerol-3-phosphate acyltransferase (lipid biosynthesis) 
GRE2    * Stress induced NADPH-dependent methylglyoxal reductase  
GRE3 p   * Stress induced aldose reductase  
GSY2    * Glycogen synthase 
GUT2   p * Mitochondrial glycerol-3-phosphate dehydrogenase 
HSP31 p   * Possible chaperone and cysteine protease  
HXK1    * Hexokinase isoenzyme 1 
HXT13 p   * Protein with similarity to hexose transporter  
PRX1    * Mitochondrial peroxiredoxin (1-Cys Prx) 
PST2    * Uncharacterized 
SSA4   p * Heat shock protein that is highly induced upon stress 
TSA2  p  * Stress inducible cytoplasmic thioredoxin peroxidase 
YBR139W  p  * Putative serine type carboxypeptidase 
YER067W p   * Uncharacterized 
YLR177W   p * Uncharacterized 
YLR345W    * Uncharacterized 
YNL146W    * Uncharacterized 
* -documented binding site;     p -potential binding site 
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In order to better characterize the differences in the transcriptional responses to 
caffeine and the two cell wall damaging agents, we compared the transcription profiles 
elicited by the ‘inhibitory’ concentrations after 90 minutes. To this end, we analyzed these 
expression data sets using the software developed by Fellenberg et al. that uses 
correspondence analysis (Fellenberg et al., 2001). This method is an explorative statistical 
tool devoted to investigation of associations between variables (for instance, expression 
profiles obtained in different conditions) (description of method in chapter 3.1.4.3.1, pg 121). 
To illustrate the major trends in the data sets, while ignoring minor fluctuations, the data were 
expressed as a planar projection along axes, whose number corresponded to the number of 
conditions. Similarities between the conditions were shown as the distance between the axes. 
It can be seen in Figure 23 that the axes of Congo red and Calcofluor white were closer to 
each other than to the axis of caffeine. This means that the transcription profiles of CR and 
CFW were to some extent similar, while they were distinct from the profile elicited by 
caffeine. Furthermore, the axis of Congo red was the closest one to that of the control 
conditions, which is consistent with CR inducing the smallest number of differentially 
expressed genes. This analysis also highlighted association of genes involved in the cell wall 
assembly mainly to the Congo red and Calcofluor white axes. For instance, CWP1, SRL3, 
PIR1, PIR2 and PIR3, which were induced by both drugs, were located approximately 
halfway between the axes of these two conditions. On the other hand, the farther away the 
differentially expressed genes were placed from the centroid, the closer they were associated 
with the given conditions. For example, a cell wall gene, HSP12, associates with the axis of 
caffeine because of its strong induction by this drug (11-fold) although it was also induced by 
CR and CFW (1.7- and 4-fold, respectively).  
Interestingly, a detailed inspection of genes responding exclusively to caffeine 
revealed two clusters of genes comprised of 35 upregulated genes (involved mainly in 
nitrogen discrimination pathway and carbohydrate metabolism) and 21 downregulated genes 
(involved in ribosome biogenesis). Genes in both clusters are known to be regulated by the 
TOR pathway.  
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Figure 23: Comparison of 
transcriptional responses to 
CAF, CR and CFW. 
CAF
CFW
CR
C
The planar embedding 
produced by the 
Correspondence Analysis of 
genes (grey dots) whose 
expression changed after 90 
minutes of treatment with 100 
µg/ml of Congo red (CR), 100 
µg/ml of Calcofluor white 
(CFW) and 20 mM caffeine 
(CAF) in comparison to the 
control conditions (C). Axes 
represent the major trend 
according to the condition’s 
medians. Blue and green dots 
represent genes known to be 
regulated by TOR that were 
upregulated anddownregulated, 
respectively, in response to 
caffeine. Names of these genes 
are listed in Figure 24, below. Red dots represent cell wall genes (listed in Table A 1, pg 155) whose expression 
changed in response to at least one of the three drugs. The centroid is empty because normally expressed genes 
were filtered out from the analysis. 
 
 
2.1.3.2.1 Caffeine-affected expression of genes involved in the TOR pathway 
The transcriptional changes caused by caffeine suggested that this drug affected the 
TOR pathway (Figure 23, above). We observed overexpression of some transcription factors 
which are inhibited by TOR kinases in good growth conditions. Consequently, the expression 
of genes normally activated by these transcription factors was induced (Figure 24, below). 
This effect concerned mainly four branches of the TOR pathway controlled by Gln3p, Gat1p, 
and Rtg1/3p and Msn2/4p transcription factors. Gln3p and Gat1p are transcriptional 
regulators of the nitrogen catabolite repression (NCR) genes in yeast cells (Shamji et al., 
2000). In the presence of a ‘good’ nitrogen source (e.g. glutamine, glutamate, aspartate), TOR 
kinases repress nitrogen-regulated genes like MEP2 (ammonium permease), DAL5 (allantoate 
permease), and GDH2 (glutamate dehydrogenase) by inhibiting the Gln3p and Gat1p 
transcription factors. All mentioned genes were strongly up-regulated due to caffeine 
treatment, although yeast were grown in a reach medium (YPD). In addition, treatment of the 
cells with caffeine resulted in overexpression of the TCA cycle genes: CIT1 (mitochondrial 
citrate synthase), CIT2 (non-mitochondrial citrate synthase) and PYC1 (pyruvate 
carboxylase), and retrograde pathway genes, regulated by Rtg1/3p (Crespo et al., 2002). 
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Furthermore, we observed induction of MSN4 as well as of genes whose expression depends 
on this transcription factor. The Msn2 and Msn4 proteins are known to initiate gene 
expression in case of a general stress response (Martinez-Pastor et al., 1996). Interestingly, we 
detected overexpression of BMH2 coding for protein that is regulated by the TOR pathway 
and in turn itself regulates Msn2/4p cellular localization. Moreover, we found an 
overexpression of the YBR077C gene, coding for a protein of unknown function that has been 
recently identified as a new TOR pathway genetic modifier (Huang et al., 2004). Finally, we 
observed the 5-fold induction of MAF1, a gene coding for a inhibitor of polymerase (Pol) III, 
and underexpression of 17 genes (YML6, RRB1, RSA3, UTP9, MAK5, MTR4, NOC2, NAN1, 
NOG1, BMS1, NOG2, MTG1, RRP46, UTP21, DIM1, ECM1, RNT1, MRT4, UTP14, NOC3, 
NIP7, RPF2, TSR1, ARX1) involved in the ribosome biogenesis.  
Altogether, these changes in gene transcription clearly indicated inhibition of the TOR 
pathway by caffeine.  
HSP12 (11.1), ALD3 (6.3), YER067w (6.0), TSA2 (5.7), GUT2 (5,0),
HXK1 (3.7), GPH1 (3.5), PEP4 (3.3), GRE3 (3.0), CPR6 (2.7), 
PMC1 (2.7), ACH1 (2.6), HSP31 (2.6), YGP1 (1.85), PRX1 (1.8), 
GAC1 (1.7), PST2 (1.7), SPI1 (1.7), YNL146w (1.7), GSY2 (1.65), 
SSA4 (1.6), AGP1 (1.6), GRE2 (1.6), CYB2 (1.6)
TOR GLN3 (2.8)
RTG1/3 CIT2 (9.4), CIT1 (7.9), PYC1 (5,5), YDR131c (3.8), HXT13 (2.0),
NRG1 (2.0), PDH1 (1.9), MCH5 (1.6), CAR1 (1.6), AGP1 (1.6)
MSN2 MSN4 (2.4)
GAT1 (2.6)
MEP2 (15.3), DAL5 (10.0), ASP3-1 (5.1), GDH2 (4.8), CPS1 (4.5),
PEP4 (3.3), CAR1 (1.6)
DAL5 (10.0), CPS1 (4.5), PEP4 (3.3)
RRB1 (0.61), RSA3 (0.59), UTP9 (0.57), DIM1 (0.58), MAK5 (0.49), 
MTR4 (0.48), NOC2 (0.42), NOC3 (0.24), NAN1 (0.41), NOG1 (0.37), 
BMS1 (0.3), RRP46 (0.62), UTP14 (0.33), ECM1 (0.57), RNT1 (0.49),
MRT4 (0.41), NIP7 (0.18), YML6 (0.59), NOG2 (0.65), RPF2 (0.64), 
TSR1 (0.63), ARX1 (0.6)
ADR1 (2.6), MSN4 (2.4) …
NDP and CDP target genes
Retrograde pathway genes
STRE genes
Genes involved in ribosome biogenesis
PKA-regulated genes
Figure 24: Genes controlled by TOR pathway whose expression changed in response to caffeine. 
Change of gene expression after caffeine treatment is given in parentheses. Red - upregulated genes, green - 
downregulated genes. The PKA-regulated genes are listed in Figure 26, pg 63. 
 
To further provide evidence that caffeine interferes with cellular functions regulated 
by the TOR pathway, we compared the transcriptomic response to this drug to that to 
rapamycin, an inhibitor of the Tor1/2 kinases. Using a Venn diagram, we showed that caffeine 
and rapamycin caused downregulation of the same genes that belonged to the functional 
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categories of transcription, ribosome assembly and protein synthesis, while they enhanced 
expression of genes involved in the TCA cycle, retrograde pathway controlled by Rtg1/3p, 
and Gln3/Gat1p-mediated ‘nitrogen catabolite repression’ pathway (Figure 25). An additional 
comparison of the action of rapamycin and caffeine based on the regulatory motifs shared by 
the induced genes is presented in Table A 2 (pg156). In spite of several similarities, important 
differences between the responses to caffeine and rapamycin need to be pointed out, which 
indicated that these two agents do not have an identical spectrum of cellular effects. Firstly, 
the overlap of the expression data between caffeine and rapamycin amounted only to 25%, 
although care must be taken with this estimation since the experiments were not carried out 
under identical conditions (Hardwick et al., 1999). Secondly, caffeine caused expression 
changes of several genes that were regulated by the level of cAMP (Figure 25), while these 
genes were not found in the transcriptomic response to rapamycin. 
 
DEG1
LEU1
YPL207w
RPB3
RPC40
RPC34
RPA135
RPA49
RRN6
YEF3
RPL14A
GCD2
GCD7
TIF34
RPS9A
EFB1
SUI1
FRS1
PRT1
CAM1
COX4
COQ4
ARO10
PRX1
PBI2
AVT6
PST1
SPI1
MEP2
DAL5
GDH2
CPS1
AGP1
DIP5
CAR1
YML6
MRPS5
PYC1
CIT1
CIT2
NTH2
GSY2
SDH2
GRE2
ASP3-1
PEP4
SNQ2
YGP1
HSP12
GPH1
GAC1
GUT2
PHO11
PHO3
SPL2
YGL118c
YLR179c
CAFFEINE
Rapamycin pde2∆
nitrogene discrimination pathwayprotein biosynthesis
retrograde pathway transcription
ribosome biogenesis and assembly other
stress responseFunctional categories:
GSC2
ADR1
PNS1
TAD2
RRB1
RRP46
RNT1
MRT4
NIP7
TSR1
TOR cAMP
Figure 25: Comparison of expression data for cells treated with caffeine, rapamycin and for the pde2∆ 
mutant. 
Venn diagram from the BioPlot software was used to find similarly expressed genes in the data sets of 
rapamycin (Hardwick et al., 1999), caffeine {this work} and the pde2∆ mutant (Jones et al., 2003). The most 
significant genes (P value<0.05) that were similarly regulated (upregulation – arrowheads, downregulation - 
slash heads) in at least two conditions are given in this figure with their functional category. 
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2.1.3.2.2 Caffeine-affected expression of genes involved in the cAMP signaling cascade 
Caffeine has been reported to affect basal cAMP levels in eukaryotic cells. In 
agreement with these observations, our analysis identified a set of genes known to be 
regulated by the level of cAMP, whose expression was affected by caffeine (Figure 25, 
above). More importantly, caffeine affected expression of genes directly involved in the 
Ras/cAMP signaling cascade (Figure 26, below). Firstly, we detected overexpression of the 
CYR1 gene, encoding adenylate cyclase. We observed changes in expression of genes coding 
for proteins acting upstream of Cyr1p and downstream of PKA. The ERF2 gene was 
downregulated. The protein encoded by this gene is required for Ras2p palmitoylation and 
translocation to the plasma membrane (Dong et al., 2003). The RGS2 gene coding for Gpa2 
GAP, thus a negative regulator of adenylate cyclase activity, was downregulated. In contrast, 
PLC1, coding for a protein that enables a physical interaction between the Gpa2 and Gpr1 
proteins, was upregulated. Another regulatory gene found to be overexpressed due to caffeine 
treatment was RPI1. It has been reported that overexpression of this gene not only suppressed 
the effects associated with the mutational hyperactivation of the Ras/cAMP pathway but 
additionally induced GSC2/FKS2 (1,3-β-glucan synthase) transcription (Sobering et al., 
2002). Moreover, our analysis indicated that caffeine influenced expression of genes coding 
for cAMP pathway effectors, involved in storage carbohydrate metabolism (GSY2, GAC1, 
SDS22) or genes sharing a STRE regulatory motif controlled by the Msn2/4p transcription 
factors (listed in Figure 24, pg 60). Genes like GAC1 (regulatory subunit for Glc7p) or GUT2 
(glycerol-3-phosphate dehydrogenase), whose expression was induced by caffeine, are known 
to be repressed by cAMP but induced by nutrient limitation (Francois et al., 1992; Tadi et al., 
1999). We also found an upregulation of the ADR1 gene, encoding transcription factor, and 
some of its targets: CIT1 (citrate synthase), GUT2, RPM2 (mitochondrial RNase P subunit) 
and SNQ2 (plasma membrane ABC transporter). The ADR1-encoded protein is 
phosphorylated by PKA, which inhibits its ability to activate transcription of other genes 
(Cherry et al., 1989). It is worth noting that SNQ2 has been described as a suppressor of the 
caffeine sensitive phenotype of the mpk1∆ mutant (Martin et al., 2000). Altogether, the 
upregulation of genes that are normally repressed by PKA suggested that caffeine could cause 
inhibition of this cAMP-dependent protein kinase.  
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PLC1
(2.5)
RPI1
(2.5)
MSN2
MSN4 (2.4)
GSY2 (1.6), GAC1 (1.7), SDS22 (1.5),
ADR1 (2.6) CIT1 (7.9), GUT2 (4.9), 
RPM2 (4.8), SNQ2 (1.6)
RAS2
(4.0)
CYR1
(1.5)
cAMP
ERF2
(0.6)
PKA
RGS2
(0.6)
TPK1
TPK2
TPK3
(0.6)
(BCY1)
PDE1 (4.1)
STRE genes
CRZ1 YGP1 (1.8), CPS1 (4.5), FUS3 (1.6), 
GSC2 (3.4), KRE6 (2.1), PMC1 (2.7), 
SPI1 (1.7), YDR370C (1.5), YSR3 (1.6), 
YOR220W (2.4), PEP4 (3.3), 
YPR170C (3.5), YAL053W (2.2)
Figure 26: Genes involved in the cAMP signaling cascade whose expression was changed in response to 
caffeine. 
The above representation of cAMP-dependent protein kinase A (PKA) does not reflect the actual structure of the 
holoenzyme but only shows genes coding for the regulatory (BCY1) and the redundant catalytic subunits (TPK1-
3). Consequently, transcription of genes whose transcription is dependent on PKA was induced. Since Msn2/4p 
can be also regulated by the TOR pathway, STRE genes are listed in Figure 24, pg 60. Ratios of gene expression 
after caffeine treatment  to that in control conditions are given in parentheses.  
 
 
2.1.3.2.3 Caffeine-affected expression of genes involved in the Ehrlich pathway 
Independently of the concentration used, we observed interesting effects of caffeine 
treatment on genes encoding proteins involved in amino acid metabolism. Caffeine caused 
hyperactivation of the Aro80p-regulated pathway implicated in the degradation of 
phenylalanine into phenylethanol (Figure 27 below). This activation was indicated by a rapid 
and strong upregulation of ARO9, ARO10 and ADH5, which encode the three successive 
enzymes of the pathway, as well as ATF1 which encodes the alcohol acetyltransferase that 
catalyzes the formation of phenylacetate (rose taste) from phenylethanol and acetyl-CoA 
(Fujii et al., 1994; Vuralhan et al., 2003). Aro10p, phenylpyruvate decarboxylase responsible 
for the catalysis of the second step in the Ehrlich pathway has no activity in ammonia-grown 
cultures and activation of its transcription depends on the presence of aromatic amino acids in 
the medium and the transcription factor encoded by the ARO80 gene (Iraqui et al., 1999). 
How caffeine causes this potent activation is not sure. However, a possibility exists that 
beside the negative regulation of this pathway by Tor1p, caffeine could mimic the effect of 
the aromatic amino acid tryptophan as a gratuitous inducer of genes of this metabolic 
pathway. 
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L-phenylalanine phenylpyruvate phenylacetaldehyde phenylethanol phenylacetate
ARO9 (9.8) ARO10 (11.5)
ARO80 (3.9)
ADH5 (1.8) ATF1 (2.4)
2-oxoglutarate L-glutamate
CO2 H2O
Acetyl-CoA CoA
Figure 27: Caffeine-induced transcription of genes in Ehrlich pathway. 
Changes in expression levels of the genes involved in degradation of phenylalanine are given in parentheses. 
 
 
2.1.3.3 Tor1p is the cellular target of caffeine 
 
2.1.3.3.1 Caffeine affects growth of mutants impaired in the TOR pathway 
The transcriptional response of yeast to caffeine resembled the situation of depletion 
of TOR kinases. For this reason, we checked the effect of caffeine on the growth of mutants 
impaired in the TOR pathway. As the deletion of TOR2 is lethal, we tested a tor1∆ mutant and 
strains with mutated alleles of TOR kinases tor1-1 and tor2-1 tor1∆. Two mutations, tor1-1 
(Ser1972Arg) and tor2-1 (Ser1975Ile), have been shown to render cells rapamycin-insensitive 
(Heitman et al., 1991). This test revealed that the tor1∆ mutant was hypersensitive to caffeine 
even at 2 mM (result not shown), while the rapamycin-insensitive mutant tor1-1 was less 
sensitive to caffeine, but more sensitive than the wild type (Figure 28, below). Interestingly, 
although Tor2p could not rescue the sensitivity of the tor1∆ mutant, the Tor2-1p version of 
this protein from the rapamycin-insensitive tor2-1 tor1∆ mutant was able to perform this 
function. Additionally, we found that NIR1, proposed to be an important component of the 
TOR pathway (Huang et al., 2004), was required for growth on caffeine-containing media. 
To some extent, the effects elicited by caffeine were similar to those caused by 
rapamycin. For instance, incubation of yeast cells with 20 mM caffeine promoted nuclear 
localization of an Rtg1-GFP protein fusion (data not shown), albeit in a less pronounced 
manner than that caused by rapamycin (Komeili et al., 2000). In addition, we found that the 
deletions of URE2 or RTG1 conferred increased sensitivity to caffeine, whereas the gln3∆ 
mutant showed slight resistance to this drug (Figure 28). Respectively, the same phenotypes, 
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hypersensitivity or resistance, have been reported when rapamycin was used (Cardenas et al., 
1999; Xie et al., 2005).  
Interestingly, a mutant deleted for CRF1, a gene involved in the inhibition of 
transcription of ribosomal genes upon TOR inactivation (Martin et al., 2004), turned out to be 
hypersensitive to caffeine. Active TOR negatively regulates the Yak1 kinase that does not 
allow Crf1p to enter into the nucleus to exert its inhibitory effect on transcription. However, 
yeast cells deleted for YAK1 were sensitive at the wild-type level. Sensitivity test also showed 
caffeine hypersensitivity of the msn2∆msn4∆ double mutant. This result was in agreement 
with the caffeine-induced activation of genes controlled by Msn2/4p. It has been shown that 
the Msn2 and Msn4 proteins, stimulated by TOR, can bind to the cytoplasmic protein Bmh2p 
and this interaction prevents their entrance into the nucleus (Beck and Hall, 1999). BMH2 was 
also in the group of genes overexpressed upon caffeine treatment. 
wt (JK9-3da)
tor1∆
tor1-1
tor2-1 tor1∆
tor1∆mpk1∆
wt (CML128)
wt (BY4741)
nir1∆
5 mM caffeine
msn2∆msn4∆
wt (W303)
wt (BY4741)
ure2∆
gln3∆
yak1∆
rtg1∆
crf1∆
caffeine
5 mM 20 mM
Figure 28: Caffeine sensitivity of mutants in the TOR pathway. 
Serial dilutions of exponentially growing culture of each mutant were spotted onto YPD agar plates containing 
various concentrations of caffeine as indicated in the figure. Growth was scored after 2 days of incubation at 
28°C. 
 
 
2.1.3.3.2 Presence of Tor1p is crucial for induction of Mpk1 kinase phosphorylation in 
response to caffeine treatment 
As our results suggested that caffeine could inhibit the TOR pathway, we sought to 
verify whether the observed caffeine-induced Mpk1p phosphorylation was dependent on the 
TOR kinases. It can be seen in Figure 29 that the caffeine-induced phosphorylation of Mpk1p 
was lost in the tor1∆ mutant (method in chapter 3.1.8.1, pg 128). Interestingly, the mutated 
Tor1-1p and Tor2-1p were able to relay the caffeine stress to the Mpk1 kinase. These 
biochemical data were at a first glance consistent with the genetic data showing that the tor1∆ 
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mutant was hypersensitive to caffeine, whereas introduction of the mutated genes tor1-1 or 
tor2-1 alleviated this phenotype (Figure 28), suggesting a possible correlation between the 
levels of Mpk1p phosphorylation and caffeine sensitivity. However, this suggestion turned out 
to be wrong since we found that phosphorylation of Mpk1p was induced in a mutant defective 
in NIR1, a gene encoding a protein proposed to be one of the components of the TOR 
pathway (Huang et al., 2004), while this mutant was hypersensitive to caffeine.  
tor1∆ tor2-1tor1 ∆
- +        - +         - +         - +        - +        - +  
tor1-1
JK9-3da BY4741
nir1∆none none
caffeine
Mpk1p-P
Mpk1p
background
mutation
Figure 29: Tor1p is necessary for Mpk1p phosphorylation in response to CAF. 
Exponential cultures of the tor1∆, tor1-1, tor2-1 tor1∆ mutants and their isogenic wild type JK9-3a, and the 
nir1∆ mutant and its wild type BY4741 were treated with 20 mM caffeine for 90 min. Level of Mpk1p 
phosphorylation was compared to the analogous samples without caffeine added. Phosphorylated Mpk1p and 
total Mpk1p levels were determined by Western blotting as in Figure 19. 
 
 
2.1.3.3.3 Caffeine-derived signaling to Mpk1p is mediated through Rom2p 
Next step of our investigation was to elucidate at which level the cross talk between 
the TOR and CWI pathways occurrs in caffeine signaling. To achieve this goal, we decided to 
identify the component of the CWI pathway that is required for the signaling to Mpk1 kinase. 
Since we knew that sometimes phenotypes caused by deletion of a given gene might differ 
depending on the genetic background of the yeast strain, first we confirmed that the CWI 
mutants tested were caffeine sensitive (Figure 30A below). Importantly, like other groups 
(e.g. (Parsons et al., 2004)), we showed that the rlm1∆ mutant was not hypersensitive to 
caffeine, which supports our previous result of its redundancy in the caffeine-induced cell 
wall remodeling. Thanks to the work of Martin and colleagues (Martin et al., 2000) we knew 
that caffeine-induced phosphorylation of Mpk1p was dependent on Rho1p and the Mkk1 
kinase that directly activates Mpk1p. In addition, we found that the caffeine-induced Mpk1p 
phosphorylation was abolished upon the deletion of ROM2 but it was not altered by deletion 
of the two major cell surface sensors encoded by MID2 and WSC1 (Ketela et al., 1999; 
Lodder et al., 1999) (Figure 30B). This result contrasted with the fact that mutants defective 
in either one or both sensors were hypersensitive to caffeine (Figure 30A). We then elaborated 
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upon this study by investigating a mutant downstream of Pkc1p. As indicated in Figure 30B, 
the bck1∆ mutant did not show a detectable level of phosphorylated Mpk1p either before or 
after treatment with caffeine. As a conclusion, while these experiments allowed the 
identification of the components in the CWI pathway needed for Mpk1p phosphorylation in 
response to caffeine, they also provided a clear indication that the activation of this pathway 
does not protect cells from the detrimental effects of caffeine.  
The finding that the major cell wall sensors Mid2p and Wsc1p were not involved in 
the caffeine-mediated activation of the Pkc1p-Mpk1p pathway favored the idea that caffeine 
needs to be internalized to exert its effects. 
wsc1∆ mid2∆ wsc1∆mid2∆ rom2∆ bck1∆ none
caffeine
Mpk1p-P
CML128
Mpk1p
background
mutation
- +         - +          - +         - +          - +       - +  
wt (CML128)
wt (BY4741)
wsc1∆
mid2∆
wsc1∆mid2∆
rom2∆
rlm1∆
bck1∆
mpk1∆
+ caffeine
A.
B.
Figure 30: Rom2p is required for caffeine-induced Mpk1p phosphorylation. 
A. Serial dilutions of exponentially growing culture of each mutant on YPD were spotted onto YPD agar plates 
containing 0 or 5 mM caffeine. B. Mutants of the CWI pathway (wsc1∆, mid2∆, wsc1∆mid2∆, rom2∆, bck1∆) 
and their isogenic wild type CML128 were treated with 20 mM caffeine for 90 min. The level of Mpk1p 
phosphorylation was compared to analogous samples without caffeine added. Phosphorylated Mpk1p and total 
Mpk1p levels were determined by Western blotting as in Figure 19 
 
 
2.1.3.3.4 Inhibition of growth caused by caffeine can be alleviated by addition of adenine or 
sorbitol to culture medium, except for the tor1∆ mutant. 
Previously, it was proposed that caffeine was actively imported into yeast cells by an 
unknown adenine permease (Bard et al., 1980). To verify this proposal, we supplemented the 
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medium with an excess of adenine, expecting that if adenine and caffeine were transported via 
the same permease we would be able to decrease the uptake of caffeine and consequently to 
decrease its growth-inhibiting effect. Therefore, we tested the effect of adenine on the caffeine 
sensitivity of mutant strains impaired in the TOR as well as the CWI pathway (Figure 31A 
below). Given that the cell lysis caused by caffeine is an osmoremedial effect, we used 
sorbitol-supplemented medium as a control in this experiment. It turned out that addition of 
adenine as well as addition of sorbitol rescued the caffeine-sensitive phenotype of all the 
strains tested with the exception of the tor1∆ mutant. This result could reflect a competition 
between caffeine and adenine while they were transported through the same plasma-
membrane permease. In yeast, the only one known adenine permease is encoded by the FCY2 
gene (Weber et al., 1990). We tested the sensitivity to caffeine and the level of caffeine-
induced Mpk1p phosphorylation in the fcy2∆ mutant (results not shown). However, the 
mutant strain reacted like the wild type, which suggests that the FCY2-encoded adenine 
permease was not involved in the uptake of caffeine and other transporters must have 
performed this function. 
In order to investigate further the effect of adenine on the caffeine sensitivity we 
sought to examine if adenine would decrease the level of caffeine-induced phosphorylation of 
Mpk1 kinase. Contrary to our expectation, this was not the case, instead, adenine similarly to 
caffeine induced phosphorylation of Mpk1p (Figure 31B). This effect could be explained by 
adenine, an analogue of caffeine, mimicking its presence in the cell. Thus, adenine can induce 
Mpk1p phosphorylation but is not toxic to the cells. Apparently, this effect merits further 
investigation, although it showed that the mode of adenine and sorbitol action to release the 
growth inhibition of mutants by caffeine were evidently different. 
As a corollary of these data, we showed that the hypersensitivity to caffeine was not 
correlated with the ability of the mutant strains to induce Mpk1p phosphorylation. In fact, our 
experiments allowed us to distinguish two groups of the mutants tested in this study. The first 
group comprised mutants that were caffeine sensitive and unable to phosphorylate Mpk1p in 
response to this drug (rom2∆, bck1∆, mpk1∆, tor1∆). To the second group we qualified those 
caffeine-sensitive mutants that were able to activate Mpk1p as well as the wild type (wsc1∆, 
mid2∆, wsc1∆mid2∆, TOR1-1, nir1∆). This idea was further supported by the fact that 
adenine rescued cells growing on caffeine-containing medium, while adenine itself induced 
Mpk1p phosphorylation rather than repressing it, as it was in the case of sorbitol. Moreover, 
sorbitol rescued also the growth of the nir1∆ mutant that was not impaired in the caffeine-
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induced phosphorylation of Mpk1p. Consequently, the hypersensitivity to caffeine could be 
ascribed to the loss of Tor1p function, independently of the Pkc1p-Mpk1p pathway. Thus, it 
remains to be identified which Tor1p-regulated cellular functions are responsible for the 
sensitivity to caffeine. 
Figure 31: Effect of adenine and 
sorbitol on caffeine sensitivity of 
mutants in the CWI and TOR 
pathways. 
A.
B.
wt (JK9-3da)
tor1∆
tor1-1
wt (CML128)
rom2∆
bck1∆
mpk1∆
wt (BY4741)
nir1∆
+Ade +Sorb
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- +         - +        - +      - caffeine
Mpk1p-P
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mpk1∆
A. The effects of adenine and sorbitol 
on the sensitivity to caffeine. Serial 
dilutions of yeast cultures were 
spotted onto YPD agar plates without 
additions or containing 2 mM caffeine 
and supplemented with either 20 mM 
adenine (Ade) or 1 M sorbitol (Sorb). 
Growth was scored after 2 days at 
28°C. B. Effects of adenine and 
sorbitol on caffeine-induced 
phosphorylation of Mpk1p. Early 
exponential cultures of BY4742 
cultivated in the absence (control), or 
in the presence of either 20 mM 
adenine (Ade) or 1 M sorbitol (Sorb), 
were treated for 90 min with 20 mM 
caffeine. Level of Mpk1p 
phosphorylation was compared to 
analogous samples without caffeine 
added. Phosphorylated Mpk1p and 
total Mpk1p levels were determined 
by Western blotting as in Figure 19, 
pg 53. 
 
 
2.1.3.3.5 Loss of Tor1p function results in strengthening of the cell wall  
To study further the cell wall remodeling in response to caffeine we asked whether the 
changes in the cell wall composition caused by caffeine are mediated through its effect on the 
TOR pathway. To this end, we measured the sensitivity of the tor1∆ mutant to Zymolyase 
(Figure 32). As we showed before, the tor1∆ mutant was unable to activate the MAP kinase 
cascade measured as Mpk1p phosphorylation (Figure 29, pg 66), thus we expected that it 
would be also unable to elicit caffeine-induced cell wall remodeling. Contrary to expectation, 
it turned out that the mutant strain was less sensitive to cell wall digestion than wild-type 
cells. This result showed that deletion of TOR1, like the inhibition of its function caused by 
caffeine, stimulated strengthening of the cell wall. Moreover, it showed that the caffeine-
  RESULTS and DISCUSSION 69
Response to Caffeine 
derived signal for the cell wall remodeling was not mediated through Tor1p, since the cell 
wall strengthening was still possible in the tor1∆ mutant. Therefore, in the tor1∆ mutant the 
MAP kinase cascade was not responsive to caffeine and the alteration of the cell wall 
composition should depend on other transducers. 
Figure 32: Loss of Tor1p function results in 
a decrease of Zymolyase sensitivity. 
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Wild-type yeast cells and the tor1∆ mutant 
(JK9-3da background) were challenged for 90 
minutes with 20 mM caffeine prior to 
Zymolyase assay. Every 15 minutes cells lysis 
was measured as a decrease of OD at 600 nm 
(percentage of the initial value). Presented 
results are an average of three independent 
experiments ± SD. 
 
 
 
 
2.1.3.4 Caffeine causes a transient Rom2p-dependent decrease in cAMP level 
As indicated by the Venn diagram in Figure 25 (pg 61), we identified a set of 14 genes 
whose expression was affected both upon deletion of PDE2, encoding cAMP 
phosphodiesterase (Jones et al., 2003), and upon exposure to caffeine, but the genes that were 
induced by the increased cAMP level in the pde2∆ mutant were downregulated in the 
presence of caffeine. Moreover, we observed changes in the expression of genes directly 
involved in the biosynthesis of this signaling molecule. These results suggested that caffeine 
might cause an inhibition of the Ras/cAMP cascade. In accordance with this idea, we showed 
that addition of caffeine to early exponentially growing cells triggered a rapid but transient 
decrease in the intracellular level of cAMP, with an effect that was really significant at 20 
mM caffeine (Figure 33A, method in chapter 3.1.8.2, pg 129). Our result was thus at variance 
to the effects of this drug reported for mammalian cells (Belibi et al., 2002; Jafari and 
Rabbani, 2000; Naderali and Poyser, 1997). Remarkably, we found that this caffeine-induced 
decrease of cAMP was defective in a mutant deleted for ROM2, encoding a GDP/GTP 
exchange factor whose main target is Rho1p that activates the Pkc1p-Mpk1p cascade (Figure 
33B, below). This latter result was in agreement with the recent proposition of Park and co-
workers that Rom2p downregulates PKA activity by decreasing the levels of cAMP (Park et 
al., 2005).  
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Figure 33: Caffeine induced a transient decrease in intracellular level of cAMP that is abolished in the 
rom2∆ mutant.
A. Early exponential cultures (OD600 ≈ 0.2-0.4) of the wild type strain (BY4742) in YPD medium were treated 
with caffeine at a final concentration of 0, 2, or 20 mM. Samples were taken at indicated times to measure 
cAMP. Bars indicate standard deviation derived from duplicates of three independent experiments. B. Similar as 
in panel A, except that cAMP was measured in the wild type (CML128) and in the rom2∆ mutant after addition 
of 20 mM caffeine. 
 
 
2.1.3.5 Caffeine and growth regulation 
It has been shown in various organisms that the TOR pathway is implicated in the 
temporal and spatial control of growth (for a review see (Jacinto and Hall, 2003; Martin and 
Hall, 2005)). While Tor1p and Tor2p share the function of the ‘temporal’ control, only Tor2p 
takes part in the ‘spatial’ control of growth via regulating the cell cycle-dependent 
polarization of the actin cytoskeleton. The inhibition of both Tor1p and Tor2p by rapamycin 
or the deletion of respective genes causes growth arrest in the early G1 phase. The deletion of 
TOR2 causes growth arrest randomly at any phase of cell cycle, while the deletion of TOR1 
causes only mild growth defects (Barbet et al., 1996; Heitman et al., 1991; Kunz et al., 1993). 
Taking into account these data, we decided to verify whether caffeine could also influence the 
yeast cell cycle (phases of the yeast cell cycle can be seen in Figure 1, pg 4). To this end, to 
early-exponential yeast cultures various concentrations of caffeine were added and after 24 h 
of growth budding and non-budding cells (G1 cells) were counted. As shown in Table 9, 
addition of caffeine did not cause an arrest in the G1 phase of the cell cycle, since we 
observed roughly the same percentage of budded and unbudded cells. This result suggested 
that caffeine did not inhibit both Tor proteins, which is necessary for the G1 arrest of cell 
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cycle. The fact that only Tor2p has been shown to be required for G1 progression (Kunz et 
al., 1993) further supports our biochemical and genetic data indicating that caffeine affects 
Tor1p only. 
Table 9: Caffeine does not arrest the cell cycle 
Caffeine concentration G1 cells (%) Budding cells (%) 
- 59 41 
2 mM 62 38 
20 mM 63 37 
 
Additionally, we used a Nikon Eclipse E800 microscope with the Lucia G/F Screen 
Measurement System (Nikon) to measure the size of cells treated with caffeine. It turned out 
that caffeine caused an increase in the cell size (Figure 34, method in chapter 3.1.8.4, pg 130) 
and cells seemed to be more round than oval. An average of the cell radius from two 
independent experiments (in each ~200 cells were counted) was 2.96 µm (±0.41) for the 
control cells and 3.59 µm (±0.35) for caffeine-treated cells. An enlargement of yeast cells 
could be also seen in the case of rapamycin treatment, although this fact was not carefully 
studied (Cardenas and Heitman, 1995; Schmelzle et al., 2004). Eventually, it is not sure 
whether this effect of caffeine is mediated through the TOR function or not. 
Figure 34: Caffeine affected the size of yeast 
cells. 
Radius = 2.95 µm
Radius = 3.52 µm
A. B.
Light microscopy of yeast cells (Nikon Eclipse 
E800 microscope, objective magnification × 100, 
oil immersion). Radius of cells that gives 
approximation of the cell size was scored after 24 
h of growth without (A) or with 20 mM caffeine 
added (B). At least 200 cells were measured from 
two independent experiments. The radius of cells 
growing in the presence of caffeine was by 14% 
higher then the radius of untreated cells. 
 
 
2.1.3.6 Discussion 
In this part of the work, we present a number of genetic and biochemical results 
characterizing the action of caffeine in a lower eukaryotic cell. A model based on these 
experiments is shown in Figure 35. Overall, we can propose that caffeine may affect at least 
three pathways TOR, Ras/cAMP and CWI, and it also causes pronounced reinforcement of 
the cell wall. Generally, there is increasing evidence that these pathways as well as the cell 
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wall remodeling are functionally linked to each other and our data brings a new insight into 
the interdependencies among them.  
Ribosome biogenesis
Gln3p
Rtg1/3p
Gat1p
Msn2/4p
Rom2p  → Mpk1p
cAMP  → PKA
Swi4p
Crz1p
Msn2/4p
Cell wall reinforcement
Tor1p
CAFFEINE Rom2p
1.)
2.)
3.)
Figure 35: Model of caffeine action in the yeast cell. 
1.) Caffeine inhibits the function of Tor1p, which causes downregulation of ribosome biogenesis and activation 
of gene expression dependent on Gln3p, Rtg1/3p, Gat1p and Msn2/4p. In addition, the inhibition of Tor1p 
activates Rom2p GDP/GTP exchange factor that activates the Pkc1p-Mpk1p signaling cascade. 2.) Caffeine also 
elicited inhibition of the Ras/cAMP signaling cascade however, it is not sure whether Tor1p mediated this effect. 
3.) Independently of Tor1p, caffeine causes reinforcement of the cell wall that is mediated by at least three 
transcription factors, i.e. Swi4p, Crz1p and Msn2/4p. Additional regulations are indicated with the dashed lines 
although it is not verified if they were functional in the presence of caffeine. First, showing that Msn2/4p can be 
regulated by PKA as well as by the TOR pathway (Beck and Hall, 1999; Boy-Marcotte et al., 1998). Second, 
showing that Crz1p is negatively regulated by PKA (Kafadar and Cyert, 2004). Third, showing that Swi4p can 
be activated by the Mpk1 kinase (Baetz et al., 2001). 
 
Caffeine and the TOR pathway. Our results allow proposing the Tor1 kinase as the 
main target of caffeine in yeast, whose inhibition leads to the activation of the Pkc1p-Mpk1p 
signaling cascade, and indicate that this activation is not important for the cell survival in the 
presence of caffeine. These conclusions are based on the genome-wide expression analysis, 
complemented by genetic and biochemical data, showing that the response of yeast cells to 
caffeine resembled the response to rapamycin, an inhibitor of Tor1/2 kinases. With respect to 
the response of cells to caffeine, TOR1 could be apparently replaced by the tor2-1 dominant 
allele, as it was able partially to overcome the caffeine sensitivity of the tor1∆ mutant and 
restore the caffeine-induced Mpk1p phosphorylation. This result can be explained if we 
assume that the Tor2-1p variant could exhibit kinetic properties similar to those of Tor1p. 
Whatever the exact mechanism, the relative specificity of caffeine action against Tor1p is 
likely the reason for the narrower spectrum of the transcriptional response induced by this 
drug when compared to rapamycin, which inhibits both kinases. On one hand, both caffeine 
and rapamycin induced the Gln3p-dependent nitrogen catabolite-repressed genes, activated 
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Rtg1/3p-regulated genes involved in specific TCA and anaplerotic reactions, and 
downregulated genes involved in ribosome biogenesis (Cardenas et al., 1999; Hardwick et al., 
1999; Shamji et al., 2000). This result suggests the predominant role of Tor1p over Tor2p in 
controling these functions, a conclusion that could not be reached using rapamycin since this 
drug inhibits both Tor proteins (Barbet et al., 1996). Moreover, this result supports the work 
of Reinke and colleagues (Reinke et al., 2004) who proposed that Tor2p becomes a 
component of the TORC1 complex only upon Tor1p depletion. On the other hand, unlike 
rapamycin, caffeine did not affect processes that are supposed to be mainly dependent on the 
Tor2p function (Helliwell et al., 1998a; Kunz et al., 1993), like growth arrest at the G1 phase 
of the cell cycle (Table 9, pg 72). 
While we observed effects consistent with Tor1p inhibition, the exact mechanism by 
which caffeine could exert this effect remains unknown. Since cells bearing the rapamycin-
insensitive Tor1-1p were still more sensitive to caffeine than wild-type cells, this mechanism 
should be distinct from the action of rapamycin, i.e. independent of the binding between 
Tor1p and the yeast FKBP12 protein. Additionally, one cannot exclude that the caffeine effect 
on Tor1p requires the presence of one of its specific protein partners. Since we assume that 
Tor2p is not implicated in the caffeine effect, protein members of the TORC2 complex can be 
excluded. Likewise Lst8p, which is present in both TORC1 and TORC2 complexes, probably 
is not involved either (Loewith et al., 2002). An involvement of Tco89p, which interacts 
specifically with Tor1p, is very unlikely since the loss of its function did not induce the 
transcriptional readouts associated with the inhibition of the TOR function (Reinke et al., 
2004), leaving Kog1p as a potential candidate. Finally, the most probable scenario is that 
caffeine in yeast, similarly to mammalian cells, directly inhibits the Tor1 kinase (McMahon et 
al., 2005). This action of caffeine could be likely extended to other PI3K-related kinases, like 
Tel1p or Mec1p proposed previously to be involved in yeast response to caffeine (Moser et 
al., 2000; Saiardi et al., 2005), since also the mammalian counterparts of these kinases, ATM 
and ATR, were shown to be inhibited by caffeine in vitro (Blasina et al., 1999; Hall-Jackson 
et al., 1999). Thus, it will be interesting to examine further the sensitivity of these three PI3K-
related kinases to the action of caffeine in order to evaluate which of them is the most 
sensitive target of this drug in yeast and in mammalian cells. 
Lack of correlation between caffeine sensitivity and the activation of Mpk1 
kinase. One of the important findings of this study was to show that the hypersensitivity to 
caffeine was not correlated with the phosphorylation/activation of Mpk1p. Actually, our 
experiments allowed distinguishing two groups of caffeine-dependent phenotypes. The first 
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group comprised mutants that were caffeine hypersensitive and unable to phosphorylate 
Mpk1p in response to this drug (rom2∆, bck1∆, mpk1∆, tor1∆), while the second group 
contained caffeine-hypersensitive mutants that were still able to activate Mpk1p like wild-
type cells (wsc1∆, mid2∆, wsc1∆mid2∆, tor1-1, nir1∆). Moreover, addition of adenine to the 
growth medium could overcome the caffeine hypersensitivity of mutants impaired in the CWI 
pathway, despite the fact that it acted oppositely to sorbitol on the level of phosphorylated 
Mpk1p, i.e. adenine induced phosphorylation of the kinase, while sorbitol diminished this 
effect. In addition to these data, we show that caffeine-induced Mpk1p phosphorylation was 
fruitless in terms of Rlm1p activation, which is the main transcription factor inducing the cell 
wall genes in case of the cell wall damage. Therefore, we propose that increased 
phosphorylation of Mpk1p was just a ‘side effect’ of Tor1p inhibition by caffeine, and it is not 
necessary for the cell’s survival in the presence of this drug. In favour of this idea, it was 
shown that expression of a constitutively activated allele of RHO1 could not overcome 
caffeine hypersensitivity of the rom2∆ mutant (Park et al., 2005). 
Caffeine and the cell wall remodeling. Since caffeine was used in yeast to identify 
mutants impaired in cell wall biosynthesis we verified its action concerning this cellular 
structure by comparing its effects with those of two cell wall damaging agents, Congo red and 
Calcofluor white (Figure 23, pg 59; Table A 1, pg 155). These agents are known to disturb the 
cell wall directly by interacting with it, and the defense of the cells includes activation of the 
CWI pathway (de Nobel et al., 2000; Kopecka and Gabriel, 1992; Roncero and Duran, 1985). 
Thus, these two compounds shared with caffeine one common feature, i.e. the induction of 
Mpk1p phosphorylation. When we proved the occurrence of caffeine-induced changes in the 
cell wall we addressed the question whether the cell wall remodeling induced by caffeine was 
a direct consequence of the Mpk1p activation. Our results clearly demonstrated that this was 
not the case. On the contrary, the caffeine-induced phosphorylation of Mpk1p was not 
accompanied by induction of the Rlm1-dependent genes encoding the cell wall proteins, and 
remodeling of the cell wall could occur independently of the RLM1 gene. On the other hand, 
we identified three mutants swi4∆, crz1∆ and msn2∆msn4∆, which were impaired in the 
caffeine-induced cell wall remodeling, showing that each of them was contributing to this 
process. An involvement of these transcription factors was consistent with the induction of 
their targets in the transcription profile of the cells treated with caffeine. In the tested 
conditions, Swi4p could be activated by phosphorylated Mpk1p (Baetz et al., 2001), although 
some other way of activation cannot be excluded. The Crz1p and Msn2/4p transcription 
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factors were both shown to be negatively regulated by PKA (Beck and Hall, 1999; Boy-
Marcotte et al., 1998). Hence, it would be interesting to verify whether Crz1p and Msn2/4p 
were activated because of the decreased cAMP level or independently of this effect. 
The cell wall gene most affected by caffeine treatment was HSP12 (11-fold induction). 
This gene was shown to be required for biofilm formation (Zara et al., 2002), cell wall 
flexibility as well as growth on caffeine-containing media (Motshwene et al., 2004). It was 
also shown to be negatively regulated by PKA (Siderius et al., 1997), which is consistent with 
our observation of inhibited Ras/cAMP pathway.  
In addition, typical sensors of the cell wall damage like Wsc1p and Mid2p were not 
involved in transmitting the caffeine-derived signal to Mpk1p. The transcriptional response of 
yeast cells, when compared to the response to cell wall damaging agents, was rapid and 
transient at a low concentration of caffeine. Altogether, these results support the idea that 
caffeine does not act directly at the cell surface to trigger its effects but it must enter the cell 
first. 
Caffeine inhibits the Ras/cAMP pathway. In this work, we report genetic and 
biochemical results showing that unlike in mammalian cells, in yeast caffeine causes a rapid 
and transient decrease in the intracellular level of cAMP. Then a new question emerged, 
whether this effect was a consequence of Tor1p inhibition by caffeine. In a previous work 
from M. Hall’s group, it was reported that the rapamycin-induced inhibition of TOR resulted 
in the translocation of one of the PKA catalytic subunits to the nucleus (Schmelzle et al., 
2004). This translocation reflects the inactivation of PKA that is usually caused by a decrease 
of cAMP. However, the question whether TOR could control PKA directly via a protein-
protein interaction or by decreasing cAMP level was not addressed in that study.  
Furthermore, we identified Rom2p as required for the observed drop of cAMP. This 
result was consistent with another report in which Rom2p was proposed to regulate negatively 
PKA by decreasing cAMP level (Park et al., 2005). Importantly, that report suggested that 
Rom2p acted on cAMP independently of downstream components of the Pkc1p-Mpk1p 
cascade, as a constitutive allele of RHO1 did not rescue the caffeine-sensitivity of the rom2∆ 
mutant, additionally supporting the redundancy of this pathway in resistance to caffeine. 
Moreover, we found that while Wsc1p, a protein that directly interacts with Rom2p to activate 
it, was not necessary for mediating the caffeine-derived signal to Mpk1 kinase, a mutant 
lacking WSC1 was still hypersensitive to caffeine. This result could be explained by the 
putative role of the WSC1-3 genes in the Ras/cAMP signaling that was shown in the work of 
Verna and colleagues (Verna et al., 1997). In that report, it was shown that the heat shock 
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sensitivity of cells carrying a hyperactive allele of RAS2 was rescued by overexpression of the 
WSC genes. Moreover, the heat shock sensitivity of the wsc∆ mutants was rescued by deletion 
of RAS2. Hence, now it would be interesting to verify if the caffeine-induced decrease in 
cAMP level was also dependent on the WSC genes. 
In addition, we showed that the ‘inhibitory’ concentration of caffeine induced 
phosphorylation of Mpk1 kinase but also of two other MAP kinases, Kss1p and Fus3p. These 
two proteins have also been reported to regulate Ras/cAMP signaling. Fus3p represses cAMP 
accumulation regardless of its phosphorylation status, while Kss1p represses accumulation of 
cAMP only when it is not phosphorylated, otherwise it is a positive regulator of cAMP 
(Cherkasova and Hinnebusch, 2003). Interestingly, in cells treated with caffeine we detected 
overexpression of FUS3 but not of KSS1. It is possible that the caffeine-induced 
phosphorylation of Fus3p and Kss1p could be linked to the observed decrease of the cAMP 
level. In future studies it will be important to verify whether Fus3p could act in concert with 
Rom2p to repress cAMP accumulation. However, our data imply rather that Fus3p should be 
under control of Rom2p, since deletion of ROM2 was sufficient to abolish the caffeine-
induced drop of cAMP level. How Rom2p affects cAMP is still unknown, although it was 
reported that its action was independent of Ira2p, a GAP for Ras2p (Park et al., 2005). On the 
other hand, Fus3p and Kss1p were shown to affect cAMP through interaction with Cdc25p, a 
GEF for Ras2p (Cherkasova and Hinnebusch, 2003). 
In conclusion, we present here a comprehensive study of caffeine action in yeast at the 
cellular level and we propose that Rom2p, a component of the CWI pathway, is a 
convergence point for conveying the caffeine-induced signal to the Ras/cAMP pathway and 
the Pkc1p-Mpk1p signaling cascade. 
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2.2 REGULATION OF THE ISOPRENOID PATHWAY 
 
2.2.1 Transcriptional response of yeast to inhibitors of isoprenoid pathway 
In order to investigate regulation of the IP pathway, we chose to manipulate isoprenoid 
metabolism using two inhibitors, lovastatin and zaragozic acid, that have the same effect on 
the cellular ergosterol level but act differently on the availability of FPP (see Figure 6, pg 21). 
While lovastatin would decrease the level of FPP, zaragozic acid, by inhibition of SQS, the 
main FPP-consuming enzyme, increases its availability for other branching pathways. We 
have chosen to use 25 µg/ml lovastatin and 10 µg/ml zaragozic acid, as these concentrations 
had been reported, respectively, to inhibit and induce Hmg2p degradation, which is dependent 
on FPP availability in the yeast cell. Moreover, addition of 25 µg/ml lovastatin to the medium 
was sufficient to abolish the enhancing effect of 10 µg/ml zaragozic acid on Hmg2p 
degradation (Gardner et al., 2001). According to our measurements both drugs at the chosen 
concentrations inhibited the growth rate by only ~5% {unpublished data}, therefore we had a 
good chance of observing primary effects of these drugs and not secondary processes 
typically associated with the growth inhibition and death of the cell. As the effects of these 
inhibitors were earlier studied only after long incubation times, to complement those studies, 
we have decided to focus on the short-term response to these agents. To this end, we analyzed 
the genome-wide transcriptional response of yeast cells after 10, 30 and 60 minutes of 
treatment with lovastatin and zaragozic acid.  
 
2.2.1.1 Short-term response of yeast cells to lovastatin 
In order to examine yeast response to lovastatin, a HMG-CoA reductase (HMGR) 
inhibitor, we performed genome-wide expression analysis in cells treated with lovastatin (25 
µg/ml) and compared it with expression pattern of the cells grown without any additions (see 
details in chapter 3.1.4, pg 117). Samples were taken after 10, 30 and 60 minutes. 
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Figure 36: Number of genes whose expression was changed in 
response to lovastatin. 
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Then, all differentially expressed genes were ascribed to the SGD functional 
categories. The numbers of upregulated (red histograms) or downregulated (green histograms) 
genes in each category are shown in Figure 37, reflecting a relative activation or repression of 
a given category. The majority of genes fell into the categories of transport and organelle 
organization. Overal effect of lovastatin stress was to induce gene expression. This concerned 
especially genes involved in meiosis and cell cycle as well as in protein catabolism, protein 
biosynthesis and ribosome biosynthesis. 
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Figure 37: Distribution of lovastatin-responsive genes among functional categories according to Slim 
Mapper. 
In the tested conditions, lovastatin did not cause expression changes of genes that were 
directly involved in the IP pathway. We did not observe significant changes in the expression 
of genes involved in dolichylphosphate-dependent protein glycosylation, and expression of 
only two genes coding for prenylated proteins was increased, i.e. RCY1 involved in the 
recycling of plasma membrane proteins and YNL234W coding for a protein of unknown 
function and possessing a heme-binding domain. In agreement with the previous work of 
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Dimster-Denk and colleagues who did not observe any changes in the HMG1 transcript in the 
mevalonate-starved or lovastatin-treated cells (Dimster-Denk et al., 1994), there was no 
change in the expression of this gene upon lovastatin treatment.  
Nevertheless, we detected overexpression of DAN1 that is responsible for uptake of 
sterols in aerobic conditions, which suggested an increased demand of the cell for these 
compounds (Alimardani et al., 2004). In agreement with the fact that the level of sterols 
affects the plasma membrane we observed overexpression of 13 genes coding for plasma 
membrane proteins (SSY5, SRO7, HIP1, DUR3, ASG7, MEP1, OPT2, TNA1, LSB6, PUT4, 
AZR1, HXT14, MMP1) and underexpression of six genes involved in membrane lipid 
metabolism (PLB1, TSC3, OPI3, YDC1, SCS3, CDS1).  
Lovastatin affected expression of some genes encoding proteins of which activity 
could be dependent on FPP level. For instance, COQ8, upregulated in response to lovastatin, 
was initially isolated as a multicopy suppressor of a defect in cytochrome b mRNA translation 
(Bousquet et al., 1991). The protein encoded by this gene as well as FPP are required for the 
biosynthesis of ubiquinone Q. Upon depletion of COQ8, cells accumulate a prenylated 
intermediate (prenyl-4-hydroxybenzoic acid) of ubiquinone Q biosynthesis and have a 
decreased activity of cytochrome c oxidase (Do et al., 2001). Two other genes involved in 
cytochrome C oxidase activity, OXA1 and COX20, were downregulated due to lovastatin 
treatment. Changed expression of these genes can reflect a problem with FPP availability 
since cytochrome c oxidase uses heme A as a cofactor, which is synthesized from FPP 
(Keyhani and Keyhani, 1978). In fact, earlier data from our laboratory suggest that Coq8p 
could interact with Erg20p (FPP synthase), as evidenced by a yeast two-hybrid screen {K. 
Grabinska, PhD thesis}. In the same screen, we identified Hir3p and Yta7p. Remarkably, we 
found genes coding for these proteins overexpressed in response to lovastatin. Interestingly, 
we detected an overexpression of YAL011W. This gene was identified in a screen for Hmg1p-
sensitive mutants (Wright et al., 2003), as cells lacking YAL011W and overexpressing HMG1 
are characterized by abnormal karmellae assembly.  
In the tested conditions, we did not observe changes of expression of genes belonging 
to the sterol branch of the IP pathway, which obviously does not exclude response at the 
protein level. Altogether, these data imply that the first reaction of the cell to lovastatin is to 
increase the uptake of sterols and activation of genes involved in sterol biosynthesis could be 
the next step of this response. However, this assumption is based only on the transcript data 
and should be further investigated.  
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2.2.1.2 Short-term response of yeast cells to zaragozic acid 
To investigate the transcriptional response to zaragozic acid, a squalene synthase 
(SQS) inhibitor, we treated yeast cells with this drug (10 µg/ml final concentration) for 10, 30 
and 60 min. According to this analysis, zaragozic acid rapidly changed the level of 
transcription of a large number of genes; already after 10 min there were 229 such genes, and 
their number remained approximately unchanged after 30 and 60 minutes (Figure 38). 
Figure 38: Number of genes whose expression was changed in 
response to zaragozic acid. 
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To get a systematic view of this transcriptomic response, all the differentially 
expressed genes were assigned to the SGD functional categories. The majority of 
differentially expressed genes fell into the categories of transport and organelle organization. 
In the categories like meiosis, protein catabolism, ribosome biogenesis and protein 
biosynthesis repression of expression prevailed. 
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Figure 39: Distribution of zaragozic acid-responsive genes among functional categories according to Slim 
Mapper. 
 
Zaragozic acid induced expression of two genes involved directly in ergosterol 
biosynthesis, i.e. ERG6 and ERG26. ERG26 encodes C-3 sterol dehydrogenase, an enzyme 
that catalyzes the second of three steps required to remove two C-4 methyl groups from an 
intermediate in ergosterol biosynthesis (Gachotte et al., 1998). The enzyme removes 3-alpha-
hydrogen, resulting in the decarboxylation of the 3-ketocarboxylic acid sterol intermediate. 
ERG6 encodes delta (24)-sterol C-methyltransferase which converts zymosterol to fecosterol. 
This result suggests that expression of these genes was the most sensitive to the decreased 
efficiency of squalene synthase. We also observed changes in the expression of other genes 
involved in sterol metabolism, like ARE2, OSH1, DAN3, UGT51, YLR101C and ECM22. The 
product of ARE2, which was downregulated, is an enzyme that contributes the major sterol 
esterification activity in the presence of oxygen and this esterified form of sterol is considered 
to serve as a storage of sterols in the cell (Zweytick et al., 2000). Since the action of this 
enzyme reduces the amount of free sterol that could be integrated in the plasma membrane, 
repression of ARE2 upon depletion of the cellular sterol pool seems reasonable. OSH1 
encodes one of the seven oxysterol binding proteins identified in yeast. It has been shown that 
the level of oxysterol in cells decreases after treatment with zaragozic acid (Gardner et al., 
2001). Thus, repression of OSH1 could be a response to the presumable decrease in oxysterol 
content. ECM22, which was downregulated in response to zaragozic acid, encodes a protein 
belonging to the fungus-specific Zn(2)-Cys(6) binuclear cluster family of transcription 
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factors. These proteins bind sterol regulatory element and regulate transcription of the sterol 
biosynthetic genes, like ERG2 or ERG3. Recently it has been shown that the amount of 
Ecm22p decreases upon sterol depletion, consistently with our observations (Davies et al., 
2005). Additionally, Ecm22p was shown to regulate expression of the DAN3 and DAN2 genes 
but not of other DAN/TIR genes (Abramova et al., 2001). Accordingly, we observed 
overexpression of DAN3 in the tested conditions. We also found the UGT51 gene to be 
overexpressed. UGT51 encodes sterol glucosyltransferase and although we know that sterol 
glycosides can be integrated in the yeast membranes their detection is difficult and the 
function remains unknown (Warnecke et al., 1999). Another gene which was overexpressed 
was YLR101C. The function of this gene is unknown but it could potentially affect the sterol 
pathway as its open reading frame overlaps the 3' end of the essential ERG27 gene encoding 
3-keto sterol reductase. 
Zaragozic acid also affected expression of genes involved in protein prenylation 
including BET4 (2.63-fold increase) coding for one of the geranylgeranyltransferases in yeast. 
Additionally, we observed overexpression of genes coding for two prenylated proteins, 
Ypr092wp of unknown function and Ras2p, a small GTP-binding protein. Consistently with 
RAS2 overexpression, we observed changes in expression of other genes involved in 
cAMP/Ras signaling, i.e. upregulation of ERF2 and IRA2, required for regulation of Ras2p 
function, upregulation of SRV2 coding for a regulatory subunit of adenylate cyclase, and 
downregulation of BCY1, a regulatory subunit of cAMP-dependent kinase (PKA). 
Moreover, we found repression of some genes involved in heme metabolism. First, 
COX10 coding for farnesyltransferase of heme A, which is the prosthetic group required for 
cytochrome c oxidase activity. COX18 that is required for the assembly of cytochrome c 
oxidase and HMX1 encoding peroxidase involved in the degradation of heme, were 
downregulated. On the other hand, PAU2 coding for seripauperin that is normally repressed 
by heme was overexpressed.  
Additionally, the process of glycosylation dependent on dolichyl phosphate, which is 
synthesized from FPP, seemed to be affected. We detected underexpression of PMT2 
(dolichyl phosphate-D-mannose protein mannosyltransferase), ALG2 (mannosyltransferase 
involved in N-linked glycosylation, alg2∆ mutants accumulate truncated oligosaccharides 
linked to dolichyl phosphate), OST5 (zeta subunit of the protein oligosaccharyltransferase 
complex) and SAC1 (depending on the dolichyl phosphate mannose synthase Dpm1p for its 
attachment to the ER membrane).  
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Interestingly, we found GOS1 that was identified in a screen for Hmg1p-sensitive 
mutants (Wright et al., 2003) to be underexpressed due to zaragozic acid treatment. Cells 
lacking this gene are additionally characterized by abnormal karmellae assembly. 
 
 
2.2.1.3 Genes regulated both by lovastatin and zaragozic acid  
While we were analyzing further transcriptional data, we found a large group of genes 
(59 genes) whose transcription rate was oppositely regulated upon lovastatin and zaragozic 
acid treatment, suggesting that there was an inverse correlation between expression levels of 
these genes and FPP availability. Theoretically, the genes presented in Table 10 and Table 11 
could be regulated by the changing level of FPP or its derivatives. Importantly, except for a 
few genes (overexpressed- SRD1, NFT1, HXT14, YPR116w; underexpressed- VPH1, 
YNL100w) we did not find genes that would be regulated in the same way by both inhibitors. 
Forty-four genes whose expression was activated by lovastatin and repressed by zaragozic 
acid were mainly involved in RNA metabolism, transcription, protein catabolism and protein 
biosynthesis (Table 10). These genes seemed to be positively regulated by a decreased 
availability of FPP or its derivatives and negatively regulated by an increased availability of 
FPP or its derivatives. Among these genes, we found YTA7 whose supposed role in the IP 
pathway will be further examined. 
Moreover, we found the OPT2 gene coding for an oligopeptide transporter to be 
overexpressed and underexpressed upon treatment with lovastatin and zaragozic acid, 
respectively. An involvement of Opt2p in the IP pathway is still uncertain but it is supported 
by another work where this gene was found to be downregulated in a strain with reduced 
susceptibility to azoles (Barker et al., 2003). Another gene in this category was AZR1, 
encoding a plasma membrane transporter that is required for resistance to azoles (Tenreiro et 
al., 2000). A direct involvement of other identified genes in the IP pathway remains unknown 
and requires further investigation. 
 
Table 10: Genes whose expression was activated by lovastatin and repressed by zaragozic acid 
Functional 
category 
Gene Ratio of 
expression 
Description 
  Lo ZA  
RNA 
metabolism 
YGR251W 2.31 0.43 Putative protein of unknown function; deletion mutant has 
defects in pre-rRNA processing 
 YGR272C 2.25 0.58 Putative protein of unknown function; deletion mutant has 
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defects in pre-rRNA processing 
 JSN1 2.32 0.53 Member of the Puf family of RNA-binding proteins, interacts 
with mRNAs encoding membrane-associated proteins 
 LSM7 1.92 0.22 Lsm (Like Sm) protein; part of heteroheptameric complexes 
involved in mRNA decay and in processing tRNA, snoRNA, 
and rRNA 
 UTP8 2.16 0.28 Nucleolar protein required for export of tRNAs from the nucleus 
and in processing of pre-18S rRNA 
Protein 
catabolism 
NAS2 1.62 0.41 Protein with similarity to the p27 subunit of mammalian 
proteasome modulator; not essential; interacts with Rpn4p 
 CIC1 2.0 0.21 Essential protein that interacts with proteasome components and 
has a potential role in proteasome substrate specificity; also 
copurifies with 66S pre-ribosomal particles 
 YTA7 2.0 0.61 Protein of unknown function, member of CDC48/PAS1/SEC18 
family of ATP-ases, potentially phosphorylated by Cdc28p 
Transcription POL2 2.34 0.59 Catalytic subunit of DNA polymerase epsilon, one of the major 
chromosomal DNA replication polymerases  
 YAP6 1.54 0.29 Putative basic leucine zipper (bZIP) transcription factor; 
overexpression increases sodium and lithium tolerance 
 RPB3 1.66 0.59 RNA polymerase II third largest subunit B44, part of central 
core; similar to prokaryotic alpha subunit 
 RPC25 2.0 0.57 RNA polymerase III subunit C25 
Protein 
biosynthesis 
RPL39 1.61 0.22 Protein component of large (60S) ribosomal subunit, required 
for ribosome biogenesis; exhibits genetic interactions with SIS1 
and PAB1 
 RPL14B 2.8 0.37 Protein component of large (60S) ribosomal subunit 
 YHR181W 1.53 0.63 (SVP26); Integral membrane protein of the early Golgi 
apparatus, may function to promote retention of proteins in early 
Golgi compartment; mutation affects protein N-glycosylation 
and cell wall integrity 
Cell cycle SWE1 2.27 0.36 Protein kinase that regulates G2/M transition by inhibition of 
Cdc28p kinase activity; potential Cdc28p substrate 
 SPC72 1.57 0.48 Component of cytoplasmic Tub4p (gamma-tubulin) complex, 
binds spindle pole bodies and links them to microtubules 
 PMS1 1.57 0.4 ATP-binding protein required for mismatch repair in mitosis and 
meiosis 
Other MST28 1.63 0.45 Putative integral membrane protein, involved in vesicle 
formation; forms complex with Mst27p; binds COPI and COPII 
vesicles 
 AZR1 1.82 0.37 Plasma membrane transporter of the major facilitator 
superfamily, involved in resistance to azole drugs such as 
ketoconazole and fluconazole 
 COB 1.95 0.2 Cytochrome b, mitochondrially encoded subunit of ubiquinol-
cytochrome c reductase complex  
 VMA21 2.33 0.6 Integral ER membrane protein that is required for vacuolar H+-
ATPase (V-ATPase) function, functions in the assembly of V-
ATPase 
 CIN2 1.92 0.24 Tubulin folding factor C (putative) involved in beta-tubulin 
(Tub2p) folding 
 DAL7 2.2 0.46 Malate synthase, role in allantoin degradation unknown 
 RHR2 1.51 0.56 Constitutively expressed isoform of DL-glycerol-3-phosphatase; 
involved in glycerol biosynthesis, induced in response to both 
anaerobic and osmotic stress 
 PUT4 1.95 0.55 Proline permease, required for high-affinity transport of proline 
 OPT2 2.3 0.36 Oligopeptide transporter; member of OPT family, with potential 
orthologs in S. pombe and C. albicans 
 MTM1 3.04 0.52 Mitochondrial protein of the mitochondrial carrier family, 
involved in activating mitochondrial Sod2p  
 ATX1 1.87 0.44 Cytosolic copper metallochaperone that transports copper to 
secretory vesicle copper transporter Ccc2p for eventual insertion 
  RESULTS and DISCUSSION 85
Genes co-regulated by Lo and ZA  
into Fet3p 
 BCY1 1.54 0.43 Regulatory subunit of cyclic AMP-dependent protein kinase 
(PKA) 
 YJL171C 2.17 0.3 GPI-anchored cell wall protein of unknown function; induced in 
response to cell wall damaging agents and by mutations in cell 
wall genes  
 YJR096W 1.77 0.51 Putative xylose and arabinose reductase 
 PGA1 1.66 0.53 Essential protein required for maturation of Gas1p and Pho8p; 
has synthetic genetic interations with secretory pathway genes 
 YOR129C 2.41 0.4 Putative component of the outer plaque of spindle pole body; 
may be involved in cation homeostasis or multidrug resistance 
Unknown YBR191WA 1.61 0.25 Dubious open reading frame unlikely to encode a protein 
 YGR126W 2.45 0.54 Protein of unknown function; localized to the cytoplasm and 
nucleus 
 YOL035C 1.85 0.65 Hypothetical protein 
 YIL015CA 2.53 0.63 Hypothetical protein 
 YOR268C 1.54 0.6 Hypothetical protein 
 YJL182C 2.51 0.39 Hypothetical protein 
 YPL109C 1.51 0.55 Hypothetical protein 
 YPL073C 1.62 0.49 Hypothetical protein 
 YML101CA 2.35 0.42 Hypothetical protein 
 YCR049C 2.0 0.42 Hypothetical protein 
 
Fifteen genes whose expression was activated in response to zaragozic acid and 
repressed in response to lovastatin were involved mainly in RNA metabolism, transcription 
and cytokinesis. With the exception of MAF1, these genes had not been functionally linked to 
the IP pathway by other reports. The role of MAF1 will be discussed in the next chapter 
(2.2.1.3.2). 
 
Table 11: Genes whose expression was activated by zaragozic acid and repressed by lovastatin 
Functional Gene Ratio of 
expression 
Description 
category  Lo ZA  
RNA 
metabolism 
AI2 0.58 6.0 Reverse transcriptase required for splicing of COX1 pre-mRNA, 
encoded by a mobile group II intron within mitochondrial COX1 
gene 
 NOP14 0.57 2.75 Nucleolar protein involved in maturation and nuclear export of 
40S ribosomal subunits; and also in processing of pre-18S rRNA 
 DBP3 0.56 2.43 Putative ATP-dependent RNA helicase of DEAD-box family 
involved in ribosomal biogenesis 
Cytokinesis SAC6 0.63 2.53 Fimbrin, actin-bundling protein 
 BUD6 0.62 2.39 Actin- and formin-interacting protein, involved in actin cable 
nucleation and polarized cell growth; potential Cdc28p substrate 
Transcription MAF1 0.22 2.16 Negative regulator of RNA polymerase III; targets initiation 
factor TFIIIB 
 DNA43 0.63 2.1 (MCM10); Essential, chromatin-associated protein involved in 
initiation of DNA replication 
Other FDH1 0.64 3.78 NAD(+)-dependent formate dehydrogenase, may protect cells 
from exogenous formate; involved in purine fermentation 
 RPN6 0.59 2.72 Essential, non-ATPase regulatory subunit of 26S proteasome lid 
required for the assembly and activity of 26S proteasome 
 JEN1 0.43 2.0 Lactate transporter, required for uptake of lactate and pyruvate; 
expression is repressed in the presence of glucose, fructose, and 
mannose 
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 MDH1 0.66 2.4 Mitochondrial malate dehydrogenase, catalyzes interconversion 
of malate and oxaloacetate; involved in tricarboxylic acid (TCA) 
cycle 
Unknown YCL020W 0.59 2.23 TyA Gag protein; main structural constituent of virus-like 
particles (VLPs) 
 YLL055W 0.46 2.0 Putative ion transporter activity localized to ER 
 YDL068W 0.58 1.69 Hypothetical protein 
 YLR124W 0.59 2.41 Hypothetical protein 
 
2.2.1.3.1 Rpn4p transcription factor and proteasome-regulated protein degradation 
To identify potential transcription factors involved in the early response to inhibitors 
of the IP pathway we looked for regulatory motifes in the promoters of the responsive genes. 
We have restricted our search only to documented interactions between a gene and a given 
transcription factor. The most striking and common feature of the genes responsive to 
lovastatin or zaragozic acid was the fact that many of them contained in their promoter region 
a sequence binding the Rpn4p transcription factor (Figure 40). Potentially, Rpn4p could 
regulate approximately 15% of the genes overexpressed due to lovastatin and 15% of those 
overexpressed due to zaragozic acid. Interestingly there was no overlap between those two 
groups of genes, suggesting that Rpn4p could act as a condition-altered transcription factor, 
i.e. targeting different genes depending on the stimuli. Although Rpn4p is known to acts as an 
activator of transcription, it is important to mention that ~12% of the genes underexpressed in 
the presence of zaragozic acid and ~4% repressed by lovastatin also contained an Rpn4-
binding sequence in their promoters. This suggests an additional regulation of these genes in 
the tested conditions, likely by a distinct transcription factor.  
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Figure 40: Genes responsive to lovastatin or zaragozic acid potentially regulated by Rpn4 transcription 
factor. 
 
The Rpn4 protein is known to be required for normal expression of 26S proteasome 
subunits, however, a global analysis of expression in the rpn4∆ mutant has shown much wider 
effects of its depletion (Fleming et al., 2002; Xie and Varshavsky, 2001). The 26S proteasome 
is a giant protein complex (comprising more than 30 proteins) devoted to ATP-dependent 
degradation of proteins, which were earlier ubiquitinated. When we compared the distribution 
of the genes responsive to lovastatin and zaragozic acid we could notice that while the 
response to lovastatin was characterized by activation of protein catabolism (upregulated 
genes- YTA7, AMA1/SPO70, CIC1, GRR1, CNE1, NAS2, PNG1, DOC1; downregulated 
genes- YDR306C, ATE1, RPN6), zaragozic acid caused rather a suppression of genes 
representing this category (upregulated genes- RPN6, JEM1; downregulated genes- NAS2, 
SCJ1, RPN12, CIC1, PEP4, YTA7, GGA2, APC2, BAR1, MNS1, PUP3, PRE6) (see Figure 
37, pg.79 and Figure 39, pg 82). Some of these genes, which are involved in proteasome-
dependent protein degradation, are described in Table 12. It can be seen that zaragozic acid 
caused repression of five proteasome subunits while lovastatin induced expression of two.  
These transcriptional effects are important since we know that 26S proteasome-
dependent degradation of proteins is one of the ways to regulate the performance of the IP 
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pathway. Remarkably, expression of an essential gene, RPN6, coding for a proteasome 
subunit was activated by zaragozic acid and repressed by lovastatin. This subunit is 
responsible for recognition of a subset of substrates of the proteasome. 
An independent study has shown that expression of RPN4 and consequently 26S 
proteasome-dependent proteolysis are regulated by Pdr1p, a transcription factor that mediates 
multiple drug response (Owsianik et al., 2002). We detected overexpression of PDR1 in cells 
treated with zaragozic acid. Additionally, we observed changes in the expression of genes 
involved in proteasome function but apparently lacking a binding site for Rpn4p, e.g. RPN6 
and NAS1. These genes and others that are involved in ubiquitination that precedes protein 
degradation are presented in Table 12. 
Altogether, these results suggest that the activity and substrate specificity of 26S 
proteasome could be inversely affected by the presence of lovastatin and zaragozic acid.  
 
Table 12: Genes involved in protein ubiquitination and degradation in 26S proteasome, whose expression 
changed in response to lovastatin (Lo) or zaragozic acid (ZA) 
Gene Ratio of 
expression* 
Description 
 Lo ZA  
RPN6 0.59 2.72 Essential, non-ATPase regulatory subunit of 26S proteasome lid required for 
assembly and activity of 26S proteasome 
CIC1 2.02 0.21 Essential protein that interacts with proteasome components and has potential role 
in proteasome substrate specificity 
NAS2 1.62 0.49 Protein with similarity to p27 subunit of mammalian proteasome modulator; not 
essential; interacts with Rpn4p 
PRE6 - 0.33 20S proteasome subunit 
RPN12 - 0.42 Subunit of 19S regulatory particle of 26S proteasome lid; synthetically lethal with 
RPT1, which is an ATPase component of 19S regulatory particle; physically 
interacts with Nob1p and Rpn3p 
PUP3 - 0.45 Beta subunit of 20S proteasome involved in ubiquitin-dependent protein 
catabolism 
PNG1 1.53 - Conserved peptide N-glycanase required for deglycosylation of misfolded 
glycoproteins during proteasome-dependent degradation 
GID7 - 2.08 Protein of unknown function, involved in proteasome-dependent catabolite 
inactivation of fructose-1,6-bisphosphatase 
APC2 - 0.58 Subunit of Anaphase-Promoting Complex/Cyclosome (APC/C), which is a 
ubiquitin-protein ligase required for degradation of anaphase inhibitors 
DOC1 1.52 - Processivity factor required for the ubiquitination activity of APC, mediates 
activity of APC by contributing to substrate recognition; involved in cyclin 
proteolysis 
GRR1 1.94 - F-box protein component of SCF ubiquitin-ligase complex, required for Cln1p 
and Cln2p degradation 
HSE1 1.75 - Subunit of endosomal Vps27p-Hse1p complex required for sorting of 
ubiquitinated membrane proteins into intralumenal vesicles prior to vacuolar 
degradation, as well as for recycling of Golgi proteins and formation of lumenal 
membranes 
UBC11 1.59 - Ubiquitin-conjugating enzyme not required for degradation of mitotic cyclin Clb2 
UBP8 0.63 - Ubiquitin-specific protease that is a component of SAGA (Spt-Ada-Gcn5-
Acetyltransferase) acetylation complex; required for SAGA-mediated 
deubiquitination of histone H2B 
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BUL1 - 1.61 Ubiquitin-binding component of Rsp5p E3-ubiquitin ligase complex, functional 
homologue of Bul2p 
PIB1 - 1.52 RING-type ubiquitin ligase of endosomal and vacuolar membranes, binds 
phosphatidylinositol(3)-phosphate 
TOM1 - 1.74 E3 ubiquitin ligase of hect-domain class; has a role in mRNA export from 
nucleus and may regulate transcriptional coactivators 
RPL40A - 0.45 Fusion protein, identical to Rpl40Bp, that is cleaved to yield ubiquitin and a 
ribosomal protein of large (60S) ribosomal subunit with similarity to rat L40; 
ubiquitin may facilitate assembly of the ribosomal protein into ribosomes 
RPL40B - 0.47 Fusion protein, identical to Rpl40Ap, that is cleaved to yield ubiquitin and a 
ribosomal protein of large (60S) ribosomal subunit with similarity to rat L40; 
ubiquitin may facilitate assembly of the ribosomal protein into ribosomes 
CSN9 - 1.76 Subunit of Cop9 signalosome, which is required for removal of ubiquitin-like 
protein Rub1p from Cdc53p (cullin); involved in adaptation to pheromone 
signaling 
 
*  ‘-‘ indicates no significant changes of expression level 
 
 
2.2.1.3.2 RNA polymerase III transcription 
Several genes putatively regulated by FPP availability play a role in transcription 
(compare Table 10 & Table 11). A detailed list of genes involved in various aspects of tRNA 
metabolism responsive to lovastatin or zaragozic acid is presented in Table 13. Interestingly, 
only zaragozic acid affected tRNA methylation (P value 0.0095) which is the most prevalent 
modification of yeast tRNA. However, the function of this modification remains unclear. On 
the other hand, lovastatin caused downregulation of THG1 gene whose depletion results in 
accumulation of uncharged tRNAHis in the nucleus and activation of the GCN4 pathway (Gu 
et al., 2005). This activation is to some extent dependent on GCN2 whose expression was 
induced by lovastatin treatment. In these circumstances, it is possible that the GCN4 pathway 
was activated due to lovastatin action especially that we observed an overexpression of 14 
genes (ACO2, ADE8, ARG3, BAT1, FOL2, GIP1, MUP3, PCL5, PEX21, SNO1, TDH3, 
THR1, TPK1, YHR020W) that are known targets of this pathway. 
 
Table 13: Genes involved in tRNA metabolism that were responsive to lovastatin (Lo) or zaragozic acid 
(ZA) 
Gene Ratio of 
expression 
                                Description 
 Lo ZA  
Repressor of Pol III 
MAF1 0.22 2.16 Negative regulator of RNA polymerase III; targets initiation factor TFIIIB 
TF III 
TFC3 - 2.0 Largest of six subunits of RNA polymerase III transcription initiation factor 
complex (TFIIIC)  
BRF1 - 0.49 TFIIIB subunit, 70 kDa, interacts with Maf1p 
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Pol III 
RPC25 1.99 0.57 RNA polymerase III, 25 KD subunit 
RPO26 - 1.66 RNA polymerase I, II, III 18 KD subunit 
RPC11 - 1.53 RNA polymerase III subunit C11, required for RNA cleavage activity and 
transcription termination 
tRNA metabolism 
UTP8 2.16 0.28 Nucleolar protein required for export of tRNAs from nucleus 
GRS1 - 0.61 Cytoplasmic and mitochondrial glycyl-tRNA synthase  
YMR087w - 0.60 Putative ADP-ribose-1''-monophosphatase that converts ADP-ribose-1''-
monophosphate to ADP-ribose; may have a role in tRNA splicing 
SEN15 0.66 - Subunit of tRNA splicing endonuclease, which is composed of Sen2p, Sen15p, 
Sen34p, and Sen54p 
DED81 - 0.42 Cytosolic asparaginyl-tRNA synthetase, required for protein synthesis 
RNH70 - 0.5 3' exoribonuclease, required for 5S and tRNA-Arg3 maturation 
PUS6 - 0.36 Pseudouridine synthase responsible for modification of cytoplasmic and 
mitochondrial tRNAs at position 31 
ATE1 0.64 - arginyl-tRNA-protein transferase 
THG1 0.53 - tRNAHis guanylyltransferase, adds guanosine residue to 5' end of tRNAHis after 
transcription and RNase P cleavage 
GCN2 1.74 - Protein kinase, phosphorylates eIF2 (Sui2p) in response to starvation; activated 
by uncharged tRNAs and Gcn1p-Gcn20p complex 
tRNA methylation 
TRM12 - 1.91 S-adenosylmethionine-dependent methyltransferase of seven beta-strand family; 
required for wybutosine formation in phenylalanine-accepting tRNA 
TRM7 - 1.62 2'-O-ribose methyltransferase, methylates nucleotides at positions 32 and 34 of 
tRNA anticodon loop 
TRM8 - 1.51 Subunit of tRNA methyltransferase complex composed of Trm8p and Trm82p 
that catalyzes 7-methylguanosine modification of tRNA 
TRM82 - 0.32 Subunit of tRNA methyltransferase complex composed of Trm8p and Trm82p 
that catalyzes 7-methylguanosine modification of tRNA 
GCD10 - 1.64 Subunit of tRNA (1-methyladenosine) methyltransferase, required with Gcd14p 
for modification of adenine at position 58 in tRNAs 
 
Among genes inversely regulated by IP pathway inhibitors and involved in tRNA 
metabolism we can find MAF1, a gene encoding repressor of polymerase (pol) III and RPC25, 
encoding a subunit of pol III that is required for initiation of transcription (Desai et al., 2005; 
Pluta et al., 2001; Zaros and Thuriaux, 2005) as well as UTP8 required for export of tRNAs 
from the nucleus. Pol III is responsible for the transcription of tRNAs as well as many other 
essential small untranslated RNAs.  
So far, there is only one established connection between tRNA biosynthesis and the IP 
pathway since both pathways use DMAPP as a substrate. DMAPP, apart from being required 
for FPP synthesis, is also used by Mod5p to create in tRNA molecules N6-(∆2-isopentenyl) 
adenosine (i6A tRNA) that alters tRNA-mediated nonsense suppression (Benko et al., 2000). 
The amount of Mod5p is co-regulated with the amount of tRNA available for modification 
and consequently with the general rate of tRNA synthesis (Boguta et al., 1997). Importantly, 
when Maf1p is depleted, the levels of tRNA and Mod5p increase while the level of ergosterol 
goes down (Kaminska et al., 2002). This is consistent with an earlier hypothesis regarding 
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competition between the Mod5 and Erg20 proteins for the limited pool of DMAPP (Benko et 
al., 2000). 
Figure 41 gives a general comparison between the effects of lovastatin and zaragozic 
acid on the genes involved in tRNA synthesis. It can be seen that while lovastatin could 
positively regulate the transcription and nuclear export of mature tRNAs, zaragozic acid had 
an opposite effect.  
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Figure 41: Effects of lovastatin and zaragozic acid on tRNA biosynthesis. 
A. Model of lovastatin (Lo) action. B. Model of zaragozic acid (ZA) action. Known affected pathways are 
marked in blue. Dashed lines indicate pathways of which the components are not shown. Other genes involved in 
tRNA metabolism are listed in Table 13, pg 90. 
 
Generally, the main difference between the two compared conditions, i.e. lovastatin or 
zaragozic acid stress (Figure 41), would be the availability of FPP that is expected to decrease 
in the presence of lovastatin and to increase in the presence of zaragozic acid (details in 
chapter 1.2.2, pg 25). Our transcriptomic data implies a positive feedback regulation of the 
MAF1 gene expression by increased availability of FPP or DMAPP. The observed 
upregulation of MAF1 might result in the inhibition of tRNA biosynthesis. It is known that 
tRNA synthesis, as an energy-costly event, is coupled to the cell growth. When FPP 
accumulates (as in the case of SQS inhibition) toxic farnesol is produced which results in 
growth inhibition (Machida et al., 1999). Thus, it is reasonable that cells treated with 
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zaragozic acid would decrease tRNA biosynthesis because of toxic farnesol. Accordingly, 
tRNA synthesis has been shown to be repressed in the various conditions that are not favoring 
the growth and this repression is dependent on Maf1p (Upadhya et al., 2002).  
On the other hand, a decrease of FPP availability in the cell, by the repression of 
MAF1 expression, could increase the rate of tRNA synthesis and consequently lead to an 
increase of protein synthesis, including the proteins of the IP pathway. By this means, the cell 
would be able to biosynthesize more FPP. Nevertheless, the level of tRNA after treatment of 
yeast with IP pathway inhibitors remains to be verified.  
It has been suggested before that Maf1p could be involved in the control of the IP 
pathway (Kaminska et al., 2002). Our data imply that, reciprocally, compounds of this 
pathway might regulate MAF1 expression and consequently tune tRNA synthesis with the cell 
demand. Potential candidates for playing this role would be signals derived from DMAPP, a 
non-sterol FPP offshoot or FPP itself. It is important to note that ergosterol is unlikely to have 
a regulatory function on MAF1 expression as the action of both tested inhibitors should result 
in a decreased metabolite flux of the ergosterol branch of the IP pathway. 
 
 
2.2.1.4 Discussion 
To enlarge upon earlier studies of the IP pathway we treated yeast cells with two 
agents, lovastatin, an inhibitor of HMG-CoA reductase, and zaragozic acid, an inhibitor of 
squalene synthase. Both these inhibitors are known to have the same reducing effect on the 
amount of cellular sterols while having an opposite effect on the FPP availability. Analysis of 
the response to lovastatin showed that the first reaction of the cells at the transcriptional level 
was to increase the expression of genes engaged in the uptake of sterols from the medium, 
while transcription of other genes directly involved in the IP pathway was not changed. The 
first response to zaragozic acid was upregulation of two genes coding for components of the 
sterol branch of the IP pathway. Also other genes, known to regulate sterol metabolism were 
affected. Remarkably, we noticed that approximately 15% of the genes whose expression 
changed due to lovastatin or zaragozic acid treatment contained in their promoter a region 
binding site for the Rpn4p transcription factor that is involved in expression of the 26S 
proteasome subunits. Moreover, both inhibitors caused changes in the expression of genes 
involved in ubiquitination and proteasomal degradation of proteins. Importantly, while 
lovastatin preferably caused activation of genes involved in protein catabolism, this functional 
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category was suppressed by zaragozic acid. These data together with the fact that Hmg2p is 
regulated by proteasomal degradation support the notion that this kind of cellular control, in 
response to changing availability of FPP, could affect more proteins belonging to the IP 
pathway.  
Additionally, the transcription profiles of the response to lovastatin and to zaragozic 
acid indicated that availability of FPP could affect tRNA biosynthesis. Probably because of 
this regulation, lovastatin caused activation of genes involved in ribosome biogenesis and 
protein biosynthesis while zaragozic acid tended to suppress both groups of genes. Both these 
transcriptional responses, concerning the 26S proteasome and tRNA biosynthesis, should be 
investigated further. 
Overall, we have identified 59 genes whose expression was presumably regulated by 
the changing availability of FPP. Among these genes, there was a nonessential gene coding 
for Yta7p of unknown function. Since it had previously been suggested that this protein could 
be involved in the IP pathway {K. Grabinska, PhD thesis} we decided to focus our further 
investigation on the YTA7 gene. 
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2.2.2 Involvement of Yta7p in the isoprenoid pathway 
YTA7, a gene coding for a protein of unknown function, was previously found to 
interact with ERG20, coding for one of the IP pathway’s enzymes, FPP synthase. Cells 
lacking YTA7 had an increased level of squalene. This increase could be explained in two 
ways: by increased squalene synthase activity or a decreased turnover of squalene. The latter 
explanation is less probable since the levels of other sterol products were not changed in the 
yta7∆ mutant {Grabińska, unpublished}. In this study, we discovered that expression of YTA7 
was regulated in opposite ways by the two inhibitors of the mevalonate pathway investigated 
in this work, acting oppositely on the intracellular availability of FPP. Altogether, these 
results suggested an involvement of Yta7p in the IP pathway. To establish the function of 
Yta7p, in the next step we measured the enzymatic activities of proteins belonging to the IP 
pathway upon depletion of YTA7.  
 
 
2.2.2.1 Enzymatic activities of FFP synthase, cis-prenyltransferase and dolichol level in 
the yta7∆ mutant 
Since earlier data showed a 2-fold increase in the level of squalene in the yta7∆ mutant 
{K. Grabinska, PhD thesis} we decided to investigate the effect of YTA7 depletion on other 
enzymes of the IP pathway beside squalene synthase. Cis-prenyltransferase, as the first 
enzyme committed to dolichol biosynthesis and one of the enzymes consuming FPP in the 
cell, was chosen for further investigation. It turned out that Yta7p apparently had an inhibitory 
effect on FPP as we observed a moderate increase of this enzyme’s activity in the yta7∆ 
mutant (Figure 42B; see the method in chapter 3.1.7.1, pg 127). Although this increase was 
not statistically significant, in cells treated with lovastatin the increase of the activity reached 
31% of the wild type level and was significant. This result suggests that the inhibitory effect 
of Yta7p on cis-prenyltransferase activity should be more pronounced upon lovastatin 
treatment, i.e. when the level of FPP is decreased. This view would be in agreement with the 
higher demand of cells for Yta7p activity when the level of FPP is decreased and could 
explain YTA7 overexpression in response to lovastatin. In agreement with the very moderate 
increase in cis-prenyltransferase activity in the yta7∆ mutant (by 19% of the wt level), 
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dolichol level showed a similar increase (by 23% of the wt level) (Figure 42D; see the method 
in chapter 3.1.7.3, pg 128). Lovastatin decreases the efficacy of the mevalonate pathway and 
in agreement with this well-established fact we observed a decrease in the total amount of 
dolichol in cells treated with this inhibitor. A similar decrease was observed in the yta7∆ 
mutant upon lovastatin treatment, suggesting that the process leading to this decrease was not 
affected by YTA7 deletion.  
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Figure 42: Cis-prenyltransferase activity and dolichol level.  
A. Autoradiogram of polyprenols synthesized in vitro. In order to measure the activity of cis-prenyltransferase, 
{14C} IPP was used as the radiolabeled substrate. The products of the reaction were developed on RP18 HPTLC 
plates and detected by autoradiography. B. Activity of cis-prenyltransferase. Regions of RP18 HPTLC plates, 
from panel A, containing radiolabeled products were scraped and quantified by liquid scintillation counting.  
C. Dolichols on RP18 HPTLC plates stained with iodine vapor. To measure dolichol levels, lipid fraction was 
isolated from cellular membranes, developed on an RP18 HPTLC plate and revealed with vapor of iodine.  
D. Intracellular level of dolichol. The intensity of dolichol signal was quantified and compared to that in the wild 
type strain, taken as 100%. Results shown in panel B and D are averages of three independent experiments ± SD. 
Where indicated, 25 µg/ml of lovastatin (Lo) was added to the growth medium. 
 
Since we assumed that Yta7p could inhibit the activity of cis-prenyltransferase our 
next move was to check if deletion of YTA7 could affect the activity of FPP synthase, acting 
upstream of both cis-prenyltransferase and squalene synthase. To verify this, we measured 
FPP synthase activity in the yta7∆ mutant (Figure 43; see the method in chapter 3.1.7.2, pg 
127). Our experiment clearly showed a lack of any significant effects of the YTA7 deletion on 
the activity of FPP synthase. Moreover, this result showed that the activity of FPP synthase in 
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wild-type cells was moderately affected by lovastatin treatment while it was not affected in 
the yta7∆ mutant. 
Figure 43: FPPS activity in vitro.  
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The assay was performed with DMAPP as the allylic starter 
and {14C} IPP as a radiolabeled substrate and yeast cell extract 
as the source of the enzyme. Where indicated, 25 µg/ml 
lovastatin (Lo) was added to the growth medium. The results 
shown are averages of three independent experiments ± SD. 
 
 
 
 
 
 
2.2.2.2 HMG2 but not HMG1 is a multicopy supressor of lovastatin sensitivity of the 
yta7∆ mutant 
Since we observed overexpression of the YTA7 gene in the cells with the lovastatin-
impaired IP pathway, we decided to verify the effects of decreased FPP availability in the 
yta7∆ mutant. Thus, in an attempt to decrease the cellular level of FPP we added lovastatin to 
yeast cultures of the wild type and yta7∆ mutant. Additionally, we tested cells overexpressing 
HMGR encoding genes. It can be seen in Figure 44 that HMG1 or HMG2 expressed from a 
multicopy plasmid alleviated the growth inhibition of the wild type strain caused by 
lovastatin. 
Figure 44 : HMG2 but not HMG1 is a multicopy supressor of 
lovastatin sensitivity of the yta7∆ mutant. 
wt HMG1
yta7∆
HMG2
HMG2
HMG1
-
-
+Lo
Serial dilutions of exponentially growing cultures of each mutant 
were spotted onto SD agar plates containing 0 or 300 µg/ml 
lovastatin (Lo). Growth was scored after 5 days of incubation at 
28ºC. HMG1, strain bearing pNEVHMG1; HMG2, strain bearing 
pNEVHMG2; - strain bearing empty vector. 
 
 
 
However, in the yta7∆ mutant only overexpression of HMG2 was able to exert this 
effect. This result suggests that Yta7p is either needed for one of the steps of HMG1 
expression or it is required further at the level of FPP-consuming enzymes. The fact that the 
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YTA7 deletion did not affect FPP synthase activity suggests that Yta7p acts downstream of 
this enzyme in the IP pathway Since it was proposed that Yta7p was involved in chromatin 
silencing, we considered the possibility that Yta7p could play a role in HMG1 silencing. 
Importantly, this effect could not occur in our experimental design because the multicopy 
plasmids we used bear only ORF of the gene without the surrounding regions where the 
Dpb4p complex guarding the boundary of silent chromatin could potentially bind. 
Nevertheless, we verified whether this regulation might occur in the genome, i.e. we 
compared coordinates of the HMG1 and HMG2 loci to the coordinates of regions binding 
Dpb4p complex (Tackett et al., 2005). Surprisingly, it turned out that HMG1 could be 
potentially regulated in this way because it was placed just upstream of the boundary region 
of heterochromatin (Chromosome XIII, coordinates 118898 bp to 120089 bp) while HMG2 
was not located in the neighborhood of such regions. On the other hand, it cannot be excluded 
that overexpression of HMG1 was not functional in the yta7∆ cells for some other reasons. 
The different effects of HMG1 and HMG2 overexpression in the yta7∆ mutant in 
terms of lovastatin sensitivity additionally support the notion of distinct regulation of these 
two genes.  
 
 
2.2.3 Characterization of molecular properties of Yta7p 
 
2.2.3.1 Yta7 protein localization 
As we decided to focus our study on the Yta7 protein function, we first investigated its 
cellular localization. In parallel, we localized Erg20p, a protein that had earlier been proposed 
to interact physically with Yta7p {K. Grabinska, PhD thesis}. In order to visualize Yta7p two 
independent methods were used, subcellular fractionation and immunofluorescence 
microscopy. 
 
2.2.3.1.1 Subcellular fractionation 
Subcellular fractionation is a method based on the separation of intracellular 
organelles according to their density by centrifugation (for details see chapter 3.1.6.1, pg 
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125). Obviously, this method allows only an approximation of a protein’s localization due to 
the inevitable minor contaminations between fractions. To trace the Yta7 and Erg20 proteins 
in individual fractions, they were fused with a ProtA tag. This experiment showed that Yta7p 
was not freely dispersed in the cytoplasm since it was absent in the 100 000×g supernatant 
fraction containing soluble cytoplasmic proteins (Figure 45). Yta7p was present in the 500×g, 
3000×g and 100 000×g pellet fractions, showing exactly the same pattern of localization as 
Dpm1p (dolichyl phosphate mannose synthase), which is known to localize to the ER 
membrane. The 3000×g pellet fraction is supposed to contain nuclei, but as the ER membrane 
differentiates directly from the nucleus membrane, this fraction is by its nature contaminated 
with the ER membrane. Erg20p showed an ubiquitous pattern of localization. The protein was 
most abundant in the 100 000×g pellet containing the ER compartment and 100 000×g 
supernatant containing the cytosol, while its amount was reduced in the nuclei.  
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Figure 45: Localization of Yta7 and Erg20 proteins – subcellular fractionation. 
 Yeast spheroplasts from cells expressing ProtA-Erg20p or ProtA-Yta7p from a single-copy vector were 
homogenized and subjected to a series of centrifugations: 500×g, 3000×g,  10 000×g, 25 000×g, 50 000xg and 
100 000×g. Aliquots were taken from pellets (P) and supernatant (S) (100000×g) fractions and analyzed by 
immunoblotting. Dpm1p (dolichyl phosphate mannose synthase) detected with anti-Dpm1p antibody was used as 
an ER membrane marker. 
 
 
2.2.3.1.2 Immunofluorescence microscopy 
As previously, to trace the Yta7 and Erg20 proteins they were fused with ProtA tag, 
which was visualized with an antibody conjugated to Cy3-fluorophore. It can be seen in 
Figure 46A that Yta7p exhibited high concentration in and around the nucleus and a punctate 
pattern in the cytoplasm (see the method in chapter 3.1.6.2, pg 126). Erg20p was barely 
detected in the nucleus but it was present in the cell zone tightly surrounding this structure. 
Additionally, Erg20p not only showed a punctate pattern but was also dispersed in the 
cytoplasm (Figure 46A). We also performed control staining of ER membranes in the tested 
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strain using Dpm1p as an ER-marker protein (Figure 46B). ER was localized to the thin layer 
surrounding the nucleus. 
Cy3 DAPI Cy3+DAPI
Yta7p-ProtA
Erg20p-ProtA
A. B.
Tx Red + DAPI
Dpm1p
Figure 46: Localization of Yta7 and Erg20 proteins – immunofluorescence microscopy.  
A. Yeast cells expressing ProtA-Erg20p or ProtA-Yta7p from single-copy vectors were fixed with formaldehyde 
cross-linking. Fusion proteins were detected with an antibody conjugated with Cy3-fluorophore. After DAPI 
staining of DNA, cells were subjected to immunofluorescence microscopy. B. A control experiment done in 
order to visualize ER in BY4742 cells. As an ER marker protein, Dpm1p was used. Nikon Eclipse E800 
microscope was used for the visualization of yeast (magnification × 100, oil immersion). 
 
 
2.2.3.1.3  Binding of Yta7p to cellular membranes 
After having localized Yta7p to the ER membrane we decided to verify whether Yta7p 
was an integral or a peripheral protein. According to SGD PepPlot analysis of hydrophobic 
properties of the protein sequence, two transmembrane regions were predicted (533-550aa, 
838-857aa). However, careful analysis showed that these hydrophobic regions lie within 
predicted ATP-binding domains (Figure 47B) which possess some hydrophobic regions likely 
buried in the protein’s core (Beyer, 1997). To investigate this problem, we isolated membrane 
fraction from logarithmically growing yeast cells expressing Yta7p fused with a TAP-tag, and 
treated it with various polar reagents (NaCl, Na2CO3, and urea) and a detergent (TritonX-100) 
(method in chapter 3.1.8.6, pg 131). Then the samples were centrifuged and the efficacy of 
Yta7p solubilzation was determined by assessing the translocation of the protein from the 
membrane fraction (pellet) to the aqueous solution (supernatant). As a control, the same 
experiment was performed tracing Dpm1p, an integral protein of the ER membrane (not 
shown). As shown in Figure 47A, all the reagents used were able to break the association of 
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Yta7p with the membrane which indicates that it is a peripheral protein linked to the 
membrane indirectly, probably by an interaction with another protein.  
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Figure 47: Yta7p is a peripheral membrane protein.  
A. Western blot analysis of the membrane fraction isolated from a yeast strain carrying fusion Yta7-TAP 
protein-encoding gene integrated in the genome. The membrane fraction was treated with the indicated 
compounds and after centrifugation, the presence of the protein was checked in the pellet (P) and in the 
supernatant (S) fraction. B. Hydropathy plot of Yta7 protein, putative transmembrane (TM) regions and ATP-
binding (AA) domains are indicated. 
 
 
2.2.4 Involvement of Yta7p in ion homeostasis 
 
2.2.4.1  Global gene expression changes in the yta7∆ mutant 
To gain a broader perspective of the cellular role of Yta7p we analyzed a genome-
wide transcription pattern in a mutant strain lacking the YTA7 gene. Deletion of YTA7 caused 
only moderate changes in the gene expression and after statistical analysis (see the method in 
chapter 3.1.4, pg 117), we accepted 20 transcripts as significantly changed when compared to 
the levels of expression in the wild type. These genes, their expression ratio and brief 
descriptions are listed in Table 14. This experiment clearly showed that deletion of YTA7 did 
not cause changes in the genes directly involved in the isoprenoid biosynthesis, suggesting 
that the previously observed effects on the enzymes of the IP pathway do not occur at the 
transcriptional level. The most induced gene turned out to be TRK1, coding for a high affinity 
potassium pump. Three genes were involved in cell wall biosynthesis and organization, 
namely GSC2, coding for a subunit of glucan synthase, KNR4, whose gene product interacts 
with Mpk1 kinase and CRZ1, encoding a transcription factor positively regulating GSC2 
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expression. Among the downregulated genes we observed SDL1 coding for serine 
dehydratase, which controls the major route of serine catabolism. Serine, besides its 
occurrence in proteins, is a component of glycerophospholipids and is used for sphingosine 
and ceramide biosynthesis. BIO3, encoding 7,8-diamino-pelargonic acid (DAPA) 
aminotransferase, was also downregulated. The product of this gene takes part in biotin 
synthesis, whose essential function is to transfer carboxyl groups. Biotin serves as a cofactor 
of enzymes such as acetyl-CoA carboxylase, methylmalonyl-CoA carboxyltransferase and 
methylmalonyl-CoA decarboxylase. Almost half of the genes whose expression was changed 
are uncharacterized, which makes interpretation of this data very difficult.  
 
Table 14: Genes whose expression was changed in the yta7∆ mutant 
Rang ORF Gene * Ratio Description P-value 
1 YJL129C TRK1 2.43 Potassium transporter I 0.01549 
2 YGL093W SPC105 1.75 Protein required for accurate chromosome segregation 0.01350 
3 YJL218W YJL218W 1.74 Protein similar to E.coli galactoside O-acetyltransferase 0.04978 
4 YNL027W CRZ1 1.68 Calcineurin responsive zinc-finger transcription facor 0.03819 
5 YNL225C CNM67 1.65 Component of the spindle pole body outer plaque 0.03766 
6 YPL207W YPL207W 1.63 Protein of unknown function 0.03944 
7 YGR032W GSC2 1.62 1,3-beta-D-glucan synthase subunit 0.01075 
8 YGR120C COG2 1.57 Component of conserved oligomeric golgi complex 0.02594 
9 YNL266W YNL266W 1.54 Hypothetical protein 0.00618 
10 YGR229C KNR4 1.51 Protein involved in cell wall biosynthesis  0.01934 
11 YPL125W KAP120 0.67 Karyopherin with a role in export of 60S ribosomal subunits 0.01279 
12 YDL094C YDL094C 0.66 Hypothetical protein 0.03290 
13 YIL100W YIL100W 0.65 Hypothetical protein 0.02970 
14 YHL010C YHL010C 0.65 Homologue of human breast cancer-associated protein BRAP2 0.03875 
15 YIL037C PRM2 0.65 Pheromone-regulated protein  0.02940 
16 YHR11W UBA4 0.62 Protein that activates Urm1p before its conjugation to proteins 0.01431 
17 YJR128W YJR128W 0.62 Hypothetical protein 0.03112 
18 YIL168W SDL1 0.6 L-serine dehydratase 0.04716 
19 YNR058W BIO3 0.47 DAPA aminotransferase involved in biotin synthesis 0.04827 
20 YIL015W BAR1 0.44 Barrierpepsin precursor, cleaves and inactivates alpha factor 0.02993 
* The genes involved in the cell wall biosynthesis are shown in bold. 
 
Next, we used the obtained transcriptional data to validate the assumption on the role 
of Yta7p in chromatin silencing (described earlier in chapter 1.2.3, pg 27). Only two genes 
SMI1/KNR4 and SLD1 out of the 20 whose expression was changed in the yta7∆ mutant were 
located near the boundaries of chromatin regions enriched in the Dpb4p complex and 
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therefore could potentially be regulated by this complex. The positions of those genes in the 
chromosome next to the regions of Dpb4p-complex binding are presented in Figure 48. 
However, no simple conclusion can be drawn from this observation as while the amount of 
the KNR4 transcript increased in the yta7∆ mutant, the amount of the SDL1 transcript 
decreased. Moreover, when one considers that 368 regions enriched in the Dpb4p complex 
have been identified in the whole yeast genome (Tackett et al., 2005), the probability of 
founding two genes in a group of 20, according to the z-score calculation, does not exeed that 
of a random event. To sum up, our data are inconclusive as to the involvement of Yta7p in 
chromatin silencing and in fact suggest no such involvement. 
A.
B.
dubious ORFWatson strand ORF Crick strand ORF
Figure 48: Chromosomal position of KNR4 and SDL1 near the boundary regions of heterochromatin.  
A. Chromosome VII features spanning coordinates 940000 - 960000 bp. The region enriched in Dbp4 complex 
is located between two vertical red dashed lines (coordinates 950890 bp to 951885 bp). KNR4/SMI1 locus is 
indicated by an arrow. B. Chromosome IX features spanning coordinates 21000 - 37000 bp. The region enriched 
in Dbp4 complex is located between two vertical red dashed lines (coordinates 27569 bp to 29032 bp). The 
SDL1 locus is indicated by an arrow. Represented chromosomal maps were obtained at SGD Database (Cherry et 
al., 1997). 
 
 
2.2.4.2  YTA7-TRK1 genetic interaction 
 
2.2.4.2.1 The yta7∆ mutant has a decreased level of intracellular potassium 
The gene with the most strongly affected expression in the yta7∆ mutant was TRK1 
coding for a potassium pump (Gaber et al., 1988). In yeast there are two proteins responsible 
for specific potassium uptake, i.e. Trk1p, a high affinity pump, and Trk2p with a much lower 
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affinity for potassium. Nevertheless, deletion of both genes is not lethal because yeast have 
other non-specific systems of cation uptake (Bihler et al., 2002; Ko and Gaber, 1991).  
To investigate the putative genetic interaction between the YTA7 and TRK1 genes we 
constructed a double mutant trk1∆yta7∆ (see the method in chapter 3.1.2, pg. 114) and we 
measured the content of intracellular K+. Analysis of the mutant strains showed that yta7∆ and 
trk1∆yta7∆ exhibited a decreased potassium level, similar to that of the trk1∆ mutant (Figure 
49B; see the method in chapter 3.1.8.7, pg 131). According to our measurements, deletion of 
the TRK1 gene alone caused a ~10% decrease in the cellular potassium content, in the cells 
grown on YPD or SC supplemented with potassium, while mutant cells cultivated in SC 
without additions contained 22% of potassium less than the wild type (only results obtained 
on SC+0.1 M KCl are shown). Recently, it has been shown that, depending on the strain 
background, loss of both TRK1 and TRK2 genes caused a 10 to 27% decrease in the cellular 
potassium level (Merchan et al., 2004; Ruiz et al., 2004). The uptake of potassium in this 
situation was attributed to unspecific transport systems, which remain to be identified. 
When the yta7∆ mutant was grown on the synthetic complete (SC) medium its growth 
was severely impaired comparing to that on YPD (Figure 49A), an effect similar to that 
observed by others for a trk1∆ strain (Bertl et al., 2003). It is known that the reduced growth 
of the trk1∆ mutant on the SC medium is caused by potassium deficit and can be rescued by 
addition of potassium to the medium. Therefore we tested the growth of the mutant strains on 
the SC medium with or without addition of 0.1 M KCl as well as on the rich YPD medium 
(Figure 49A). It could be seen that the trk1∆, yta7∆ and trk1∆yta7∆ mutants exhibited a 
growth defect on the SC medium which could be overcome by addition of potassium only in 
trk1∆ and trk1∆yta7∆ but not in the case of the yta7∆ mutant.  
Figure 49: Growth characteristics and potassium content 
in the trk1∆, yta7∆ and trk1∆yta7∆ mutants.   
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A. Serial dilutions of mutants were spotted onto agar plates 
containing SC, SC supplemented with 0.1 M KCl or YPD. 
Growth was scored after 2 days at 28°C. B. Measurement of 
cellular potassium level using flame atomic absorbtion 
spectrometry (FAAS). Cells were grown in SC supplemented 
with 0.1 M KCl. The results shown are averages of two 
measurements ± SD. 
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Interestingly, we observed a negative effect of the KCl supplementation in the SC 
medium on the cis-prenyltransferase activity. Our measurements showed that in wild type 
cells, during growth on SC medium supplemented with 0.1 M KCl, the activity of cis-
prenyltransferase decreased to ~60% of that seen in the cells grown on SC without additions 
(Figure 50; see the method in chapter 3.1.7.1, pg 127). This result, although very difficult to 
explain without further investigation, reflects the same tendency as was observed in the yta7∆ 
mutant: upon deletion of YTA7, i.e. when the level of intracellular K+ was lower comparing to 
the level in wild-type cells, the activity of cis-prenyltransferase was increased. Addition of 
potassium to the SC medium did not enhance the growth of the yta7∆ mutant. Interestingly, 
additional deletion of TRK1 in this strain led to an improvement of the growth in response to 
KCl supplementation. Moreover, in these conditions, all three mutants contained comparable 
levels of cellular K+. These results suggested that the yta7∆ mutant growth defect was not 
linked to the decreased level of potassium.  
Figure 50: Effect of the KCl supplementation on cis-prenyltransferase 
activity. 
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Wild-type cells were grown in SC medium supplemented with 0.1 M KCl 
or without additions. The isolated membrane fraction served as a source of 
the enzyme. The activity of cis-prenyltransferase was measured using 
{14C} IPP as the radiolabeled substrate. Products of the reaction were 
developed on RP18 HPTLC plates and quantified by liquid scintillation 
counting. The result shown is an average of three measurements ± SD. 
 
 
The non-specific uptake of potassium into cells is impaired in the presence of high 
extracellular concentrations of competing monovalent cations. Thus, when grown on media 
containing high concentrations of monovalent cations, yeast cells are expected to exhibit a 
greater dependence on specific potassium uptake mechanisms. Recently, it has been shown 
that specific potassium uptake in wild-type cells grown in the presence of 100 mM LiCl 
depends exclusively on Trk1p activity (Bertl et al., 2003). Given that, we studied the 
sensitivity of mutants to Li+ (Figure 51) and Na+ (results not shown). It turned out that yta7∆ 
was more sensitive to Li+ than the wild type but less sensitive than trk1∆ and the trk1∆yta7∆ 
double mutant. Tests with Na+ did not indicate an increased sensitivity of the yta7∆ mutant. 
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Figure 51: Li+ sensitivity assay. 
 form of CPY, 
w
hypersensitivity to Hygromycin B of the tr 1∆yta7∆ strains was caused by 
hyperpolarization of the plasma membrane. 
ilutions of yeast cultures were spotted onto 
YPD ag ates containing 50 µg/ml of Hygromycin B 
(Hyg B) or 500 µg/ml of Chloramphenicol (Ch). Growth 
was scored after 2 days at 28°C. B. Western analysis of 
CPY glycosylation. Only a single band (62 kDa) was 
detected corresponding to the mature form of CPY 
(mCPY). 
 
 
Serial dilutions of yeast cultures were spotted onto YPD agar plates 
without additions or with 0.15 M LiCl added. Growth was scored after 
2 days at 28°C. 
 
As a decreased level of K+ renders cells more 
sensitive to positively charged antibiotics we tested the 
sensitivity of our mutants to Hygromycin B (Figure 52A). Consistently with an earlier study 
(Madrid et al., 1998) the trk1∆ mutant was hypersensitive to this antibiotic. Also the double 
mutant trk1∆yta7∆ turned out to be hypersensitive to Hygromycin B but yta7∆ was as 
sensitive as the wild type. To be sure that the observed increased sensitivity was not due to the 
possible increase of cell wall permeability we tested also the sensitivity to other antibiotics 
like chloramphenicol (Figure 52A) and cycloheximide (result not shown). None of the tested 
strains was more sensitive to these antibiotics. On the other hand, the hypersensitivity to 
Hygromycin B can also indicate defects in protein glycosylation (Dean, 1995). For this 
reason, we tested the efficiency of protein glycosylation in our mutants. To this end, we 
examined glycosylation of carboxypeptidase Y (CPY), which is a good marker protein of this 
process (see the method in chapter 3.1.8.8, pg 132). When glycosylation is impaired, several 
forms of partially glycosylated CPY can be observed in Western analysis due to distinct gel 
mobilities of proteins carrying different numbers of sugar residues. It can be seen in Figure 
52B, that all the mutants tested contained only the mature fully glycosylated
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2.2.4.2.2 Deletion of YTA7 alters the cell wall structure and rescues CR- and CFW-sensitive 
phenotype of trk1∆ mutant 
The genome-wide analysis of gene expression levels in the yta7∆ mutant indicated that 
Yta7p could influence the cell wall biosynthesis (Table 14, pg 102). Observing 
overexpression of the GSC2 gene, coding for glucan synthase, and its transcriptional activator 
CRZ1, we decided to verify if deletion of YTA7 could cause changes in the cell wall features. 
To this end, we performed a test of Zymolyase sensitivity (see method in chapter 3.1.5.1, pg 
123). We found out that the yta7∆ and trk1∆yta7∆ mutants were more resistant to the 
digestion of the cell wall with Zymolyase than the wild type strain suggesting an increased 
level of glucan in the cell wall of these mutants (Figure 53A). Then, we tested the sensitivity 
of the mutant strains to two cell-damaging agents, Congo red and Calcofluor white (Figure 
53B). Interestingly, the trk1∆ mutant was hypersensitive to both tested drugs and this effect 
. 
YTA7 led to changes in the cell wall composition.  
 
 
igestion with 
Zymolyase 20-T (50 µg/ml) was taken as 100%. 
Values g are averages ± SD of three independent 
experime ts. B. Deletion of YTA7 rescues the 
sensitivity of trk1∆ mutant to Calcofluor white (CFW) 
and Congo red (CR). Serial dilutions of yeast cultures 
were spotted onto YPD agar plates containing 50 µg/ml 
Calcofluor white or 50 µg/ml Congo red. Growth was 
 54, only the levels of glucans were significantly increased in the yta7∆ 
mutant (by ~11%), while in the case of mannans and chitin a similar, but statistically non-
 
Altogether, these results implied that a lack of was abolished after deletion of the YTA7 gene
Figure 53: Deletion of YTA7 changes the properties 
of the cell wall. 
A. Deletion of YTA7 caused a decrease in the 
sensitivity to Zymolyase. The fraction of wild-type 
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To further support these results, we isolated the cell wall fractions from the mutant 
strains and using high-performance anionic exchange chromatography measured the content 
of the three main carbohydrate compounds (see the method in chapter 3.1.5.2, pg 124). As can 
be seen in Figure
+CFW +CR
YPD
wt
yta7∆
trk1∆
trk1∆ yta7∆
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significant tendency was found. Additionally, we observed that deletion of YTA7 in the 
mutant also caused an elevation of the amount of glucan in the cell wall, which could explain 
the decreased sensitivity of the double mutant to the cell wall damaging agents comp
the trk1∆ strain.  
trk1∆ 
ared to 
Figure 54: Content of the
n of the CWI 
pathway in chapter 1.1.2.2.1, pg 9). To examine this possibility we analyzed the amount of 
e
yta7∆ had a normal level of phosphorylated 
the CWI pathway in the observed effects of 
Yeast were cultivated in YPD medium to reach OD600 0.5 
and were assayed for phosphorylation level of Mpk1p 
using an phospho-p44/42 antibodies (Mpk1-P) and anti-
Mpk1p antibodies (Mpk1p). The gas1∆ mutant was used as 
a positive control of Mpk1p phosphorylation and mpk1∆ as 
a negative control. The experiment was performed twice 
with consistent results. 
 
 
 cell wall components.  
Glucose, mannose and glucosamine were released from the cell wall polysaccharides glucans, mannans and 
chitin, respectively, by sulfuric acid hydrolysis of purified cell wall fraction and quantified by high-performance 
anionic exchange chromatography (HPAEC). The results are averages of two independent experiments ± SD. 
 
Since induction of GSC2 expression can be also caused by Rlm1 the transcription 
factor, which is activated by the CWI pathway (Jung et al., 2002; Zhao et al., 1998), we 
investigated if this pathway was activated in the yta7∆ mutant (see descriptio
phosphorylated Mpk1 kinase (Figure 55; m thod in chapter 3.1.8.1, pg 128). It turned out that 
Mpk1p, thus we could exclude an involvement of 
the YTA7 deletion on the cell wall. 
Figure 55: Mpk1p phosphorylation in yta7∆ mutant. 
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2.2.4.3 Discussion 
To summarize our results up to this point we can say that deletion of YTA7 affected 
activity of at least two enzymes of the IP pathway, i.e. cis-prenyltransferase and squalene 
synthase, resulting in an increased level of dolichol and squalene in the yta7∆ mutant. 
Expression of the YTA7 gene changed upon lovastatin or zaragozic acid treatment suggesting 
its dependency on FPP level. Yet, we showed that the effects on the IP pathway elicited by 
YTA7 do not occur at the transcriptional level. Moreover, we discovered that for some 
unknown reasons overexpression of the HMG1 gene was not functional in the cells lacking 
YTA7 while overexpression of HMG2 was. All these data strongly support the importance of 
Yta7p for the IP pathway. We also showed, with two independent methods, that Yta7p was 
localized mainly to the nucleus, the endoplasmic reticulum (ER) membranes and it could be 
seen in the cytosol in a punctate pattern. Localization to the ER compartment was in 
agreement with the previously discovered ER retention signals in Yta7p sequence {M. 
Grynberg, unpublished}. These properties of Yta7p strongly indicated a role in the cell 
additional to the one putatively played in chromatin silencing, which was proposed by Tackett 
and coworkers (Tackett et al., 2005). If Yta7p exerted its function only through binding to 
chromatin, how could we explain its other cellular localizations? Among the genes whose 
expression changed upon 
at could be performed in the nucleus.  
by a two-hybrid screen, could occur in this compartment. Additionally, we showed that Yta7p 
level of K+. Additionally, the yta7∆ mutant was sensitive to Li+ while it was not sensitive to 
YTA7 depletion we found only two located to the immediate 
proximity of the silent regions and only one of them was downregulated. The fact that we did 
not detect downregulation of HMG1 in the yta7∆ mutant argues against the idea that deletion 
of YTA7 could cause silencing of this gene. Although our data does not support an 
involvement of Yta7p in the silencing we also cannot exclude it as one of the functions of this 
protein th
It is relevant that Yta7p was localized also to the ER compartment where many 
reactions of the IP pathway take place. Since Erg20p is also localized to the ER membranes, it 
is likely that the previously proposed physical interaction between Yta7p and Erg20p, shown 
was not a transmembrane protein but it was likely associated with an unknown membrane 
protein. 
A genome-wide transcriptome analysis of the yta7∆ strain pointed to the TRK1 gene, 
coding for a potassium pump, as the most strongly induced gene. Our further experiments 
supported this genetic interaction as we showed that the yta7∆ mutant had a decreased cellular 
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Ca2+. Since in the presence of high concentrations of Li+ uptake of K+ is dependent 
exclusively on Trk1p (Bertl et al., 2003), these results implied that the Trk1p-dependent 
specific
less K+, apparently they were not 
hyperp
 TRK1 gene rendered cells Congo red 
and Ca
 of this strain. We verified that the observed cell wall remodeling in the yta7∆ 
cells w
ays in the cell. However, our preliminary data 
suggest that the cellular potassium level can influence the activity of enzymes of the IP 
pathway. It needs further investigation whether the observed changes in the cell wall structure 
were the effects of an impairment of the IP pathway and potassium homeostasis or were 
caused by a direct effect of Yta7p depletion. 
 
 
 uptake of potassium could be impaired in the yta7∆ mutant. This impairment of 
potassium uptake could be reflected by observed overexpression of the TRK1 gene in this 
mutant. Although cells depleted for YTA7 contained 
olarized as shown by their normal Hygromycin B sensitivity.  
Although it is not known what could be the precise function of YTA7 in the IP pathway 
and ion homeostasis, for the first time we have reported here a dependency between the 
activity of cis-prenyltransferase and cellular K+ content. 
Interestingly, we found out that the deletion of
lcofluor white sensitive. It is not clear why the deletion of TRK1 could cause the 
sensitivity to the cell wall damaging agents. Nevertheless, since K+ is the cation responsible 
for the turgor of the cell (Serrano, 1996), it is likely that changes in the tension of the plasma 
membrane can influence the structure of the cell wall.  
Deletion of YTA7 also influenced expression of a few genes involved in the cell wall 
remodeling (CRZ1, GSC2, KNR4) and consistently with this induction we have detected 
changes in the cell wall structure in the yta7∆ cells. Deletion of YTA7 in the trk1∆ strain 
caused the same effects on the cell wall structure, rescuing the Congo red and Calcofluor 
white sensitivity
as independent of the typical CWI pathway. Nevertheless, it is worth noting that a 
physical interaction of Mpk1p with the Knr4 protein is necessary for correct signaling to the 
Rlm1p transcription factor (Martin-Yken et al., 2003) and KNR4 was upregulated in cells 
lacking YTA7.  
Altogether, these data show that Yta7p is involved in both the IP pathway and 
potassium homeostasis. So far, it is not known if this due to two separate activities played by 
this protein or to co-regulation of both pathw
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3 EXPERIMENTAL PROCEDURES 
 
 
Abreviations that are commonly used in this chapter: 
 
BSA - Bovine serum albumin 
EDTA – ethylenediaminetetraacetic acid 
HEPES – N-2-hydroxyethylpiperazine-N’-ethanosulfonic acid 
PMSF - phenylmethylsulfonyl fluoride 
RT – room temperature (~20°C) 
SDS – sodium dodecyl sulfate 
SSC – solution containing 0.15 M NaCl and 15 mM sodium citrate, pH 7.0. 
TBS – Tris buffered saline (50 mM Tris and 0.9% NaCl, pH 8.0) 
Tris - Tris(Hydroxymethyl)aminomethane 
 
 
3.1.1 Bacterial and yeast strains, plasmids and media used in this study 
 
Bacterial strain 
E.coli strain DH5αF’ was used for cloning and plasmid propagation. 
DH5αF’ genotype; F’ supE44 ∆lacU169 {φ80 lacZ∆M15} hsdR17 recA1 endA1 gyrA96 thi-1 
relA1 (Hanahan, 1983) 
 
Yeast strains 
For the majority of the experiments in this study, we have chosen a haploid, BY4742, 
which is widely used laboratory strain. This strain originated from S288C strain that was 
sequenced, which facilitates genetic manipulations. Exceptionally, in some experiments other 
yeast backgrounds were used. All strains used in this study are listed in Table 15. Since some 
studies reported that in the individual cases using different yeast strains might lead to 
discrepancies in the results, the special care was taken while interpretating the obtained data. 
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 Table 15: S. cerevisiae strains used in this study 
Strain name/ 
Euroscarf acc. no.  
Relevant genotype Reference or source 
BY4741/Y00000 MATa a (Brachmann et al., 1998) 
BY4742/Y10000 MATα b (Brachmann et al., 1998) 
JK9-3da MATa c (Helliwell et al., 1998a) 
MML378 MATa tor1::kanMX4 c (Torres et al., 2002) 
MML380 MATa tor2-1 tor1::kanMX4 c (Torres et al., 2002) 
JH11-1c MATa tor 1-1 c (Helliwell et al., 1998a) 
CML128 MATa d (Torres et al., 2002)  
MML447 MATa tor1::kanMX4 mpk1::URA d (Torres et al., 2002) 
MML382 MATα wsc1::CaURA3 d (Torres et al., 2002) 
MML387 MATa mid2::kanMX4 d  (Torres et al., 2002) 
MML393 MATa wsc1::CaURA3 mid2::natMX4 d (Torres et al., 2002) 
MML391 MATα rom2::kanMX4 d (Torres et al., 2002) 
MML200 MATα bck1::kanMX4 d (Torres et al., 2002) 
Y00993 MATa mpk1::kanMX4 a (Brachmann et al., 1998) 
Y02739 MATa rlm1::kanMX4 a (Brachmann et al., 1998) 
Y03214 MATa ybr077c::kanMX4 a (Brachmann et al., 1998) 
Y01983 MATa ure2::kanMX4 a (Brachmann et al., 1998) 
Y00173 MATa gln3::kanMX4 a (Brachmann et al., 1998) 
Y01759 MATa rtg1::kanMX4 a (Brachmann et al., 1998) 
Y03921 MATa crf1::kanMX4 a (Brachmann et al., 1998) 
Y07006 MATa yak1::kanMX4 a (Brachmann et al., 1998) 
Y00191 MATa fcy2::kanMX a (Brachmann et al., 1998) 
Y06109 MATa swi4::kanMX4a (Brachmann et al., 1998) 
W303 MATa e (Martinez-Pastor et al., 1996) 
W303msn MATa msn2-3::HIS3 msn4-1::TRP1 e (Martinez-Pastor et al., 1996) 
W303gas1 MATa gas1::LEU2 e (Popolo et al., 1997) 
Y21258 Mat a/α erg20::kanMX4/ERG20 f (Brachmann et al., 1998) 
Y11296 MATα trk1::kanMX4 b (Brachmann et al., 1998) 
Y15922 MATα yta7::kanMX4 b (Brachmann et al., 1998) 
KY1 MATα yta7::HIS3 b This study 
KTY1 MATα trk1::kanMX4 yta7::HIS3 b This study 
K314 MAT a TAPtag-N-YTA7 g This study 
YDL401 MAT a g (Lafontaine and Tollervey, 1996) 
a) background: his3∆1 leu2∆0 met15∆0  ura3∆0 
b) background: his3∆1 leu2∆0 lys2∆0  ura3∆0  
c) background: leu2-3 112 ura3-52 trp1 his4 GAL+ HMLa 
d) background: leu2-3 112 ura3-52 trp1 his4 can1r 
e) background: ade2-1 ura3-1 leu2,3-112 trp1-1 his3-11 15 can1-100  
f) background: his3∆1/his3∆1; leu2∆0/leu2∆0; met15∆0/MET15; LYS2/lys2∆0; ura3∆0/ura3∆0 
g) background: ura3-52 trp leu2∆0 his3-∆200 gal2 gal∆108 
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Yeast and bacterial media 
 
 Yeast strains were grown in solid or liquid media at 28ºC. 
1) YPG - rich medium: 
1% yeast extract (Difco), 1% bacto peptone (Difco), 2% glucose as a carbon source 
 
2) SD - synthetic minimal medium:  
0.7 g/l yeast nitrogen base, 2% glucose, supplemented with amino acids as required.  
 
Growth supplements- amino acids and nucleotides:  
adenine (2 mg/ml), uracil (2 mg/ml), histidine (2 mg/ml), leucine (3 mg/ml), lysine (2 
mg/ml), methionine (2 mg/ml), tryptophan (2 mg/ml), tyrosine (1 mg/ml).  
 
3) SC - synthetic complete medium: 
0.7 g/l yeast nitrogen base, 2% glucose, supplemented with all required amino acids. 
 
 E. coli  was grown in solid or liquid LB medium containing 2% bacto-tryptone, 
0.5% yeast extract, 0.5% NaCl, the pH was adjusted to 7.5. When necessary LB was 
supplemented with ampicilin (100 µg/ml).  
 
 Solid media were prepared with 20 g/l of bacto-agar (Difco). For preparation 
of selective medium purified bacto-agar was used (Sigma) 
 
 
3.1.2 Yeast genetics procedures 
 
Construction of the trk1∆yta7∆ mutant (KTY1). In order to obtain double 
trk1∆yta7∆ mutant we deleted YTA7 in the trk1∆ strain (trk1::MX4- Y11296). To delete 
YTA7, the HIS3 gene was amplified from pF6aHIS3 (Longtine et al., 1998) by PCR using 
primers: 
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 YTAfHIS: 
5’GGTCTATTTCTCTCTTCTCGCTATTTATTCACAATTGGTGCGGATCCCCGGGTTAATTAA3’ 
YTArHIS: 
5’GTAAGAGCCAGTAATGGGCTTTGCATACGGTCTTGTTCACTGAATTCGAGCTCGTTTAAAC3’ 
 
The linear product was transformed into yeast. Transformants were screened on the selective 
medium and genomic DNA was isolated using Wizard Genomic Purification kit (Promega) 
according to manufacturer instructions. The presence of both the YTA7 and TRK1 deletions 
was confirmed by diagnostic PCR using primers: 
diagTRK1f- 5’ TATTGCTACGGCCATCGACT 3’  
diagTRK1r- 5’ ATGGCGTTGACGATGACGAA 3’ 
diagYTA7f- 5’ CTGAAGGATCTTGCGTACTC 3’ 
diagYTA7r- 5’ ACGTATGCCAGAACAGTGAC 3’ 
 
Construction of the strains used for the Yta7 and Erg20 proteins localization. The 
yta7∆ mutant (Y15922) was transformed with a centromeric plasmid expressing Yta7p-ProtA 
protein fusion (pRS316 YTA7-ProtA). As the ERG20 deletion is lethal, to obtain yeast cells 
expressing Erg20p-ProtA the heterozygous erg20∆ mutant (Y21258) was transformed with a 
centromeric plasmid pRS316 ERG20-ProtA. Resulting transformants were sporulated in 
medium containing 1% potassium acetate and 2% bacto-agar. Then yeast spores were treated 
for 15 min with 0.22 mg/ml cytohelicase and for 20 min with ethyl ether. Obtained haploid 
cells were selected based on the ERG20 deletion marker (KanR) and pRS316 ERG20-ProtA 
maker (URA3). Additionaly, to ensure that Erg20p-ProtA was indispensable for the cells 
survival we performed the test with FOA (5-fluoroorotic acid). 
 
Construction of the YTA7-TAP mutant (K314). In order to introduce N-terminal 
TAP (Tandem Affinity Purification) tag into the YTA7 gene the procedure described by Puig 
et al. (Puig et al., 2001) was thoroughly followed. Briefly, the pBS1761 plasmid was used as 
a template to amplify PCR product for yeast transformation. PCR primers contained regions 
of homology to the YTA7 gene:  
YTA7NA -  
5’TCTCTTCTCGCTATTTATTCACAATTGGTGCAGAAAGAACGAACAAAAGCTGGAGCTCAT3’ 
YTA7NB -  
5’CAACGTCGCTACCGCGTCTATTCCTTAAATTTCGTGCCATCTTATCGTCATCATCAAGTG3’ 
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YDL401 strain that does not contain GAL1 promoter was a recipient for 
transformation with the tagging cassette that comprised also the GAL1 promoter and TRP1 
marker nedded for the selection of transformants. Finaly, the GAL1 promoter and the TRP1 
marker were removed from the genome by Cre recombinase leaving tagged YTA7 under the 
control of its natural promoter. As the deletion of YTA7 was reported to cause sensitivity to 
6% ethanol (Agostoni Carbone et al., 1998), we used this phenotype to verify functionality of 
Yta7-TAP protein. 
 
Transformation 
Transformation of the yeast strains was performed according to the lithium acetate 
(LiAc)/single-stranded DNA (SS-DNA)/polyethylene glycol (PEG) procedure (Gietz et al., 
1995). Transformation of E. coli was performed with the use of Gene Pulser (BioRad) 
according to the supplied instruction. 
 
 
3.1.3 General molecular biology procedures 
 
3.1.3.1 Yeast extract preparation 
In order to prepare yeast extract, suspension of cells in appropriate buffer was lysed by 
vigorous shaking with glass beads (Ø 45mm) using a vortex (8 × 30 sec with 30 sec-interval 
on ice). Cell extracts were separated from glass beads and cell debris, collected in a new 
Eppendorf tube by centrifugation, and clarified by a 13 000 × g spin for 15 min at 4°C. The 
obtained supernatant served as the source of proteins. 
Further, in particular methods the compositions of the lysis buffers are indicated. 
 
 
3.1.3.2 Western blot analysis 
To the samples a sample buffer was added (60 mM Tris/HCl pH 6.8, 2% SDS, 10% 
glycerol, 0.025% Bromophenol Blue) and they were denaturated for 5 min at 100°C. Aliquots 
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 corresponding to the 60 µg of proteins were loaded into the wells of the 10% SDS-
polyacrylamid gel (SDS-PAGE). Electrophoresis was performed for 4 h at 80V then proteins 
were transferred by a semi-dry system (1h, 1.2 mA/cm2 of the gel) to the Immobilon-P 
(Milipore) membrane. After protein transfer, membrane was shortly immersed in the 
methanol and dried. For the incubation times and dilutions of antibodies instructions of the 
manufacturers were followed. Usually, in order to visualize a given protein the secondary 
antibodies conjugated with alkaline phosphatase were used (DakoCytomation, 1:2000, 2h, 
RT) and the activity of this protein was detected with BCIP/NBT solution (Sigma). 
 
 
3.1.3.3 Estimation of protein concentration 
Protein concentration was determined according to Lowry et al. (LOWRY et al., 
1951) or with Bradford reagent (Sigma). Bovine serum albumin (Promega) was used as a 
standard of the protein quantification. 
 
 
3.1.4 DNA microarrays 
 
The microarray datasets of Congo red, Calcofluor white and caffeine are available in a 
query-format at http://biopuce.insa-toulouse.fr/jmf/cellwallgenomics. This work is fully 
MIAME-compliant and has been deposited at GEO website with accession number GSE4049. 
All statistically treated datasets described in this work are presented in the separately printed 
SUPPLEMENT. 
 
 
Figure 56 represents a general overview of the method that we used to perform 
analysis of the genome-wide transcription pattern elicited by the tested drugs. Particular steps 
of this method are described in the following chapters. 
  EXPERIMENTAL  PROCEDURES 117
 Sample (S)
Control (C)
RNA isolation cDNA labeling (dye swap)
Signal detection
Cy5-dCTP Cy3-dCTP
RNA analysis
Hybridyzation
Statistical
treatment of
data
Image analysis
DATA
INTERPRETATION
S+C S+C
Figure 56: DNA microarray – a scheme of the method. 
Yeast cells were grown without (C) or with a given drug added (S), and the respective RNAs were isolated. The 
obtained RNA was assayed for its quality and quantity (Bioanalyzer 2100) and transcribed into the labeled DNA 
using Cy5- and Cy3-dCTP. In this procedure dye swap was applied. After hybridization of the control DNA and 
sample DNA to the DNA chip, slides were scanned (GenePix 4000B) and the image analysis was performed. 
The obtained signal intensities were treated statistically prior to the interpretation. 
 
 
3.1.4.1 Experimental design and drug treatment of yeast cultures  
The used strains, drugs concentrations and other details of the experimental design are 
presented in Table 16. Papulacandin B was a generous gift from A. Duran (Ciba-Geigy, 
Basel, Switzerland). A stock solution was prepared at concentration 20 mg/ml Papulacandin B 
in methanol and stored at -20°C. Caffeine and Congo red were purchased from Sigma, and 
Calcofluor white was from ICN Biomedicals. Lovastatin was purchased from A.G. Scientific 
and zaragozic acid from Merck. Lovastatin, prior to use was changed into its active form by 
alkaline lysis. For 25 mg of the powdered lovastatin 0.5 ml of 95% EtOH was added and it 
was placed at 55ºC for 5 min. Than 62.6 µl of 1 M NaOH and 0.5 ml of H2O was added and it 
was incubated for 10 min at 55ºC. Again 62.6 µl of 1M NaOH was added and mixture was 
further incubated with periodic swirling for 30 min at 55ºC. Finaly, mixture was brought to 
the room temperature, 40 µl of 1M Tris/HCl pH 8.0 and 20 µl of 1 M HCl were added. 
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 Solution was brought to the final volume of 2 ml. Prepared stock was stored at -20 ºC. At the 
same time a vehicle solution that lack lovastatin was prepared and it was later on added to the 
media of the control cultures. Stock solutions of other drugs were prepared with water. 
 
Drug treatment of the yeast cultures was carried out as follows. Yeast cells were 
cultivated in YPD medium at 28°C to the logarithmic phase of growth (0D600 1.0). Then they 
were diluted to an initial OD600 0.05 and grown until OD600 0.2. The culture was then quickly 
divided in several parts. One part was allowed to grow under the same conditions (control), 
while others were treated with the various concentrations of the appropriate drugs. After 
indicated times (Table 16) yeast cells were collected by centrifugation, rapidly frozen in a 
liquid nitrogen and kept at -80°C until use.  
 
Table 16: DNA microarrays – Sumary of the experimental design 
Rank Strain Additions 
  Control Sample 
Time of 
incubation 
(min) 
Number of 
Experiments 
(cultures) 
Number of slides 
per experiment 
1 BY4742 - 2 mM CAF 5, 15, 90 2 1 
2 -//- - 20 mM CAF 5, 15, 90 2 1 
3 -//- - 20 µg/ml CR 5, 15, 90 2 1 
4 -//- - 100 µg/ml CR 5, 15, 90 2 1 
5 -//- - 20 µg/ml CFW 5, 15, 90 2 1 
6 -//- - 100 µg/ml CFW 5, 15, 90 2 1 
7 W303 vehicle 0.25 µg/ml PAP 60 2 1 
8 -//- vehicle 2.5 µg/ml PAP 60 2 1 
9 -//- vehicle 25 µg/ml PAP 60 2 1 
10 BY4742 vehicle 25 µg/ml Lo 10, 30, 60 2 2 
11 -//- - 10 µg/ml ZA 10, 30, 60 2 2 
12 BY4742 (wt and yta7∆) - - 5h 2 2 
 
 
3.1.4.2 RNA isolation, cDNA synthesis and hybridization to microarrays 
Frozen cells (10 units of OD600) were mechanically disrupted (MicroDismembrator 
Braun, Melsungen) and total RNA was isolated using RNeasy Mini kit (Qiagen) following the 
protocol of the manufacturer. The quantity and the quality of the extracted RNA were 
determined by microcapillary electrophoresis using Bioanalyzer 2100 and the RNA6000 
Nano LabChip Kit (Agilent Technologies, Wilmington, DE, USA). Incorporation of Cyanine 
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 3- or Cyanine 5-dCTP (Amersham Bioscience) was performed during reverse transcription of 
20 µg of denaturated RNA using Label Star Reverse Transcriptase (Qiagen). Labeled cDNA 
was purified with MinElute spin columns (Qiagen) and was hybridized on the dendrimer-
activated glass slides which represented whole yeast genome by covalently attached DNA 
probes (70-mer oligonucleotides) (Le, V et al., 2003). In the each slide a single gene was 
represented four times. Prehybridisation was performed with solution of 1% BSA, 2 ×SSC, 
0.2% (v/v) SDS over 1hour at 42°C. After automatic washing according to manufacturer’s 
instructions, the slides were hybridised for 10 h in 200 µl of ChipHybeTM buffer (Ventana 
Medical System, Inc). After hybridisation, the slides were washed for 2 min in 2 ×SSC/0.2% 
(v/v) SDS, for 2 min in 0.2 ×SSC/0.2% (v/v) SDS and for 2 min in 0.2 ×SSC, immersed 
briefly in isopropanol and then dried under a stream of air.  
To reduce biological and systematic variability, total RNA from two independent 
cultures were extracted, labeled with dCTP-Cy3 (and reciprocally with dCTP-Cy5) and 
hybridized on two independent microarrays. Thus, every gene was represented by four 
intensities from two independent DNA arrays. The hybridization signal was detected by 
scanning with GenePix 4000B laser Scanner (Axon Instruments), and the signal quantification 
was transformed to numerical values using the integrated GenePix software version 3.01. 
 
 
3.1.4.3 Transcript data acquisition and treatment  
Both raw and statistically treated data are presented at http://biopuce.insa-
toulouse.fr/jmflab/cellwallgenomics/, which provides full details for normalization and 
statistical regimes using our home-made Bioplot software. Briefly, raw intensities were 
corrected from the background. To take into account non-homogeneity of the noise on the 
array, background was measured locally around each spot. The normalisation was applied 
were the mean expression value of a whole genome was considered as a reference. As the spot 
replicates on the same array are statistically dependent first step in averaging was to calculate 
the mean value over spot duplicates for a given gene on the same array and then an average 
on arrays was calculated. Log-ratios of normalized intensities from duplicate samples were 
tested for statistical significance using Student’s test. The differentially expressed genes (1.5-
fold change in expression and p-value ≤ 0.05) were attributed to functional categories 
according to Saccharomyces Genome Database. When necessary, search for known DNA 
binding sites on gene promoter was performed using Yeastract software, which interrogates a 
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 yeast database containing experimentally validated associations between genes and their 
transcription factors (Teixeira et al., 2006). Regarding dataset of Papulacandin B, GeneSpring 
was used to obtain hierarchical clustering of genes that were similarly expressed in three 
tested concentrations of this drug. GeneSpring provides sophisticated clustering methods to 
uncover patterns of gene expression data and the relationships between these patterns. As 
similarity measure Standard correlation was used which finds especially overexpressed genes 
(Eisen et al., 1998). 
 
 
3.1.4.3.1 Correspondence analysis of the DNA microarray data. 
We analyzed transcriptional response to the ‘inhibitory’ concentrations of Congo red, 
Calcofluor white and caffeine, after 90 min of growth, using Correspondence Analysis 
(Fellenberg et al., 2001). Signal intensities were uploaded into the M-CHIPS (multi-
conditional hybridization intensity processing system) which provides a MATLAB-based tool 
that was used for analysis, normalization and filtering. For normalization, log-linear 
regression accounting for affine-linear deviations among the different hybridizations was 
applied. Each hybridization experiment was normalized with the respect to the gene-wise 
median of the control conditions (culture w/o drugs after 90 min of growth). Signal intensities 
of repeated hybridizations were normalized and significance levels assessed by the ‘min–max 
separation’, a stringency criterion calculated by taking the minimum distance between all data 
points of the two conditions. To visualize interdependencies among the high-dimensional data 
received in two-way contingency tables with rows representing genes and columns 
representing hybridizations, singular value decomposition was used for reducing 
dimensionality, and the chi squared (χ2) distance among the data points was approximated. 
Afterwards, genes and hybridizations were plotted together in a two-dimensional space, where 
expression specificities are indicated by the distances from the center. The interpretation of 
the exemplary correspondence analysis (CA) plot is shown in Figure 57. 
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Figure 57: Interpretation of the CA plot 
A. This plot shows an example of the virtual dataset comprising 24 genes. There are two perfectly reproducible 
hybridizations for each experimental condition. It resembles the real situation because the majority of genes does 
not change their expression in the tested conditions. B. Dataset from panel A was embedded into a plane using 
correspondence analysis where both axes, X and Y, are dimensionless. Gene clusters are shown together with the 
corresponding gene profiles. The hybridizations with similar expression profiles are the neighbours in this 
projection. The red, green and blue axes illustrate the major trends according to the condition medians. The 
genes with unchanged expression or those not expressed to a measurable amount in any tested conditions are 
concentrated in the center of the plot called ‘centroid’. The distance to the centroid of the genes located to the 
outer regions of the plot reflects the significance of having a changed expression. The genes with the high 
expression in a given condition are placed in the direction of this condition, while the underexpressed genes are 
placed on the opposite side of the centroid. (adapted from a theorethical script ‘Correspondence Analysis and 
Data Warehousing with Microarray Data’ by K. Fellenberg ) 
 
 
3.1.4.3.2 Grouping genes in functional categories 
SGD Slim Mapper and Term Finder 
Slim Mapper and Term Finder are provided by SGD database that currently contains 
7292 genes annotated to at least one GO term. Slim Mapper is a tool allowing grouping genes 
in broad biological categories e.g. ‘carbohydrates metabolism’, which is very useful 
especially for analyzing the results of microarray expression data. On the other hand, to find a 
particular GO term shared by genes in a given list and to calculate its significance we used 
Term Finder. The number of genes representing a given process in the tested transcription 
profile is compared with the number of genes representing this process in the whole genome, 
without taking into account their ratio of expression.  
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 T-Profiler 
T-profiler uses the t-test to score the difference between the mean expression level of 
predefined groups of genes and that of all other genes on the microarray (Boorsma et al., 
2005). The main advantage of this software is that a user does not have to apply cutoffs to the 
expression level of individual genes. We used this software to group genes according to gene 
ontology (GO) nomenclature. For calculations only GO groups containing more than 6 
members were used (1389 groups). Analysis of the data sets with T-profiler also allows 
identification of regulatory motifs in the promoter of responsive genes (region -600 to -1 bp). 
It is important to note that T-Profiler does not take into account how often a particular motif 
occurs in a promoter region and it does not allow overlapping with the neighboring ORFs. 
Currently, there are 153 motif groups in use. Groups of genes with a P-value < 0.05 are 
accepted as significantly changed. 
 
 
3.1.5 Determination of the changes in the cell wall structure 
 
3.1.5.1 Zymolyase sensitivity test 
Zymolyase sensitivity test is a simple method used to verify the changes in the cell 
wall structure. This method is based on the rate of the cell lysis, which is fast or slow 
depending mainly on the level of β-1,3-glucan. As the cell wall degrading enzyme we used 
Zymolyase which acts mainly at the glucose polymers at the β-1,3-glucan linkages but it has 
also a protease activity. This additional protease ativity causes that increased resistance to 
Zymolyase cannot be simply explained by the increased level of β-1,3-glucan. In order to 
perform the test, cells collected by centrifugation were resuspended in a buffer (10 mM 
Tris/HCl pH 7.4, 40 mM β-merkaptoethanol) to reach OD600 0.9 and incubated for 30 min. 
Then 50µg/ml Zymolyase 20-T (ICN Biomedicals Inc.) were added and the lysis of the cells 
was followed by measurements of decreasing OD600 at RT. The OD600 at time 0 was taken as 
100%. Presented results are averages of three experiments. 
 
It has been shown that a treatment with the cell wall disturbing agents results in the 
increased resistance to the cell wall degrading enzymes (Boorsma et al., 2004). We have used 
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 this fact to verify if the used concentrations of CR, CFW and caffeine were eliciting changes 
in the cell wall. Yeast were cultivated like it was described for DNA microarrays (3.1.4.1, pg 
118). Samples were taken after 30, 60, 90 min and 5 h of growth.  
In addition, we used Zymolyase sensitivity test to examine involvement of several 
transcription factors in the cell wall remodeling induced by CR, CFW and caffeine. In these 
experiments each mutant and its parental strain were grown with the ‘inhibitory’ 
concentrations of drugs. There was no significant difference regarding Zymolyase sensitivity 
between the used wild-type strains (BY4741 and W303). The OD600 was measured each 15 
min for 105 min. The increase of resistance after treatment of yeast with the tested drug in the 
wild-type strain was taken as 100% and the resistance of mutant strains treated with the same 
drug was compared to this value. 
Finally, we tested sensitivity of various mutants to Zymolyase treatment to asses 
whether the particular deletion could influence the cell wall biosynthesis. The fraction of 
wild-type cells that resisted lysis after 90 min of digestion with Zymolyase 20-T (50 µg/ml) 
was taken as 100% and compared to mutant cells.  
 
 
3.1.5.2 Determination of glucose, mannose and glucosamine levels in the cell wall 
After 20 hours of growth in the presence or without drugs, cells were collected by 
centrifugation at 4°C, and frozen with liquid nitrogen. Cells were broken mechanically with 
glass beads and obtained cell walls were washed consequently with cold 10 mM Tris/HCl pH 
8.0 buffer until the supernatant became clear. Glucose, mannose and glucosamine were 
released from the cell wall polysaccharides during sulfuric acid hydrolysis. To isolated cell 
walls suspended in 100 µl of water 50 µl of 72% H2SO4 was added and incubated in room 
temperature for 3h. Than 650µl of water was added to obtain 2 N H2SO4 concentration and 
samples were incubated at 100°C for 4 h. Finaly, to each sample 6 ml of water was added and 
the pH was brought to 7.0 with solution of 40 g/l of Ba(OH)2. Precipitated BaSO4 was 
removed by centrifugation and remaining in the supernatant carbohydrates were quantified 
using DIONEX column (SunnyVale, USA) by high-performance anionic exchange 
chromatography (HPAEC) as described by Dallies et al. (Dallies et al., 1998). This method 
was used to measure glucose that corresponds to the level of β-1,3- and β-1,6-glucans, 
mannose and acetyloglucosamine representing mannans and chitin, respectively. 
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3.1.6 Cellular localization of proteins 
 
3.1.6.1 Subcellular fractionation 
An overnight culture of yeast was diluted to OD 0.1 and grown to reach an OD 0.5. 
160 OD units of cells were collected by centrifugation washed with water and resuspended in 
20 ml in buffer A. After 45 min at 30ºC, cells were transferred to 10 ml of buffer B and in 
order to obtain spheroplasts Zymolyase (10 U/1 OD) was added. After 30min of incubation at 
30 ºC, spheroplasts were washed with the buffer C and resuspended in 2 ml of cold buffer 
TEA. Next, spheroplasts were homogenized (Potler Homogenizator) at 4 ºC and centrifuged. 
After each round of centrifugation the pellet was kept and the supernatant was submitted for a 
following centrifugation. Finally, to separate organelles, six centrifugations were performed:  
1) 500×g, 5 min 
2) 3 000×g, 15 min 
3) 10 000×g, 30 min 
4) 25 000×g, 30 min 
5) 50 000×g, 60 min 
6) 100 000×g, 90 min 
To decrease the level of contamination between fractions, three first pellets (1-3) were 
resuspended in TEA buffer and centrifuged again. Other pellets were washed without 
resuspending. All pellets and the last supernatant were transferred to the sample buffer, 
proteins were denaturated (4 min, 100ºC) and stored in -80ºC. 
 
Buffer A: 100 mM Tris/HCl pH 9.5, 100 mM β-mercaptoethanol, 10 mM NaN3, 40 mM 
EDTA 
Buffer B: 1.5 M sorbitol, 10 mM Tris/HCl pH 7.5 
Buffer C: 1 M sorbitol, 150 mM KAc, 5 mM MgAc, 20 mM HEPES pH 6.8 
Buffer TEA: 10 mM triethanolamine pH 7.5, 10 mM KF, 10 mM NaN3, 1 mM EDTA, 0.8 M 
sorbitol  
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 Sample buffer: 31 µl Tris/HCl pH 6.8, 100 µl 10% SDS, 50 µl glycerol, 25 µl β-
mercaptoethanol, 294 µl H2O 
 
 
3.1.6.2 Immunofluorescence microscopy 
An overnight culture of yeast was diluted to OD 0.1 and grown to reach an OD 0.5. 
For fixation of the cells, to 10 ml culture 1.2 ml of 37% formaldehyde was added. After 15 
min cells were collected by centrifugation, resuspended in the buffer A with additional 0.6 ml 
of 37% formaldehyde and incubated 30 min. Then cells were centrifuged and washed 4 times 
with buffer B. To obtain protoplasts cells were incubated 1h at 37 ºC in the 0.5 ml of buffer B 
with 5 µl β-mercaptoethanol, 20 µl Zymolyase and 27 µl Glusulase added. After 
centrifugation (2000 rpm, 5min), protoplasts were washed twice with buffer B and 
resuspended for 1 h in buffer F. Then protoplasts were centrifuged (2000 rpm, 5min), washed 
7 times with buffer F, primary antibody diluted in the same buffer was added and suspension 
was incubated overnight. Next, protoplasts were washed (7 times with buffer F) the reaction 
with the secondary antibody conjugated with Texas Red lasted 2 h in the dark and was 
followed by analogous washing. Finally, protoplasts were resuspended in the buffer B and 
spread on the polylysine-coated slides (Sigma). After 45 min protoplast were attached to the 
slides and buffer could be delicately removed  with the pipette. The slides were allowed to dry 
and than a rapid (1min) staining with water solution of DAPI was performed after which 
protoplasts were washed twice with water, covered with MOUNT and a glass slide. 
 
Buffer A: 160 ml 50 mM KPO4 pH 6.5, 1ml 0.1 M MgCl2, up to 200 ml H2O 
Buffer B: 160 ml 50 mM KPO4 pH 6.5, 1ml 0.1 M MgCl2, 43.73 g sorbitol, up to 200 ml H2O 
Buffer F: 0.01 g KH2PO4, 0.85 g NaCl, 0.1 g BSA, 0.1 g NaN3, up to 100 ml H2O (pH 7.4) 
MOUNT: 50 mg p-phenylenediamine, 5 ml 1×TBS, 45 ml glycerol (pH 9.0) 
 
Subsequently, prepared yeast were observed using Nikon Eclipse E800 microscope 
(magnification × 100, oil immersion).  
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 3.1.7 Activity of the IP pathway enzymes 
 
3.1.7.1 Cis-prenyltransferase activity assay 
Activity assay. Yeast cultures were grown overnight in YPD medium, then they were 
diluted to OD 0.1 and (were indicated 25 µg/ml lovastatin was added) grown to reach OD 0.5 
when the cells were collected. The cells were subjected to the isolation of the membrane 
fraction (method described in chapter 3.1.8.5, pg 130) which served as the source of the 
enzyme. The enzyme assay was carried out according to Szkopinska et al. (Szkopinska et al., 
1997). The reaction mixture in a final volume of 250 µl contained 50 mM phosphate buffer 
pH 7.5, 0.5 mM MgCl2, 20 mM β-mercaptoethanol, 10 mM KF (to inhibit isoprenoid 
phosphatase), 3×105 cpm {14C} IPP (specific activity 52 mCi/mM) and 46 nM FPP and 450 
µg of proteins. The reaction lasted 1h at 30 ºC and was terminated by addition of 2 ml of 
Chloroform : Methanol (3:2). 
Lipids extraction. After addition of 2 ml of Chloroform : Methanol (3:2) samples 
were incubated 30 min in -20ºC. This mixture was washed three times with 0.5 ml of 10 mM 
EDTA pH 8.0 in 0.9% NaCl. After each washing and centrifugation (1 min, 4000×rpm) the 
upper phase and the proteins were removed. Clear organic phase phase was concentrated 
under stream of nitrogen, resuspended in 30 µl of Chloroform : Methanol (3:2), subjected to 
thin-layer chromatography on HPTLC RP-18 plates and developed in 50 mM H3PO4 in 
acetone. Then, autoradiograph which can be seen in Figure 42A was obtained (14 days of 
exposure). The zones containing radiolabeled polyprenols were scraped and the radioactivity 
was measured with a scintillation counter (LKB Wallac 1209 RockBeta Counter). 
 
 
3.1.7.2 Farnesyl diphosphate (FPP) synthase activity 
Yeast cultures were grown overnight in YPD medium, then they were diluted to OD 
0.1 and (were indicated 25 µg/ml lovastatin was added) grown to reach OD 0.5 when the cells 
were collected. Yeast extract, which served later as the source of FPP synthase, was prepared 
in 50 mM phosphate buffer pH 7.5 supplemented with 5 mM iodoacetamide. The enzyme 
assay was carried out according to Chambon et al. (Chambon et al., 1991). The reaction 
mixture in the final volume of 100 µl contained 50 mM phosphate buffer pH 7.5, 1 mM 
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 MgCl2, 5 mM iodoacetamide, 1×105 cpm {14C} IPP (specific activity 52 mCi/mM), 60 µM 
IPP, 120 µM DMAPP and 100 µg of protein. The reaction lasted 5 min at 37 °C and was 
terminated by addition of 0.5 ml of H2O, 1 ml of hexane and 0.2 ml of 1 N HCl (to 
dephosphorylate the products). After 30 min of additional incubation at 37°C, samples were 
vigorously mixed, the upper phase was separated and washed 3 times with water. The 
radioactivity of the organic phase was subjected to liquid scintillation counting (LKB Wallac 
1209 RockBeta Counter). 
 
 
3.1.7.3 Measurement of dolichol level 
Yeast cultures were grown overnight in YPD medium, then they were diluted to OD 
0.1 and (were indicated 25 µg/ml lovastatin was added) grown to reach OD 0.5 when the cells 
were collected. The cells were subjected to the isolation of the membrane fraction (method 
described in chapter 3.1.8.5, pg 130) which served as the source of dolichol. Lipids were 
extracted from the membrane fraction corresponding to 450 µg of protein, as described in cis-
prenyltransferase assay (3.1.7.1, pg 127), and subjected to thin-layer chromatography on 
HPTLC RP-18 plates that were developed in 50 mM H3PO4 in acetone. After 15 min 
incubation of the plate in iodine vapor (Figure 42C), intensity of the bands corresponding to 
the major form of dolichol (Dol16) were quantified using ImageQuant software (Molecular 
Dynamics). Intensity of the band of non-treated wild type cells were taken 100% of dolichol 
level. The result of this experiment is an average of values from three independent yeast 
cultures and each sample was measured in duplicate. 
 
 
3.1.8 Other procedures 
 
3.1.8.1 Mpk1 kinase phosphorylation assay 
Yeast extracts for assays of the amount of Mpk1p phosphorylation were prepared in 
150 µl of cold lysis buffer (50 mM Tris/HCl pH 7.5, 10% glycerol, 1% Triton X-100, 0.1% 
SDS, 150 mM NaCl, 50 mM KF, 1 mM sodium orthovanadate, 50 mM β-glycerol phosphate, 
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 5 mM sodium pyrophosphate, 5 mM EDTA, 1 mM PMSF) supplemented with protease 
inhibitors (Protease Inhibitors Cocktail, Sigma), as described in Martin et al. (Martin et al., 
2000). Total protein concentration in the supernatants was measured using Bradford reagent 
(Sigma). Denaturated protein samples (60 µg) were subjected to SDS-PAGE electrophoresis 
and transferred to Immobilon-P membrane (Millipore). To detect the phosphorylated form of 
Mpk1p kinase, the membranes were probed overnight at RT with anti-phospho-p44/42 
MAPK antibody (New England Biolabs) at 1:1000 dilution in TBS buffer and 5% non-fat 
milk. To quantify total Mpk1p abundance polyclonal anti-Mpk1 antibodies were used (Martin 
et al., 1993). Primary antibodies were detected using alkaline phosphatase-conjugated anti-
rabbit antibody (DakoCytomation, 1:2000, 2h, RT) and BCIP/NBT solution (Sigma). As a 
negative control, protein extract from the mpk1∆ mutant was used. The protein extract from 
the gas1∆ mutant served as a positive control. All experiments were repeated at least twice 
with consistent results. 
 
 
3.1.8.2 Determination of cAMP level 
Cells were grown with caffeine as described for DNA microarrays (3.1.4.1, pg 118) 
and samples were collected by rapid filtration just before caffeine addition and after 5, 15, 90 
minutes and 20 hours of growht. To extract cAMP cells for 3 min were boiled in ethanol 
buffered with 70 mM HEPES pH 7.5 as described previously by Gonzales et al. (Gonzalez et 
al., 1997). Ethanol was then evaporated using the Buchi rotary evaporator (water bath 40°C, 
70 mbar – 3 min, 40 mbar – 9 min). Dry residue was resuspended in 0.5 ml of water and the 
level of cAMP was determined with an enzyme immunoassay system (R&D Systems, 
DE0450) as indicated by manufacturer.  
 
 
3.1.8.3 Spot assays of yeast sensitivity to various compounds 
To test growth capacity of the yeast cells on various solid media, they were grown 
overnight in appropriate liquid medium, in the morning they were transferred to the fresh 
medium, diluted (OD 0.1) and allow to grow for 6 h. Then cells were washed in sterile water 
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 and diluted to reach OD 0.5. This yeast suspension served to prepare 10-fold dilutions which 
were spotted onto agar plates that could be supplemented with one of the listed compounds:  
100 µg/ml Congo red  
50 µg/ml Calcofluor white 
2, 5 or 20 mM Caffeine 
1 M Sorbitol 
20 mM Adenine 
500 µg/ml lovastatin 
50 µg/ml Hygromycin B 
500 µg/ml chloramphenicol 
0.15 M LiCl 
0.1 M KCl 
0.5 M NaCl 
cyclohexymide - 10 µl of a 10 mg/ml solution in ethanol was poured into the well in 
the solid YPD. Approximatelly 107 cells were spread as a lawn on medium surface. 
 
 
3.1.8.4 Measurement of the cell size and bud counting 
Cells were cultivated for 24h in YPG medium without or with addition of 20 mM 
caffeine. Cells were visualized with Nikon Eclipse E800 microscope (magnification × 100, oil 
immersion) and radius of the cells was calculated using LuciaG software (Screen 
Measurement System, Nikon). Since yeast cells have an oval shape, a radius can only give an 
estimation of the actual size. Simultaneously the numbers of budding and non-budding cells 
were calculated.  
 
 
3.1.8.5 Isolation of the membrane fraction from yeast 
Collected yeast cells were suspended in Tris I solution (50 mM Tris/HCl pH 7.4, 15 
mM MgCl2, 9 mM β-mercaptoethanol) and broken with the glass beads (vortexing 8× 30 sec 
with a 30 sec-intervals on ice). After first centrifugation (4ºC, 5 min, 2000×g) supernatant was 
centrifuged for 1.5 h, 50 000×g at 4 ºC. Obtained pellet was resuspended in Tris II solution 
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 (50 mM Tris/HCl pH 7.4, 3.5 mM MgCl2, 6 mM β-mercaptoethanol) and homogenized 
(Potler Homogenizator). The obtained membrane fraction was stored at -80°C until use.  
 
 
3.1.8.6 Membranes solubilization 
For the membrane solubilization we used K314 strain expressing TAP-tagged YTA7 
(detailed description of the K314 strain in chapter 3.1.2, pg 114). Yeast were grown to reach 
OD600 0.5 then yeast extract was prepared in a TEG buffer (50 mM Tris/HCl pH 7.5, 1 mM 
EDTA, 5% v/v glycerol) supplemented with Cocktail of Protease Inhibitors (Sigma). Yeast 
extract was divided on equal volumes, and to each part one of the following reagents was 
added to a final concentration: 1 M NaCl, 0.1 M Na2CO3 pH 11.5, 2 M urea or 2% Triton X-
100. Additionally each sample was supplemented with 1 mM PMSF. After 1 h of incubation 
at 4 ºC samples were centrifuged 1.5h at 100 000×g. Then, proteins from the pellet and 
supernatant fraction served for western analysis. Yta7-TAP protein (ProtA epitope) was 
visualized with rabit developed primary antibodies, then secondary antibodies conjugated 
with alkaline phosphatases were used (Dako, Cytomation) and the activity of this protein was 
detected with BCIP/NBT solution (Sigma). As it can be seen in Figure 47 (pg 101), Triton X-
100 was not concentrated enough to solubilize totally the membrane, but our control with an 
integral membrane protein Dpm1 proved that 2% concentration of Triton X-100 was enough 
to wash away a significant amount of this protein (not shown) as well as Yta7p.  
 
 
3.1.8.7 Measurement of the K+ content in yeast 
Yeast were grown overnight in the YPD medium then they were washed with MQ 
water and resuspend (OD 0.1) in the fresh media YPD, SC or SC supplemented with 0.1 M 
KCl. When cultures reached OD 1.0 cells were collected by centrifugation and washed 3 
times with cold 20 mM MgCl2 solution then they were frozen in liquid nitrogen and 
lyophilized. Content of potassium was measured using flame atomic absorbtion spectrometry 
(FAAS). The results shown are averages of two experiments. 
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 3.1.8.8 CPY glycosylation assay 
CPY glycosylation assay was performed as described in Schenk et al. (Schenk et al., 
2001). Briefly, yeas cells growing in YPD to OD600 0.5 and extracts were prepared in a buffer 
containing 50 mM Tris/HCl pH 7.5, 5 mM EDTA, 1 mM PMSF supplemented with protease 
inhibitors (Protease Inhibitors Cocktail, Sigma). Proteins were separated by 8% SDS-PAGE 
electrophoresis and Carboxipeptidase Y was detected with the anti-CPY mouse monoclonal 
antibody (1:4000, 2h, RT). This antibody was a kind gift from Prof. Ludwig Lehle 
(Universitaet Regensburg, Germany). Primary antibodies were detected using alkaline 
phosphatase-conjugated anti-mouse antibody (DakoCytomation, 1:4000, 2h, RT) and 
BCIP/NBT solution (Sigma). 
 
3.1.9 Software and databases used in this study 
Databases: 
Yeast databases: 
o Proteom BioKnowledge Library. http://www.proteome.com/  
o SGD - Saccharomyces Genome Database. http://www.yeastgenome.org/  
o CYGD - the MIPS Comprehensive Yeast Genome Database 
http://mips.gsf.de/genre/proj/yeast/ 
o SCMD - Saccharomyces cerevisiae Morphological Database.  
      http://scmd.gi.k.u-tokyo.ac.jp/datamine/  
 
Other databases: 
o KEGG - Kyoto Encyclopedia of Genes and Genomes. 
      http://www.genome.ad.jp/kegg/  
o Entrez - The Life Sciences Search Engine.  
      http://www.ncbi.nlm.nih.gov/gquery/gquery.fcgi  
 
Software: 
DNA microarray data mining:  
o BioPlot - web service. http://biopuce.insa-toulouse.fr/  
o M-CHiPS - Multi-Conditional Hybridization Intensity Processing System. 
http://mchips.org/  
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 o GeneSpring (Silicon Genetics) 
o Gene Pix Pro (Axon Instruments) software for slide image analysis. 
 
Detection of regulatory signals in non-coding sequences: 
o RSAT - Regulatory Sequence Analysis Tools. http://rsat.ulb.ac.be/rsat/ 
o T-profiler: Scoring the activity of pre-defined groups of genes using gene 
expression data  http://studentst.bio.columbia.edu/t-profiler/index.html  
o YEASTRACT -(Yeast Search for Transcriptional Regulators And Consensus 
Tracking) http://www.yeastract.com/  
o SCPD - The Promoter Database of Saccharomyces cerevisiae. 
http://rulai.cshl.edu/SCPD/  
 
Others: 
o ImageQuant (Molecular Dynamics) 
o LuciaG/F (Screen Measurement System, Nikon) 
o VectorNTI (Invitrogen) 
o CloneManager (Sci Ed Software) 
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 SUMMARY and CONCLUSIONS 
Nowadays, while fungal infections are an increasing threat to public health we have to 
face the problem of the deficit of antifungal drugs. Moreover, fungi have a potential to 
become resistant to some drugs, thus there is a demand for the elaboration of novel 
compounds with differentiated modes of action. In order to design an antifungal drug, 
scientists have to know details of the mechanisms that allow the survival of the 
microorganisms in an unwelcoming environment. Therefore, we focused our research on the 
fungal response to the chemical compounds which, similarly to antifungal drugs, impair the 
cell wall or ergosterol biosynthesis. Both pathways are essential for survival of fungi. The cell 
wall protects them from the harmful environment whereas ergosterol ensures correct 
functioning of the plasma membrane. For investigation of those mechanisms, we have chosen 
the genetically tractable fungus, the yeast Saccharomyces cerevisiae. 
The first part of this work was devoted to a comprehensive investigation of fungal the 
response to cell wall damaging agents. We have chosen four chemical compounds that are 
known to perform this action. First, we characterized the transcriptional response of yeast 
cells to Papulacandin B, an inhibitor of glucan synthase that is one of the main enzymes 
responsible for the biosynthesis of the cell wall. Then we investigated the defensive 
mechanisms elicited by Congo red and Calcofluor white, drugs that weaken the tight cell wall 
structure by binding to its components. Finally, we examined the action of a putative cell wall 
drug, caffeine. This drug has been implicated in the cell wall assembly since, similarly to 
Congo red and Calcofluor white, it activates the cell wall integrity pathway, which could be 
observed as phosphorylation of the Mpk1 kinase. In an attempt to verify the effect of caffeine 
on the cell wall structure, we performed suitable experiments to compare the qualitative and 
quantitative effects of this drug with the effects of Congo red and Calcofluor white. The 
obtained results led us to the conclusion that caffeine indeed induced strengthening of the cell 
wall but, in contrast to other drugs, this effect was not exerted through a direct interaction 
with the cell wall structure. Moreover, the caffeine-induced remodeling of the cell wall did 
not occur through the usual Rlm1p-mediated way but it required some other transcription 
factors like Crz1p, Swi4p and Msn2/4p. Interestingly, a genome-wide expression analysis 
revealed a striking resemblance of the caffeine-induced transcription profile to the profile 
elicited by rapamycin, a potent inhibitor of the Tor1 and Tor2 kinases. Consistently, we found 
that the tor1∆ mutant was hypersensitive to caffeine and unable to induce phosphorylation of 
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 Mpk1p when treated with this drug. Another effect of caffeine was a rapid but transient 
decrease in the intracellular level of cAMP that was followed by changes in the expression of 
genes belonging to the cAMP signaling cascade. Finally, we have identified Rom2p, a 
component of the cell wall integrity pathway, as a pivotal protein mediating caffeine-derived 
signaling to Mpk1 kinase as well as to the cAMP signaling pathway. Altogether, we report 
here a number of results that bear on the relationship between the cell wall integrity, the TOR 
pathway and the cAMP signaling cascade that together control the growth of the fungal cell in 
response to stressing conditions. 
In the second part of this work, we investigated the regulation of the isoprenoid 
pathway that biosynthesizes ergosterol in eukaryotic cells. We have applied a novel approach 
to identify genes whose expression could be regulated by availability of the farnesyl 
diphosphate, a molecule that is crucial not only for the biosynthesis of ergosterol but also for 
other isoprenoid compounds and the feedback regulation of the isoprenoid pathway. Thus, we 
treated yeast cells with two drugs, lovastatin and zaragozic acid, both known to have the same 
reducing effect on the amount of ergosterol with opposite effects on the cellular availability of 
farnesyl diphosphate. We have analyzed changes in the genome-wide expression in response 
to these agents and we identified the 26S proteasome-regulated protein degradation and tRNA 
biosynthesis as primarily affected processes. Further, we identified 59 genes whose 
expression was presumably regulated by the changing availability of farnesyl diphosphate. 
Among these genes, we have chosen YTA7, a gene encoding an AAA ATPase of unknown 
function and investigated its functional link to the isoprenoid pathway. We have characterized 
Yta7p as a membrane-associated protein localized to the nucleus but also to the endoplasmic 
reticulum. We observed that depletion of Yta7p affected the cellular levels of some isoprenoid 
compounds. Moreover, we presented a genetic evidence of an interaction between YTA7 and 
HMG1 coding for 3-hydroxy-3-methylglutaryl coenzyme A reductase, a tightly regulated 
enzyme of the early steps of the isoprenoid pathway. To conclude, we propose that Yta7p is a 
novel protein that affects the isoprenoid pathway. 
Altogether, these results bring a new insight into the fungal response to the 
interruption of the cell wall biosynthesis and the isoprenoid pathway by various drugs. We 
believe that in the future, these data can be useful in identifying novel targets for antifungal 
drugs. 
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 Common Abbreviations: 
 
 
 
CAF - caffeine 
cAMP – cyclic 3’,5’ adenosine monophosphate 
CFW – Calcofluor white 
cis-PT – cis-prenyltransferase 
CR – Congo red 
CWI – cell wall integrity 
CWP – cell wall protein 
DMAPP – dimethylallyl diphosphate 
ER – endoplasmic reticulum 
FPP – farnesyl diphosphate 
FPPS – farnesyl diphosphate synthase 
GAP – GTPase activating proteins 
GEF - guanosine nucleotide exchange factor 
HMG-CoA – 3-hydroxy-3-methylglutaryl coenzyme A 
HMGR - HMG-CoA reductase 
IC50 – concentration of the drug that causes a 50 % reduction of the growth rate 
‘non-inhibitory’ concentration – concentration that exerts less than 10% of the IC50 value 
‘inhibitory’ concentration – concentration that exerts twofold of IC50 value 
IP – isoprenoid 
IPP – isopentenyl diphosphate 
MAP – mitogen-activated protein 
MIC – minimal inhibitory concentration 
Lo – lovastatin 
OD600 – optical density measured at 600nm 
PKA – cAMP-dependent protein kinase A 
SQ – squalene 
SQS – squalene synthase 
TOR – target of rapamycin 
ZA – zaragozic acid 
 
 
Other abbreviations are defined in the text. 
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 Table A 1: The genes implicated in cell wall remodeling, whose expression changed in response to CR, 
CFW or CAF - comparision with other published conditions 
ORF Gene Ratio of expression Fingerprint of cell 
wall stress 
Description 
  CFW1 CFW2 CR1 CR2 CAF1 CAF2 1CW 2CR 3CFW  
YKL096W CWP1 3.63 3.88 4.27 5.68 - - * * * Cell wall 
mannoprotein 
YFL014W HSP12 3.92 4.12 1.6 1.76 - 11.1 * * * Response to stress 
YKR091W SRL3 2.26 1.88 1.75 2.52 - - * * * Function unknown 
YAL053W  1.89 2.27 1.44 1.88 - 2.24 * * * Function unknown 
YLR414C  1.58 2.47 - - - - * * * Function unknown 
YMR315W  1.79 1.99 1.48 1.74 - - * * * Function unknown 
YLR194C  - 3.07 2.05 2.31 - - * * * Function unknown 
YBR071W  1.67 2.02 1.59 1.49 - - * * * Function unknown 
YJL108C PRM10 - - 1.5 1.62 - - * * * Pheromone-
regulated protein 
YNL058C  1.8 1.78 2.18 2.4 - - * *  Function unknown 
YHR097C  1.46 1.86 1.66 1.9 - - * *  Function unknown 
YLR121C YPS3 - 1.82 1.63 1.62 - - * *  GPI-anchored 
aspartic protease 
YKL164C PIR1 2.1 2.04 2.37 2.25 - -  * * Structural 
constituent of cell 
wall 
YJL159W PIR2 2.55 3.8 2.84 2.24 - -  * * Structural 
constituent of cell 
wall 
YKL163W PIR3 5.44 5.9 4.6 5.56 - -  * * Structural 
constituent of cell 
wall 
YCL040W GLK1 1.99 1.8 1.52  - - * *  Glucokinase 
YHR142W CHS7 - 1.72 1.55 1.68 - 2.9 * *  Involved in chitin 
synthesis 
YKR013W PRY2 - 1.64 - 1.6 - -  *  Function unknown 
YHR209W  3.23 2.97 2.28 3.24 - -  *   S-
adenosylmethionine-
dependent 
methyltransferase  
YDL072C YET3 1.71 1.85 1.52 1.65 - - *   Function unknown 
YOL052CA DDR2 - 1.56 - - - -   * Response to stress 
YPR030W CSR2 1.51 - - - - -    Chs5 Spa2 Rescue 
YDR483W KRE2 - - - 1.67 - 1.5    α-1.2-
mannosyltransferase 
YBL061C SKT5 - - - 1.61 - 1.95    Activator of Chs3p 
YPR159W KRE6 - - - - - 2.1  *  1,6-β-glucan 
synthase  
YIL146C ECM37 - - - - - 2.0    Function unknown 
YMR062C ECM40 - - - - - 1.5    acetylornithine 
acetyltransferase 
YGR032W GSC2 - - - - - 3.3 * *  1.3-β-glucan 
synthase  
YDR528W HLR1 - - - - - 0.59    Function unknown 
YGR059W SPR3 - - - - - 0.54    septin 
YAL059W ECM1 - - - - - 0.57    Function unknown 
Values correspond to the ratio of expression after 90 minutes of incubation with Congo red (CR1, 20 µg/ml; 
CR2, 100 µg/ml), Calcofluor white (CFW1, 20 µg/ml; CFW2, 100 µg/ml) and caffeine (CAF1, 2 mM; CAF2, 
20 mM). ‘-‘ indicates no significant changes in expression. An asterisk indicates activation of these genes in the 
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 independent studies of the yeast cell wall. 1CW - genes upregulated in the following cell wall mutants fks1∆, 
kre6∆, mnn9∆, gas1∆ and knr4∆ (Martin-Yken et al., 2003); 2CR -genes induced after 2, 4 and 6 hours of 
treatment with 30 µg/ml CR (Garcia et al., 2004); 3CFW -genes induced after 2 hours of treatment with 10 
µg/ml CFW (Boorsma et al., 2004). 
 
 
 
 
 
 
 
Table A 2: Pathways potentially triggered by CR, CFW, CAF and rapamycin as indicated by the 
induction of genes regulated by a given transcription factors (TF)
Congo red Calcofluor white Caffeine Rapamycin*Pathway regulated by a given 
transcription factor (TF) 
%G %F %G %F %G %F %G %F 
Ehrlich pathway 
(Aro80p) 
0 0 1.96 3.3 2.9 16.7 2.4 10.0 
Arginine metabolism 
(Arg80p) 
0 0 0 0 1.7 15.8 2.4 15.8 
TCA cycle and retrograde pathway 
(Rtg1/3p) 
0 0 0 0 4.1 15.6 6.4 17.8 
Nitrogen catabolite repression pathway 
(Gat1p & Gln3p) 
0 0 4.0 7.4 5.8 29.7 26.8 98.4 
General stress response 
(Msn2p & Msn4p) 
7.7 1.1 9.8 2.6 14.1 12.9 23.4 15.6 
Cell wall remodeling 
(Rlm1p) 
23 10.4 15.7 13.8 1.7 5.2 8.1 17.2 
Calcium-calcineurin pathway 
(Crz1p) 
15.3 2.7 13.7 4.8 8.2 9.5 12.9 10.9 
The %G value corresponded to the percentage of genes regulated by a given transcription factor (TF) relative to 
the number of all upregulated genes in the given conditions. The %F value corresponded to the percentage of 
genes regulated by a given transcription factor (TF) relative to the number of genes in the whole yeast genome 
that are regulated by this transcription factor. Only documented (published) regulations were taken into account 
of this analysis. *Data used for YEASTRACT analysis were from Hardwick et al. (Hardwick et al., 1999). 
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Caffeine (CAF)
Papulacandin B (PAP) Congo red (CR)
Calcofluor white (CFW)
Lovastatin (Lo)Zaragozic acid (ZA)
Figure A 1: 2D structures of the chemical compounds tested in this study. Abbreviations of their names, 
which were used in this study, are given in parentheses. 
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